We leverage our core strengths in innovation and technology with a robust intellectual property portfolio - also referred to as Intellectual Property Rights - that includes patents, trademarks, trade secrets, know-how, and technology licenses. This intellectual property portfolio enables us to enhance and leverage our competitive position and the commercial exploitability of its technologies, and to generate benefits for itself and its customers.
To that end we are committed to protecting our core innovation and technology by actively pursuing patent protection for the inventions arising from its research and development activities. By navigating the drop-down menu below, you will find a detailed breakdown of our patent assets.
For questions related to intellectual property and Lonza, please Contact Us.
Patent Portfolio - Pharma Biotech & Nutrition
| Business Sector | Title | Technology Type | Country | Patent Number |
|---|---|---|---|---|
| Pharma Biotech & Nutrition (LPBN) | Immunoglobulin Variants | AggreSolve™ Screening Technology | Japan | 5901522 |
| Pharma Biotech & Nutrition (LPBN) | Immunoglobulin Variants | AggreSolve™ Screening Technology | United States | 8951516 |
| Pharma Biotech & Nutrition (LPBN) | Immunoglobulin Variants | AggreSolve™ Screening Technology | United States | 9290563 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Austria | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Belgium | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Switzerland | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | China | ZL201280010479.6 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | China | ZL 201510163661.0 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Czechia | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Germany | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Denmark | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Spain | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Finland | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | France | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | United Kingdom | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Hong Kong | 1186668 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Hong Kong | 1213773 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Hungary | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Ireland | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Italy | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Japan | 5559439 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Japan | 6169520 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Netherlands | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Norway | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Poland | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Sweden | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | Turkey | 2678037 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | United States | 10294270 |
| Pharma Biotech & Nutrition (LPBN) | Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | United States | 10214560 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Forms Comprising A Cetp Inhibitors And An Hmg-Coa Reductase Inhibitor | ASD Compositions | United States | 7897175 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | Germany | 60320940.8 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | Germany | 1920766 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | France | 1469832 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | France | 1920766 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | United Kingdom | 1469832 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | United Kingdom | 1920766 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | United States | 9486410 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | United States | 10357455 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers | ASD Compositions | United States | 9468604 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Drugs And Neutralized Acidic Polymers | ASD Compositions | United States | 8147872 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Drugs And Neutralized Acidic Polymers | ASD Compositions | United States | 8173142 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions With Enhanced Performance | ASD Compositions | United States | 8207232 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions With Enhanced Performance | ASD Compositions | United States | 8940800 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | Germany | 602007008470.9 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | France | 2101741 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | United Kingdom | 2101741 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | Ireland | 2101741 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | Belgium | 2956121 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | Germany | 602014026156.6 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | France | 2956121 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | United Kingdom | 2956121 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | Japan | 6396333 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | United States | 9737538 |
| Pharma Biotech & Nutrition (LPBN) | Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | United States | 10322126 |
| Pharma Biotech & Nutrition (LPBN) | Spray Dried Formulation | ASD Compositions | United States | 8372836 |
| Pharma Biotech & Nutrition (LPBN) | Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs, Poloxamers And Stabilizing Polymers | ASD Compositions | Germany | 602004031767.5 |
| Pharma Biotech & Nutrition (LPBN) | Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs, Poloxamers And Stabilizing Polymers | ASD Compositions | France | 1701703 |
| Pharma Biotech & Nutrition (LPBN) | Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs, Poloxamers And Stabilizing Polymers | ASD Compositions | United Kingdom | 1701703 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Belgium | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Czechia | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Germany | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Spain | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | France | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | United Kingdom | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Italy | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Japan | 6219836 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Japan | 6836977 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Netherlands | 2776016 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | United States | 9980918 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | Belgium | 1942878 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | Germany | 602006041222.3 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | Spain | 1942878 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | France | 1942878 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | United Kingdom | 1942878 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | Italy | 1942878 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | Japan | 5522937 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsules - Banding | Netherlands | 1942878 |
| Pharma Biotech & Nutrition (LPBN) | Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (HPMC) As A Base | Capsules - Banding | United States | 9579290 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Carrier | Capsules - Fill Formulations | Germany | 602010025605.7 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Carrier | Capsules - Fill Formulations | France | 2498760 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Carrier | Capsules - Fill Formulations | United Kingdom | 2498760 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Carrier | Capsules - Fill Formulations | United States | 9333177 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Filled Delivery System | Capsules - Fill Formulations | United States | 8795720 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Belgium | 3167880 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Germany | 3167880 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | France | 3167880 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | United Kingdom | 3167880 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsules - Banding | Japan | 6768060 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Belgium | 2625509 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Belgium | 3021108 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | China | ZL201180059062.4 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Germany | 602011021060.2 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Germany | 3021108 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Spain | 2625509 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Spain | 3021108 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | France | 2625509 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | France | 3021108 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United Kingdom | 2625509 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United Kingdom | 3021108 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Italy | 2625509 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Italy | 3021108 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Japan | 6000260 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Netherlands | 2625509 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Netherlands | 3021108 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United States | 9414027 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United States | 9575011 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United States | 10113977 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Belgium | 2049313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Canada | 2660041 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Germany | 602007043597.8 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | France | 2049313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | United Kingdom | 2049313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Japan | 5128596 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Mexico | 298203 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | United States | 8398912 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus for and Method of Sealing Capsules | Capsule Manufacturing Process & Equipment | Germany | 602004027364.3 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus for and Method of Sealing Capsules | Capsule Manufacturing Process & Equipment | France | 1459725 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus for and Method of Sealing Capsules | Capsule Manufacturing Process & Equipment | United Kingdom | 1617800 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | Belgium | 2358328 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | France | 2358328 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | United Kingdom | 2358328 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | Japan | 5642081 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | Mexico | 316978 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | United States | 8646591 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus for Sealing a Pharmaceutically Acceptable Hard Shell Capsule | Capsule Manufacturing Process & Equipment | United States | 8491298 |
| Pharma Biotech & Nutrition (LPBN) | Gelatin Capsules And Gelatin Compositions For Forming Capsule Coating | Capsule Manufacturing Process & Equipment | Japan | 5766205 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Pump | Capsule Manufacturing Process & Equipment | Belgium | 2185817 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Pump | Capsule Manufacturing Process & Equipment | Germany | 602008050408.5 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Pump | Capsule Manufacturing Process & Equipment | France | 2185817 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Pump | Capsule Manufacturing Process & Equipment | United Kingdom | 2185817 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Pump | Capsule Manufacturing Process & Equipment | Italy | 2185817 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Pump | Capsule Manufacturing Process & Equipment | Japan | 5452488 |
| Pharma Biotech & Nutrition (LPBN) | Liquid Pump | Capsule Manufacturing Process & Equipment | Mexico | 324362 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Belgium | 2049064 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Brazil | PI0715125-0 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Canada | 2660037 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | China | 200780029122.1 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Germany | 602007009693.6 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Spain | 2049064 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | France | 2049064 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | United Kingdom | 2049064 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Italy | 2049064 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Japan | 5197596 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Mexico | 291834 |
| Pharma Biotech & Nutrition (LPBN) | Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | United States | 8181425 |
| Pharma Biotech & Nutrition (LPBN) | Method of Sealing a Hard Shell Capsule | Capsule Manufacturing Process & Equipment | United States | 7645407 |
| Pharma Biotech & Nutrition (LPBN) | Sealing Clamp for Capsule Sealing + | Capsule Manufacturing Process & Equipment | Mexico | 265293 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | Belgium | 2457551 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | Germany | 602007027363.3 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | Germany | 602007040166.6 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | Spain | 2457551 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | France | 2083787 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | France | 2457551 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | United Kingdom | 2457551 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | Italy | 2457551 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | Mexico | 301695 |
| Pharma Biotech & Nutrition (LPBN) | Transfer Line | Capsule Manufacturing Process & Equipment | United States | 8671650 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Austria | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Belgium | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Canada | 2775227 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | China | 201080042764.7 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Czechia | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Germany | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Denmark | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Spain | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | France | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | United Kingdom | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | India | 342484 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Italy | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Japan | 5777625 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Korea, Republic of | 10-1762460 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Mexico | 334274 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Netherlands | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | Poland | 2480218 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | United States | 8852631 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | United States | 9700517 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | United States | 10231934 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Capsules | Capsule Material (alternate poly.) | United States | 10874619 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | Japan | 6306573 |
| Pharma Biotech & Nutrition (LPBN) | Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | Japan | 6598841 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | Belgium | 3219300 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | Germany | 3219300 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | Spain | 3219300 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | France | 3219300 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | United Kingdom | 3219300 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | Italy | 3219300 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | Netherlands | 3219300 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | United States | 10751255 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Comprising A Print Or Label (Dotted Lines) | Capsules | European Union | 003108505-0001 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Comprising A Print Or Label (Dotted Lines) | Capsules | European Union | 003108505-0002 |
| Pharma Biotech & Nutrition (LPBN) | Colloidal Dispersion Comprising HPMCAS | Capsules | United States | 10471152 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | Belgium | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | Switzerland | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | Germany | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | Spain | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | France | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | United Kingdom | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | Italy | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | Netherlands | 3199148 |
| Pharma Biotech & Nutrition (LPBN) | Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | United States | 10,603,286 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles | Capsules | Belgium | 3076954 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles | Capsules | Germany | 3076954 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles | Capsules | France | 3076954 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles | Capsules | United Kingdom | 3076954 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles | Capsules | United States | 9980905 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for Delayed Release | Capsules | Belgium | 3028694 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for Delayed Release | Capsules | Germany | 602014011687 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for Delayed Release | Capsules | France | 3028694 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for Delayed Release | Capsules | United Kingdom | 3028694 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for Delayed Release | Capsules | United States | 10555908 |
| Pharma Biotech & Nutrition (LPBN) | Hard Capsule Formulation | Capsules | Japan | 6420261 |
| Pharma Biotech & Nutrition (LPBN) | Hard Capsule Formulation | Capsules | United States | 10172803 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Belgium | 2777802 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Belgium | 3077086 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Canada | 2932562 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Germany | 602013005497.5 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Germany | 602014018609.2 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | France | 2777802 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | France | 3077086 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | United Kingdom | 2777802 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | United Kingdom | 3077086 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Japan | 6082850 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Netherlands | 2777802 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | Netherlands | 3077086 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartment Dosage Form Articles | Capsules | United States | 9561189 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartmented Container | Capsules | Belgium | 2211820 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartmented Container | Capsules | Germany | 602008015434.3 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartmented Container | Capsules | France | 2211820 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartmented Container | Capsules | United Kingdom | 2211820 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartmented Container | Capsules | Japan | 5667874 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartmented Container | Capsules | United States | 8968717 |
| Pharma Biotech & Nutrition (LPBN) | Multi-Compartmented Container | Capsules | United States | 9456990 |
| Pharma Biotech & Nutrition (LPBN) | Print or Label for a Capsule Surface (Vertical) | Capsules | European Union | 003107515-0001 |
| Pharma Biotech & Nutrition (LPBN) | Print or Label for a Capsule Surface (Vertical) | Capsules | European Union | 003107515-0002 |
| Pharma Biotech & Nutrition (LPBN) | Printing Process For Oral Dosage Forms | Capsules | Belgium | 3365180 |
| Pharma Biotech & Nutrition (LPBN) | Printing Process For Oral Dosage Forms | Capsules | Germany | 3365180 |
| Pharma Biotech & Nutrition (LPBN) | Printing Process For Oral Dosage Forms | Capsules | Spain | 3365180 |
| Pharma Biotech & Nutrition (LPBN) | Printing Process For Oral Dosage Forms | Capsules | France | 3365180 |
| Pharma Biotech & Nutrition (LPBN) | Printing Process For Oral Dosage Forms | Capsules | United Kingdom | 3365180 |
| Pharma Biotech & Nutrition (LPBN) | Printing Process For Oral Dosage Forms | Capsules | Italy | 502020000023740 |
| Pharma Biotech & Nutrition (LPBN) | Printing Process For Oral Dosage Forms | Capsules | United States | 10661301 |
| Pharma Biotech & Nutrition (LPBN) | Separable Capsule | Capsules | Canada | 2900305 |
| Pharma Biotech & Nutrition (LPBN) | Separable Capsule | Capsules | Japan | 6436977 |
| Pharma Biotech & Nutrition (LPBN) | Separable Capsule | Capsules | United States | 9775813 |
| Pharma Biotech & Nutrition (LPBN) | Separable Capsule | Capsules | United States | 10568838 |
| Pharma Biotech & Nutrition (LPBN) | Separable Capsule For Sprinkling Applications | Capsules | United States | 10610490 |
| Pharma Biotech & Nutrition (LPBN) | Sprinkle Design | Capsules | European Union | 002542522-0001 |
| Pharma Biotech & Nutrition (LPBN) | Sprinkle Design | Capsules | European Union | 002542522-0002 |
| Pharma Biotech & Nutrition (LPBN) | Sprinkle Design | Capsules | European Union | 002542522-0003 |
| Pharma Biotech & Nutrition (LPBN) | Sprinkle Design | Capsules | European Union | 002542522-0004 |
| Pharma Biotech & Nutrition (LPBN) | Sprinkle Design | Capsules | European Union | 002542522-0005 |
| Pharma Biotech & Nutrition (LPBN) | Sprinkle Design | Capsules | European Union | 002542522-0006 |
| Pharma Biotech & Nutrition (LPBN) | Sprinkle Design | Capsules | European Union | 002542522-0007 |
| Pharma Biotech & Nutrition (LPBN) | Tamperproof Oral Dosage Form | Capsules | United States | 10470975 |
| Pharma Biotech & Nutrition (LPBN) | Tamperproof Oral Dosage Form | Capsules | United States | 10709640 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | Belgium | 1868585 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | Switzerland | 1868585 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | Germany | 502019000096921 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | Spain | 1868585 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | France | 1868585 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | United Kingdom | 1868585 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | Italy | 1868585 |
| Pharma Biotech & Nutrition (LPBN) | Abuse Resistant Capsules | Capsules - Abusolve® Abuse Deterrent Technology | Netherlands | 1868585 |
| Pharma Biotech & Nutrition (LPBN) | Immediate Release Abuse Deterrent Formulations | Capsules - Abusolve® Abuse Deterrent Technology | United States | 10632201 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Device | Capsules - DUOCAP® capsules | Belgium | 1301178 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Device | Capsules - DUOCAP® capsules | Germany | 60126089.9 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Device | Capsules - DUOCAP® capsules | France | 1301178 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Device | Capsules - DUOCAP® capsules | United Kingdom | 1301178 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Device | Capsules - DUOCAP® capsules | Italy | 1301178 |
| Pharma Biotech & Nutrition (LPBN) | Delivery Device,Method Of Using And Method Of Manufacturing | Capsules - DUOCAP® capsules | United States | 7445795 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | Belgium | 2844297 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | Canada | 2870033 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | Germany | 2844297 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | Spain | 2844297 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | France | 2844297 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | United Kingdom | 2844297 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | Italy | 2844297 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | Japan | 6626712 |
| Pharma Biotech & Nutrition (LPBN) | Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | United States | 10525010 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Belgium | 2632584 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Belgium | 2722104 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | China | ZL201180061971.1 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Germany | 602011040483 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Germany | 2722104 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | France | 2632584 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | France | 2722104 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | United Kingdom | 2632584 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | United Kingdom | 2722104 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Ireland | 2632584 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Ireland | 2722104 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Italy | 2632584 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Italy | 2722104 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Japan | 5890428 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Korea, Republic of | 10-1900966 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Netherlands | 2632584 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | Netherlands | 2722104 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | United States | 9198868 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | United States | 9925148 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | United States | 10463625 |
| Pharma Biotech & Nutrition (LPBN) | Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | United States | 10898440 |
| Pharma Biotech & Nutrition (LPBN) | Enteric Coating For Soft Capsule | Capsules - Enteric Capsule Technologies | United States | 10660859 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formulation Comprising Bifidobacterium Bacteria and the Production Method Thereof | Capsules - Fill Formulations | Japan | 6297441 |
| Pharma Biotech & Nutrition (LPBN) | Curcumin Solid Lipid Particles and Methods for their Preparation and Use | Capsules - Fill Formulations | United States | 10166187 |
| Pharma Biotech & Nutrition (LPBN) | Fill Formulations And Capsules And Method Of Use To Avoid Mirgration Of Fill Into Or Through The Shell | Capsules - Fill Formulations | Belgium | 2750600 |
| Pharma Biotech & Nutrition (LPBN) | Fill Formulations And Capsules And Method Of Use To Avoid Mirgration Of Fill Into Or Through The Shell | Capsules - Fill Formulations | Germany | 602012031104.5 |
| Pharma Biotech & Nutrition (LPBN) | Fill Formulations And Capsules And Method Of Use To Avoid Mirgration Of Fill Into Or Through The Shell | Capsules - Fill Formulations | France | 2750600 |
| Pharma Biotech & Nutrition (LPBN) | Fill Formulations And Capsules And Method Of Use To Avoid Mirgration Of Fill Into Or Through The Shell | Capsules - Fill Formulations | United Kingdom | 2750600 |
| Pharma Biotech & Nutrition (LPBN) | Methods And Systems For Improved Bioavailability Of Active Pharmaceutical Ingredients Including Esomeprazole | Capsules - Fill Formulations | United States | 10813886 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions | Capsules - Fill Formulations | United States | 9241940 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | Belgium | 3151815 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | Germany | 3151815 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | Spain | 3151815 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | France | 3151815 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | United Kingdom | 3151815 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | Italy | 3151815 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | Netherlands | 3151815 |
| Pharma Biotech & Nutrition (LPBN) | Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXL™ capsules | United States | 10016369 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Belgium | 1915121 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Brazil | PI 0614735-6 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Canada | 2617967 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | China | ZL201210011817.X |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Germany | 602006038698.2 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Spain | 1915121 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | France | 1915121 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | United Kingdom | 1915121 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | India | 272531 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Italy | 1915121 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Japan | 4422779 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Japan | 5006913 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Mexico | 309351 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | Netherlands | 1915121 |
| Pharma Biotech & Nutrition (LPBN) | Container | Capsules - Licaps® capsules | United States | 8377471 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Belgium | 2276445 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Canada | 2722271 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | China | 200980117292.4 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Germany | 602009008078.4 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Spain | 2276445 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | France | 2276445 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | United Kingdom | 2276445 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Italy | 2276445 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Japan | 5716212 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Korea, Republic of | 1012359510000 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Mexico | 315642 |
| Pharma Biotech & Nutrition (LPBN) | Improved Capsule with Air-Vents | Capsules - Licaps® capsules | United States | 8715722 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | Belgium | 3025709 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | Germany | 3025709 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | France | 3025709 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | United Kingdom | 3025709 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | Japan | 6706254 |
| Pharma Biotech & Nutrition (LPBN) | Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | United States | 10525011 |
| Pharma Biotech & Nutrition (LPBN) | Hard Capsules | Capsules - Plantcaps® capsules | United States | 10130587 |
| Pharma Biotech & Nutrition (LPBN) | Hard Capsules | Capsules - Plantcaps® capsules | United States | 10568839 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Belgium | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Germany | 602012011096.1 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Spain | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | France | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | United Kingdom | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Ireland | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Italy | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Japan | 5860480 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Netherlands | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | Portugal | 2663294 |
| Pharma Biotech & Nutrition (LPBN) | Colored Rigid Capsule | Capsules - Press-Fit™ | Japan | 4141732 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | Belgium | 1539114 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | Canada | 2494045 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | Germany | 60335991.4 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | Spain | 1539114 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | France | 1539114 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | United Kingdom | 1539114 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | Japan | 4652052 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | United States | 7914820 |
| Pharma Biotech & Nutrition (LPBN) | Film Coating For Tablets And Caplets | Capsules - Press-Fit™ | United States | 8557294 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Belgium | 2083786 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Canada | 2667531 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | China | 200780040046.4 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Germany | 602007011963.4 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Spain | 2357452 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | France | 2083786 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | United Kingdom | 2083786 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Italy | 2083786 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Japan | 5452227 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Korea, Republic of | 1183713 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | Mexico | 298202 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | United States | 9138920 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formation | Capsules - Vcaps® capsules | United States | 9211659 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Belgium | 2078042 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | China | 200780040028.6 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Germany | 2078042 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Spain | 2078042 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | France | 2078042 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | United Kingdom | 2078042 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | India | 288423 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Italy | 2078042 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Japan | 5372761 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Korea, Republic of | 1011702830000 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Mexico | 315891 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Netherlands | 2078042 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | United States | 10004692 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | United States | 9655860 |
| Pharma Biotech & Nutrition (LPBN) | Hydroxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Canada | 2667167 |
| Pharma Biotech & Nutrition (LPBN) | Hyrdorxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Brazil | PI0717123-4 |
| Pharma Biotech & Nutrition (LPBN) | Hyrdorxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Indonesia | IDP000039591 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | Belgium | 1440005 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | France | 1440005 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | United Kingdom | 1440005 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | United States | 7712634 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | Germany | 60333075.4 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | France | 1472138 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | United Kingdom | 1472138 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Method Of Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | United States | 7665633 |
| Pharma Biotech & Nutrition (LPBN) | Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | Germany | 602005010081.4 |
| Pharma Biotech & Nutrition (LPBN) | Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | Spain | 1765673 |
| Pharma Biotech & Nutrition (LPBN) | Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | France | 1765673 |
| Pharma Biotech & Nutrition (LPBN) | Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | United Kingdom | 1765673 |
| Pharma Biotech & Nutrition (LPBN) | Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | Italy | 1765673 |
| Pharma Biotech & Nutrition (LPBN) | Dispensing Small Quantities Of Particles | Capsules - Xcelodose™ System | United States | 8074835 |
| Pharma Biotech & Nutrition (LPBN) | Weighing Apparatus | Capsules - Xcelodose™ System | Germany | 602005040670 |
| Pharma Biotech & Nutrition (LPBN) | Weighing Apparatus | Capsules - Xcelodose™ System | France | 1792148 |
| Pharma Biotech & Nutrition (LPBN) | Weighing Apparatus | Capsules - Xcelodose™ System | United Kingdom | 1792148 |
| Pharma Biotech & Nutrition (LPBN) | Weighing Apparatus | Capsules - Xcelodose™ System | Japan | 5420684 |
| Pharma Biotech & Nutrition (LPBN) | Weighing Apparatus With Improved Cleaning Capabilities | Capsules - Xcelodose™ System | United States | 7834279 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Switzerland | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | China | 102651974 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Czechia | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Germany | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Spain | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | France | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | United Kingdom | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | India | 295113 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Italy | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Japan | 5911806 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Japan | 6239579 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Korea, Republic of | 10-1761958 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Netherlands | 2509436 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | Taiwan, Province of China | I469797 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | United States | 8470382 |
| Pharma Biotech & Nutrition (LPBN) | Carnitine Granulate and Methods for its Production | CARNIKINGTM L-carnitine | United States | 9066868 |
| Pharma Biotech & Nutrition (LPBN) | Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | CARNIKINGTM L-carnitine | United States | 10016382 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Switzerland | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | China | ZL201180019495.7 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Czechia | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Germany | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Spain | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | France | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | United Kingdom | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | India | 292185 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Italy | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Japan | 6018046 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Korea, Republic of | 10-1848763 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Netherlands | 2569275 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | Taiwan, Province of China | I519505 |
| Pharma Biotech & Nutrition (LPBN) | A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | United States | 8431741 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Switzerland | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | China | 201080051331.8 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Czechia | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Germany | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Spain | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | France | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | United Kingdom | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | India | 308637 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Italy | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Japan | 6234030 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Korea, Republic of | 10-1823971 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Netherlands | 2501673 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | Taiwan, Province of China | I485126 |
| Pharma Biotech & Nutrition (LPBN) | Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | United States | 8604237 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | China | 200880117375.9 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | Germany | 60 2008 009 662.9 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | Spain | 2231587 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | India | 271284 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | Italy | 2231587 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | Japan | 5155406 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | Korea, Republic of | 1132589 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | Taiwan, Province of China | I400223 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Preparation of Betaines | Carnipure® L-Carnitine | United States | 8168823 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | Switzerland | 2702032 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | China | ZL1280020003.0 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | Czechia | 2702032 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | Germany | 2702032 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | France | 2702032 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | United Kingdom | 2702032 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | India | 308970 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | Italy | 2702032 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | Japan | 6012709 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | Taiwan, Province of China | I548619 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | United States | 9227905 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Switzerland | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | China | ZL201180042646.0 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Czechia | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Germany | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Spain | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | France | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | United Kingdom | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | India | 293603 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Italy | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Japan | 5964831 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Korea, Republic of | 10-1899015 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Netherlands | 2613778 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | Taiwan, Province of China | I574938 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | United States | 8779188 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | Switzerland | 2393578 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | China | ZL201080006621.0 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | Germany | 2393578 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | France | 2393578 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | United Kingdom | 2393578 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | Japan | 6242565 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | Korea, Republic of | 10-1728562 |
| Pharma Biotech & Nutrition (LPBN) | Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | United States | 9415346 |
| Pharma Biotech & Nutrition (LPBN) | Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnipure® L-Carnitine | Japan | JP6608858 |
| Pharma Biotech & Nutrition (LPBN) | Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnipure® L-Carnitine | United States | 10130602 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | China | ZL 201010262857.2 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | Czechia | 1901715 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | Germany | 60 2006 029 269.4 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | Spain | 2385046 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | France | 1901715 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | United Kingdom | 1901715 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | Italy | 1901715 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | Japan | 5149172 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | Korea, Republic of | 1327700 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | Netherlands | 1901715 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | United States | 9084431 |
| Pharma Biotech & Nutrition (LPBN) | Scalable Process for Therapeutic Cell Concentration and Residual Clearance | Cell and Gene Therapies | United States | 10385307 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Switzerland | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Germany | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Spain | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | France | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | United Kingdom | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Italy | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Netherlands | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Sweden | 2761024 |
| Pharma Biotech & Nutrition (LPBN) | Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | United States | 9512474 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Australia | 2016238891 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Australia | 2012255724 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Canada | 2836578 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Switzerland | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Germany | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Spain | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | France | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | United Kingdom | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Israel | 229462 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | India | 355450 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Italy | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Japan | 6140149 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Korea, Republic of | 10-1970368 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Netherlands | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Sweden | 2718424 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | United States | 10487312 |
| Pharma Biotech & Nutrition (LPBN) | Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | United States | 9885019 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Switzerland | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | China | 201480063730.4 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Germany | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Spain | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | France | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | United Kingdom | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Italy | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Japan | 6479775 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Netherlands | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Sweden | 3047020 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | United States | 10745668 |
| Pharma Biotech & Nutrition (LPBN) | Bio-Artificial Materials with Tuneable Properties | CellBio Services | Switzerland | 2184078 |
| Pharma Biotech & Nutrition (LPBN) | Bio-Artificial Materials with Tuneable Properties | CellBio Services | China | ZL200680050640.7 |
| Pharma Biotech & Nutrition (LPBN) | Bio-Artificial Materials with Tuneable Properties | CellBio Services | Germany | 2184078 |
| Pharma Biotech & Nutrition (LPBN) | Bio-Artificial Materials with Tuneable Properties | CellBio Services | France | 2184078 |
| Pharma Biotech & Nutrition (LPBN) | Bio-Artificial Materials with Tuneable Properties | CellBio Services | United Kingdom | 2184078 |
| Pharma Biotech & Nutrition (LPBN) | Bio-Artificial Materials with Tuneable Properties | CellBio Services | Japan | 5192387 |
| Pharma Biotech & Nutrition (LPBN) | Bio-Artificial Materials with Tuneable Properties | CellBio Services | United States | 8343758 |
| Pharma Biotech & Nutrition (LPBN) | Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | Switzerland | 2197504 |
| Pharma Biotech & Nutrition (LPBN) | Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | Germany | 2197504 |
| Pharma Biotech & Nutrition (LPBN) | Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | France | 2197504 |
| Pharma Biotech & Nutrition (LPBN) | Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | United Kingdom | 2197504 |
| Pharma Biotech & Nutrition (LPBN) | Biomimetic Cell Scaffolds | CellBio Services | Switzerland | 2291512 |
| Pharma Biotech & Nutrition (LPBN) | Biomimetic Cell Scaffolds | CellBio Services | Germany | 2291512 |
| Pharma Biotech & Nutrition (LPBN) | Biomimetic Cell Scaffolds | CellBio Services | France | 2291512 |
| Pharma Biotech & Nutrition (LPBN) | Biomimetic Cell Scaffolds | CellBio Services | United Kingdom | 2291512 |
| Pharma Biotech & Nutrition (LPBN) | Biomimetic Cell Scaffolds | CellBio Services | United States | 8580564 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | Switzerland | 2175897 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | China | ZL200880103049.2 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | Germany | 2175897 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | France | 2175897 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | United Kingdom | 2175897 |
| Pharma Biotech & Nutrition (LPBN) | Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | United States | 8449902 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate™ Ingredient | Australia | 2002351456 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate™ Ingredient | Mexico | 250990 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate™ Ingredient | United States | 7119110 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate™ Ingredient | United States | 7153877 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate™ Ingredient | South Africa | 2004/02688 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | Australia | 2005247967 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | Canada | 2568438 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | Switzerland | 1756262 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | Germany | 1756262 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | France | 1756262 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | United Kingdom | 1756262 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | Italy | 1756262 |
| Pharma Biotech & Nutrition (LPBN) | Advanced Tissue Engineering System | Cocoon® Platform | United States | 9499780 |
| Pharma Biotech & Nutrition (LPBN) | Automated Cell Culture System | Cocoon® Platform | Canada | 2833001 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Austria | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Australia | 2003218572 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Australia | 2009202146 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Australia | 2009202476 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Australia | 2012205259 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Belgium | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Canada | 2485350 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Canada | 2853267 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Switzerland | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Germany | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Denmark | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Spain | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Finland | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | France | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | United Kingdom | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Ireland | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Italy | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Netherlands | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | Sweden | 2330181 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | United States | 8492140 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | United States | 9701932 |
| Pharma Biotech & Nutrition (LPBN) | Automated System for Production of Tissue Engineered Products | Cocoon® Platform | United States | 9534195 |
| Pharma Biotech & Nutrition (LPBN) | Automated Tissue Engineering System | Cocoon® Platform | Japan | 6586407 |
| Pharma Biotech & Nutrition (LPBN) | Automated Tissue Engineering System | Cocoon® Platform | United States | 10723986 |
| Pharma Biotech & Nutrition (LPBN) | Automated Tissue Engineering System | Cocoon® Platform | United States | 10844338 |
| Pharma Biotech & Nutrition (LPBN) | Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | Canada | 2599823 |
| Pharma Biotech & Nutrition (LPBN) | Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | Germany | 1730267 |
| Pharma Biotech & Nutrition (LPBN) | Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | France | 1730267 |
| Pharma Biotech & Nutrition (LPBN) | Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | United Kingdom | 1730267 |
| Pharma Biotech & Nutrition (LPBN) | Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | Italy | 1730267 |
| Pharma Biotech & Nutrition (LPBN) | Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | United States | 8546142 |
| Pharma Biotech & Nutrition (LPBN) | Pectin Film Compositions | DFS Modified/Controlled/Targeted Release | United States | 7041315 |
| Pharma Biotech & Nutrition (LPBN) | Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid | DFS Modified/Controlled/Targeted Release | United States | 10188611 |
| Pharma Biotech & Nutrition (LPBN) | Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | Belgium | 3082778 |
| Pharma Biotech & Nutrition (LPBN) | Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | Germany | 3082778 |
| Pharma Biotech & Nutrition (LPBN) | Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | France | 3082778 |
| Pharma Biotech & Nutrition (LPBN) | Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | United Kingdom | 3082778 |
| Pharma Biotech & Nutrition (LPBN) | Capsule Formulation | DFS Multiparticulates | Japan | 6588193 |
| Pharma Biotech & Nutrition (LPBN) | Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Japan | 6733872 |
| Pharma Biotech & Nutrition (LPBN) | Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | United States | 10159244 |
| Pharma Biotech & Nutrition (LPBN) | Formulations To Achieve Rapid Dissolution Of Drug From Spray-Dried Dispersions In Capsules | Dosage Form | Japan | 6796083 |
| Pharma Biotech & Nutrition (LPBN) | Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | Germany | 60348508.1 |
| Pharma Biotech & Nutrition (LPBN) | Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | France | 1469829 |
| Pharma Biotech & Nutrition (LPBN) | Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | United Kingdom | 1469829 |
| Pharma Biotech & Nutrition (LPBN) | Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | United States | 9211261 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Improved Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | United States | 10801913 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Improved Container Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | United States | 10895514 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Germany | 60123030.2 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Denmark | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Spain | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | France | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | United Kingdom | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Ireland | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Italy | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Netherlands | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Sweden | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Stabilization of Highly Sensitive Nucleic Acid Stains in Aqueous Solutions | FlashGel® and Latitude® Systems/Products | Switzerland | 1272655 |
| Pharma Biotech & Nutrition (LPBN) | Continuous Reaction Micro-Reactor | FlowPlate™ Microreactor Technology | China | ZL201080017207.X |
| Pharma Biotech & Nutrition (LPBN) | Continuous Reaction Micro-Reactor | FlowPlate™ Microreactor Technology | Hong Kong | HK1164779 |
| Pharma Biotech & Nutrition (LPBN) | Continuous Reaction Micro-Reactor | FlowPlate™ Microreactor Technology | Japan | 5774580 |
| Pharma Biotech & Nutrition (LPBN) | Continuous Reaction Micro-Reactor | FlowPlate™ Microreactor Technology | United States | 9302243 |
| Pharma Biotech & Nutrition (LPBN) | Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate™ Microreactor Technology | Germany | 3031518 |
| Pharma Biotech & Nutrition (LPBN) | Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate™ Microreactor Technology | France | 3031518 |
| Pharma Biotech & Nutrition (LPBN) | Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate™ Microreactor Technology | United Kingdom | 3031518 |
| Pharma Biotech & Nutrition (LPBN) | Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate™ Microreactor Technology | Japan | 6759208 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | China | 200780027369 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | China | 201110448216.0 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | Germany | 602007014375.6 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | Germany | 60 2007 026 919.9 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | France | 2044087 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | France | 2138500 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | United Kingdom | 2044087 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | United Kingdom | 2138500 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | Japan | 5512266 |
| Pharma Biotech & Nutrition (LPBN) | Method For Grignard Type Reactions In Microreactors | FlowPlate™ Microreactor Technology | United States | 7939698 |
| Pharma Biotech & Nutrition (LPBN) | Method For Lithium Exchange Reactions | FlowPlate™ Microreactor Technology | China | 101605800 |
| Pharma Biotech & Nutrition (LPBN) | Method For Lithium Exchange Reactions | FlowPlate™ Microreactor Technology | Germany | 60 2008 002 321.4-08 |
| Pharma Biotech & Nutrition (LPBN) | Method For Lithium Exchange Reactions | FlowPlate™ Microreactor Technology | France | 2109616 |
| Pharma Biotech & Nutrition (LPBN) | Method For Lithium Exchange Reactions | FlowPlate™ Microreactor Technology | United Kingdom | 2109616 |
| Pharma Biotech & Nutrition (LPBN) | Method For Lithium Exchange Reactions | FlowPlate™ Microreactor Technology | Japan | 5394258 |
| Pharma Biotech & Nutrition (LPBN) | Method For Lithium Exchange Reactions | FlowPlate™ Microreactor Technology | United States | 8198487 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method | FlowPlate™ Microreactor Technology | Japan | 5718335 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method | FlowPlate™ Microreactor Technology | United States | 10058840 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate™ Microreactor Technology | China | 102421518 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate™ Microreactor Technology | Hong Kong | 1170447 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate™ Microreactor Technology | Japan | 6062244 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate™ Microreactor Technology | United States | 9023296 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | China | 101415485 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | Germany | 1839739 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | France | 1839739 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | United Kingdom | 1839739 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | Hong Kong | 1128007 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | Japan | 6234959 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | United States | 7919056 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | United States | 8287824 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | United States | 8512653 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | United States | 9375698 |
| Pharma Biotech & Nutrition (LPBN) | Micro-Reactor System Assembly | FlowPlate™ Microreactor Technology | United States | 9962678 |
| Pharma Biotech & Nutrition (LPBN) | Process For Performing An In-Situ-Quench Reaction | FlowPlate™ Microreactor Technology | Germany | 1500649 |
| Pharma Biotech & Nutrition (LPBN) | Process For Performing An In-Situ-Quench Reaction | FlowPlate™ Microreactor Technology | France | 1500649 |
| Pharma Biotech & Nutrition (LPBN) | Process For Performing An In-Situ-Quench Reaction | FlowPlate™ Microreactor Technology | United Kingdom | 1500649 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Australia | 2006249087 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Switzerland | 1915394 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | China | 200680017582.8 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Germany | 1915394 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Spain | 1915394 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | France | 1915394 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | United Kingdom | 1915394 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Hong Kong | HK1120050 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Israel | 187100 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | India | 263242 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Italy | 1915394 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Japan | 4991705 |
| Pharma Biotech & Nutrition (LPBN) | High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM™ | Korea, Republic of | 1273829 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM™ | Australia | 2006237193 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM™ | China | 101163792 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM™ | Hong Kong | 1119737 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM™ | India | 257246 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | China | CN 101687910 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | Germany | 60 2008 022 892.4 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | Spain | 2152728 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | France | 2152728 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | United Kingdom | 2152728 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | Japan | 5301534 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | Singapore | 182147 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM™ | United States | 8241870 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Austria | E412761 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Australia | 2003251434 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Australia | 2009200665 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Belgium | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Bulgaria | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Canada | 2489016 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Canada | 2672809 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Switzerland | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | China | ZL03816914.2 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Czechia | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Germany | 603 24 430.0-08 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Denmark | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Estonia | E002975 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Spain | 2314248 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Finland | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | France | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method of expressing recombinant protein in CHO cells | GS GENE EXPRESSION SYSTEM™ | United Kingdom | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Greece | 20090400053 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Hong Kong | 1081595 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Hungary | E004531 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Ireland | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | India | 229233 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Italy | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Japan | 4430535 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Japan | 5502406 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Japan | 5209693 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Korea, Republic of | 976098 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Luxembourg | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Netherlands | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Portugal | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Romania | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Sweden | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Singapore | 109715 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Slovenia | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Slovakia | 1525320 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | Turkey | 2009 00640 |
| Pharma Biotech & Nutrition (LPBN) | Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM™ | United States | 7932087 |
| Pharma Biotech & Nutrition (LPBN) | Customizable Facility | Ibex™ Solutions | United States | 10689873 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Dextran Polymer Derivatives And A Carrier Material | Inhalation | United States | 8815294 |
| Pharma Biotech & Nutrition (LPBN) | Antibody Purification By Protein A And Ion Exchange Chromatography | Mammalian Biopharmaceutical Services | China | 200480009347.7 |
| Pharma Biotech & Nutrition (LPBN) | Antibody Purification By Protein A And Ion Exchange Chromatography | Mammalian Biopharmaceutical Services | Singapore | 114308 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Belgium | 3540040 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Switzerland | 2393912 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Switzerland | 3540040 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Germany | 602010064092.2. |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Germany | 3540040 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Spain | 3540040 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | France | 2393912 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor for the Cultivation of Mammalian Cells | Mammalian Biopharmaceutical Services | France | 3540040 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United Kingdom | 2393912 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United Kingdom | 3540040 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Italy | 3540040 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Japan | 6121374 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 9670446 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 9783771 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 10179898 |
| Pharma Biotech & Nutrition (LPBN) | Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 10883076 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Austria | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Austria | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Australia | 2013320157 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Belgium | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Belgium | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Canada | 2880750 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Switzerland | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Switzerland | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | China | ZL201380049575.6 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Czechia | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Czechia | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Germany | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Germany | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Denmark | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Denmark | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Eurasian Patent | EA 033008 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Spain | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Spain | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Finland | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Finland | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | France | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | France | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United Kingdom | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United Kingdom | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Hong Kong | HK1206061 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Hungary | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Hungary | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Ireland | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Ireland | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | India | 333092 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Italy | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Italy | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Japan | 6162246 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Korea, Republic of | 10-1757083 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Mexico | 371007 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Netherlands | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Netherlands | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Norway | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Norway | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Poland | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Poland | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Sweden | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Sweden | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Singapore | 11201502243Y |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Turkey | 2711426 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Turkey | 2898077 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Taiwan, Province of China | I507526 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United States | 9777290 |
| Pharma Biotech & Nutrition (LPBN) | Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United States | 10294491 |
| Pharma Biotech & Nutrition (LPBN) | Filter Assembly With Filter Lock Design | Mammalian Biopharmaceutical Services | Switzerland | 3525904 |
| Pharma Biotech & Nutrition (LPBN) | Filter Assembly With Filter Lock Design | Mammalian Biopharmaceutical Services | Germany | 3525904 |
| Pharma Biotech & Nutrition (LPBN) | Filter Assembly With Filter Lock Design | Mammalian Biopharmaceutical Services | France | 3525904 |
| Pharma Biotech & Nutrition (LPBN) | Filter Assembly With Filter Lock Design | Mammalian Biopharmaceutical Services | United Kingdom | 3525904 |
| Pharma Biotech & Nutrition (LPBN) | Filter Moving Device | Mammalian Biopharmaceutical Services | United States | 10919715 |
| Pharma Biotech & Nutrition (LPBN) | Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | China | 201130052846.7 |
| Pharma Biotech & Nutrition (LPBN) | Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | European Union | 001238208 |
| Pharma Biotech & Nutrition (LPBN) | Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | European Union | 001268353 |
| Pharma Biotech & Nutrition (LPBN) | Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | Japan | 1431555 |
| Pharma Biotech & Nutrition (LPBN) | Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | United States | D664262 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression System | Mammalian Biopharmaceutical Services | Switzerland | 3341484 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression System | Mammalian Biopharmaceutical Services | Germany | 3341484 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression System | Mammalian Biopharmaceutical Services | France | 3341484 |
| Pharma Biotech & Nutrition (LPBN) | Mammalian Expression System | Mammalian Biopharmaceutical Services | United Kingdom | 3341484 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Switzerland | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Germany | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Spain | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | France | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | United Kingdom | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Italy | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Japan | 6676526 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Netherlands | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Sweden | 3030656 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Singapore | 11201600872U |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | Taiwan, Province of China | I646194 |
| Pharma Biotech & Nutrition (LPBN) | Means And Methods For The Generation Of Mammalian Producer Cells For The Production Of Recombinant Proteins | Mammalian Biopharmaceutical Services | United States | 10669541 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Austria | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Australia | 2005313530 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Belgium | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Canada | 2589823 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Switzerland | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | China | 101090963 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Czechia | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Germany | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Denmark | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Spain | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Finland | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | France | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | United Kingdom | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Hong Kong | 1115155 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Ireland | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Israel | 183609 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | India | 253340 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Italy | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Japan | 5080269 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Netherlands | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Poland | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Sweden | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Singapore | 132972 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | Turkey | 1824961 |
| Pharma Biotech & Nutrition (LPBN) | Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | United States | 8735099 |
| Pharma Biotech & Nutrition (LPBN) | Method And System For Providing Buffer Solutions | Mammalian Biopharmaceutical Services | United States | 10669518 |
| Pharma Biotech & Nutrition (LPBN) | Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | Belgium | 1516275 |
| Pharma Biotech & Nutrition (LPBN) | Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | Switzerland | 1516275 |
| Pharma Biotech & Nutrition (LPBN) | Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | Germany | 1516275 |
| Pharma Biotech & Nutrition (LPBN) | Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | France | 1516275 |
| Pharma Biotech & Nutrition (LPBN) | Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | United Kingdom | 1516275 |
| Pharma Biotech & Nutrition (LPBN) | Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | United States | 7702465 |
| Pharma Biotech & Nutrition (LPBN) | Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | European Patent Application | 3645720 |
| Pharma Biotech & Nutrition (LPBN) | Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | United States | 10655111 |
| Pharma Biotech & Nutrition (LPBN) | Protein A Chromatography | Mammalian Biopharmaceutical Services | United States | 7847071 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Switzerland | 2447717 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Switzerland | 2633313 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | China | ZL201180052286.2 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Germany | 2447717 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Germany | 2633313 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Spain | 2447717 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Spain | 2633313 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | France | 2447717 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | France | 2633313 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | United Kingdom | 2447717 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | United Kingdom | 2633313 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Hong Kong | 1181849 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Japan | 5746768 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | Singapore | 189087 |
| Pharma Biotech & Nutrition (LPBN) | Rapid Method For Targeted Cell (Line) Selection | Mammalian Biopharmaceutical Services | United States | 10139418 |
| Pharma Biotech & Nutrition (LPBN) | Reactor Surface Finish Effect On Cleanability | Mammalian Biopharmaceutical Services | United States | 10808216 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Austria | E466090 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Australia | 2005313531 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose promoter expression system | Mammalian Biopharmaceutical Services | Belgium | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Canada | 2589937 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Switzerland | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | China | 101090969 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose promoter expression system | Mammalian Biopharmaceutical Services | Czechia | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Germany | 60 2005 020 972.7 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Denmark | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose promoter expression system | Mammalian Biopharmaceutical Services | Spain | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | France | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose promoter expression system | Mammalian Biopharmaceutical Services | United Kingdom | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Hong Kong | 1115156 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Israel | 183608 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | India | 273593 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Italy | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Japan | 5069124 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose promoter expression system | Mammalian Biopharmaceutical Services | Netherlands | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Sweden | 1824980 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Singapore | 132976 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | Singapore | 149071 |
| Pharma Biotech & Nutrition (LPBN) | Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | United States | 9279128 |
| Pharma Biotech & Nutrition (LPBN) | Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | United States | 10436338 |
| Pharma Biotech & Nutrition (LPBN) | Single Use Bioreactor | Mammalian Biopharmaceutical Services | United States | 10801003 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Austria | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Australia | 2013279333 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Belgium | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Canada | 2876280 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | China | 104379753 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Czechia | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Germany | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Denmark | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Eurasian Patent | 034039 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Spain | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Finland | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | France | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | United Kingdom | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Hungary | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Ireland | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Israel | 236347 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | India | 346058 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Italy | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Japan | 6053923 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Korea, Republic of | 10-1761709 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Mexico | 351727 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Norway | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Poland | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Singapore | 11201408576Q |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Turkey | 2864489 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | Taiwan, Province of China | I523946 |
| Pharma Biotech & Nutrition (LPBN) | Site-Specific Integration | Mammalian Biopharmaceutical Services | United States | 10280436 |
| Pharma Biotech & Nutrition (LPBN) | System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | Israel | 258633 |
| Pharma Biotech & Nutrition (LPBN) | System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | United States | 10570363 |
| Pharma Biotech & Nutrition (LPBN) | Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | United States | 10370629 |
| Pharma Biotech & Nutrition (LPBN) | Wireless Sensor Information Monitoring | Mammalian Biopharmaceutical Services | United States | 10244406 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Sampling Module and Manifold | MAST® System | Switzerland | 3004318 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Sampling Module and Manifold | MAST® System | Germany | 3004318 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Sampling Module and Manifold | MAST® System | Spain | 3004318 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Sampling Module and Manifold | MAST® System | France | 3004318 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Sampling Module and Manifold | MAST® System | United Kingdom | 3004318 |
| Pharma Biotech & Nutrition (LPBN) | Aseptic Sampling Module and Manifold | MAST® System | Ireland | 3004318 |
| Pharma Biotech & Nutrition (LPBN) | Automatic Sampling System for Sampling from Enclosed Containers | MAST® System | United States | 9322749 |
| Pharma Biotech & Nutrition (LPBN) | Dielectric Spectroscopy Methods and Apparatus | MAST® System | United States | 9568449 |
| Pharma Biotech & Nutrition (LPBN) | Disposable Cell Removal System | MAST® System | Japan | 6619429 |
| Pharma Biotech & Nutrition (LPBN) | Fixed Volume Aseptic Sampling Valve for Sampling from Enclosed Containers | MAST® System | United States | 9389151 |
| Pharma Biotech & Nutrition (LPBN) | Fixed Volume Aseptic Sampling Valve for Sampling from Enclosed Containers | MAST® System | United States | 9499782 |
| Pharma Biotech & Nutrition (LPBN) | Systems and Methods for Producing Bioproducts | MAST® System | United States | 10421939 |
| Pharma Biotech & Nutrition (LPBN) | Systems and Methods for Producing Bioproducts | MAST® System | United States | 10836991 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Process For Filling Particular Materials | Multiparticulates | Belgium | 2949309 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Process For Filling Particular Materials | Multiparticulates | Germany | 602014004180.9 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Process For Filling Particular Materials | Multiparticulates | Spain | 2949309 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus and Process for Filling Particular Materials | Multiparticulates | France | 2949309 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Process For Filling Particular Materials | Multiparticulates | United Kingdom | 2949309 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Process For Filling Particular Materials | Multiparticulates | Italy | 2949309 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus And Process For Filling Particular Materials | Multiparticulates | United States | 10835451 |
| Pharma Biotech & Nutrition (LPBN) | Extrusion Process For Forming Chemically Stable Drug Multiparticulates | Multiparticulates | United States | 7625507 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Pharmaceutical Multiparticulates | Multiparticulates | Germany | 602004014805.9 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Pharmaceutical Multiparticulates | Multiparticulates | France | 1691787 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Pharmaceutical Multiparticulates | Multiparticulates | United Kingdom | 1691787 |
| Pharma Biotech & Nutrition (LPBN) | Multiparticulate Compositions With Improved Stability | Multiparticulates | United States | 7736672 |
| Pharma Biotech & Nutrition (LPBN) | Multiparticulate Crystalline Drug Compositions Having Controlled Release Profiles | Multiparticulates | United States | 7887844 |
| Pharma Biotech & Nutrition (LPBN) | Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | Germany | 602007041896.8 |
| Pharma Biotech & Nutrition (LPBN) | Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | France | 2091519 |
| Pharma Biotech & Nutrition (LPBN) | Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | United Kingdom | 2091519 |
| Pharma Biotech & Nutrition (LPBN) | Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | United States | 10357462 |
| Pharma Biotech & Nutrition (LPBN) | Novel Galenical System For Active Transport, Method For Preparation And Use | Multiparticulates | Japan | 5072355 |
| Pharma Biotech & Nutrition (LPBN) | Novel Galenical System For Active Transport, Method For Preparation And Use | Multiparticulates | United States | 8911788 |
| Pharma Biotech & Nutrition (LPBN) | Novel Galenical System For Active Transport, Method For Preparation And Use | Multiparticulates | United States | 9192679 |
| Pharma Biotech & Nutrition (LPBN) | Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | Belgium | 3154529 |
| Pharma Biotech & Nutrition (LPBN) | Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | Switzerland | 3154529 |
| Pharma Biotech & Nutrition (LPBN) | Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | Germany | 3154529 |
| Pharma Biotech & Nutrition (LPBN) | Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | France | 3154529 |
| Pharma Biotech & Nutrition (LPBN) | Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | United Kingdom | 3154529 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of A Sparingly Soluble Glycogen Phosphorylase Inhibitor | Multiparticulates | United States | 7235260 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | Belgium | 1689368 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | Germany | 602004050023.2 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | Spain | 1689368 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | France | 1689368 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | United Kingdom | 1689368 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | Italy | 1689368 |
| Pharma Biotech & Nutrition (LPBN) | Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | Germany | 602005003343.2 |
| Pharma Biotech & Nutrition (LPBN) | Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | France | 1737433 |
| Pharma Biotech & Nutrition (LPBN) | Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | United Kingdom | 1737433 |
| Pharma Biotech & Nutrition (LPBN) | Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | United States | 8236349 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Increasing Muscle Protein Synthesis and/or Functional Strength in Mammals | MuscleGuard™ Formulation | United States | 10888571 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Australia | 2004233290 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Brazil | PI0407750-4 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Canada | 2512636 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | China | ZL200480005692.3 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Germany | 2264181 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | United Kingdom | 2400659 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Hong Kong | 1148790 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Japan | 4987469 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Korea, Republic of | 1162738 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Norway | 333474 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | Singapore | 114840 |
| Pharma Biotech & Nutrition (LPBN) | Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT™ Mycoplasma Detection Kit | United States | 7585644 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Austria | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Belgium | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Switzerland | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Germany | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Denmark | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Spain | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Finland | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | France | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | United Kingdom | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Ireland | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Italy | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Japan | 6013419 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Korea, Republic of | 1686260 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Netherlands | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Norway | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Sweden | 2208780 |
| Pharma Biotech & Nutrition (LPBN) | A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | United States | 9284525 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Austria | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Australia | 2007202057 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Australia | 2002315658 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Belgium | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Canada | 2445260 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Switzerland | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | China | ZL02808704.6 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Germany | 50201240.4 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Spain | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | France | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | United Kingdom | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Italy | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Japan | 4070611 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Korea, Republic of | 0879824 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Korea, Republic of | 0845057 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Netherlands | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | Sweden | 1390518 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | United States | 8192990 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | United States | 8003389 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | United States | 8039259 |
| Pharma Biotech & Nutrition (LPBN) | Buffer Solution for Electroporation and a Method Comprising the Use of the Same Nucleofector Device | Nucleofector® System | United States | 7332332 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher | Nucleofector® System | Netherlands | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Austria | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Austria | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Australia | 2007202279 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Australia | 2002315659 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Belgium | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Belgium | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Canada | 244257 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Switzerland | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Switzerland | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | China | ZL02802650.3 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Germany | 50201472.5 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Germany | 50212037.1 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Spain | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Spain | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | France | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | France | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | United Kingdom | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | United Kingdom | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Italy | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Italy | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Japan | 4694587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Japan | 4124659 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Korea, Republic of | 0810173 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Netherlands | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Sweden | 1383901 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | Sweden | 1522587 |
| Pharma Biotech & Nutrition (LPBN) | Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | United States | 8173416 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Austria | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Austria | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Australia | 2011200804 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Australia | 2011244905 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Australia | 2005224452 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Belgium | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Belgium | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Canada | 2559580 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Switzerland | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Switzerland | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | China | ZL 201210074701.0 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | China | ZL 200580007908.4 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Czechia | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Germany | 502004005342.4 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Germany | 502004009820.7 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Denmark | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Spain | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Spain | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | France | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | France | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | United Kingdom | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | United Kingdom | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Italy | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Italy | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Japan | 4680254 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Korea, Republic of | 1077008 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Netherlands | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Netherlands | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Poland | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Sweden | 1702677 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | Sweden | 1577378 |
| Pharma Biotech & Nutrition (LPBN) | Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | United States | 8101401 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Austria | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Belgium | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Switzerland | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Germany | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Spain | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | France | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | United Kingdom | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Italy | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Japan | 5560288 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Korea, Republic of | 1686258 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Netherlands | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Sweden | 2208779 |
| Pharma Biotech & Nutrition (LPBN) | Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | United States | 9080139 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | Australia | 2003227006 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | Canada | 2476439 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | Switzerland | 1476537 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | China | ZL03805811.1 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | Germany | 50300761.7 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | France | 1476537 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | United Kingdom | 1476537 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | Japan | 4369241 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | Korea, Republic of | 0852288 |
| Pharma Biotech & Nutrition (LPBN) | Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | United States | 7678564 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Austria | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Austria | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Australia | 2015254739 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Australia | 2015254741 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Australia | 2018205130 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Belgium | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Belgium | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Switzerland | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Switzerland | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Switzerland | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | China | 106459872 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | China | 106255746 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Germany | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Germany | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Germany | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Denmark | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Denmark | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Denmark | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Spain | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Spain | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Spain | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Finland | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Finland | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | France | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | France | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | France | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | United Kingdom | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | United Kingdom | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | United Kingdom | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Ireland | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Ireland | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Italy | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Italy | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Italy | 502019000085478 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Japan | 6642875 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Japan | 6750810 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Netherlands | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Netherlands | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Netherlands | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Norway | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Norway | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Sweden | 2940120 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Sweden | 2940121 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | Sweden | 3260163 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | United States | 10336996 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Large Volume Transfection | Nucleofector® System | United States | 10633646 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | Switzerland | 1543102 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | China | ZL03824843.3 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | Germany | 50312452.4 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | Denmark | 1543102 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | Finland | 1543102 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | France | 1543102 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | United Kingdom | 1543102 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | Sweden | 1543102 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Processing Biological Material | Nucleofector® System | United States | 7704727 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Switzerland | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Germany | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Spain | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | France | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | United Kingdom | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Italy | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Netherlands | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Sweden | 1961807 |
| Pharma Biotech & Nutrition (LPBN) | Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | United States | 8450102 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | Austria | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | Switzerland | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | Germany | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | Spain | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | France | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | United Kingdom | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | Italy | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | Netherlands | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | Sweden | 1607484 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | United States | 8058042 |
| Pharma Biotech & Nutrition (LPBN) | Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | United States | 7732175 |
| Pharma Biotech & Nutrition (LPBN) | Method and Device for the Electrical Treatment of Reaction Spaces | Nucleofector® System | Japan | 5926560 |
| Pharma Biotech & Nutrition (LPBN) | Method and Device for the Electrical Treatment of Reaction Spaces | Nucleofector® System | Korea, Republic of | 1761925 |
| Pharma Biotech & Nutrition (LPBN) | Method and Device for the Electrical Treatment of Reaction Spaces | Nucleofector® System | United States | 9249384 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Switzerland | 2399984 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Switzerland | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | China | ZL201180030237.9 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | China | ZL201180030236.4 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Germany | 502010016602.5 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Germany | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Spain | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Spain | 2413557 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | France | 2399984 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | France | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United Kingdom | 2399984 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United Kingdom | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Ireland | 2399984 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Ireland | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Japan | 5840204 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Japan | 5885144 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Korea, Republic of | 10-1853514 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Korea, Republic of | 10-1853515 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Netherlands | 2399984 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Netherlands | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Sweden | 2399984 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Sweden | 2399985 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United States | 9624486 |
| Pharma Biotech & Nutrition (LPBN) | Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United States | 9701954 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produced by this Method | Nucleofector® System | United States | 8895152 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Australia | 2004283543 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Canada | 2542902 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Switzerland | 1525900 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Switzerland | 1698372 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Germany | 50303219.0 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Germany | 50312163.0 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | France | 1525900 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | France | 1698372 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | United Kingdom | 1525900 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | United Kingdom | 1698372 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Japan | 5032847 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Japan | 5124661 |
| Pharma Biotech & Nutrition (LPBN) | Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | Korea, Republic of | 1130878 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells | Nucleofector® System | Netherlands | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Austria | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Australia | 2001281911 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Belgium | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Canada | 2414542 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Switzerland | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | China | ZL01811955.7 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Germany | 50104496.5 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Spain | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | France | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | United Kingdom | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Italy | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Japan | 4794111 |
| Pharma Biotech & Nutrition (LPBN) | Method for Introducing Nucleic Acids and Other Biologically Active Molecules Into the Nucleus of Higher Eukaryotic Cells by Means of an Electrical Current | Nucleofector® System | Sweden | 1297119 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Australia | 2006268953 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Canada | 2613984 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Switzerland | 1741778 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | China | 200680024248 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Germany | 502005002350.1 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | France | 1741778 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | United Kingdom | 1741778 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Hong Kong | 1122840 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Japan | 4982489 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Korea, Republic of | 10-1362277 |
| Pharma Biotech & Nutrition (LPBN) | Method for Treating Small Volumes with Electrical Current | Nucleofector® System | United States | 7700357 |
| Pharma Biotech & Nutrition (LPBN) | Methods And Compositions For Maintaining Active Agents In Intra-Articular Spaces | Other Solubilization | United States | 9084727 |
| Pharma Biotech & Nutrition (LPBN) | Nanoparticles Comprising A Non-Ionizable Cellulosic Polymer And An Amphiphilic Non-Ionizable Block Copolymer | Other Solubilization | United States | 8974827 |
| Pharma Biotech & Nutrition (LPBN) | Nanoparticles Comprising Drug, A Non-Ionizable Cellulosic Polymer And Tocopheryl Polyethylene Glocol Succinate | Other Solubilization | United States | 9545384 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Comprising Drug And Concentration-Enhancing Polymers | Other Solubilization | United States | 7887840 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | Germany | 602008044103.2 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | France | 2231169 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | United Kingdom | 2231169 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | United States | 9724362 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Containing A Solid Dispersion Of A Poorly-Soluble Drug And A Solubility-Enhancing Polymers | Other Solubilization | United States | 8236328 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Adsorbates Of Amorphous Drug | Other Solubilization | Canada | 2448825 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Adsorbates Of Amorphous Drug | Other Solubilization | United States | 8703199 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Adsorbates Of Amorphous Drug | Other Solubilization | United States | 8389006 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | Germany | 602004036099.6 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | France | 1653927 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | United Kingdom | 1653927 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | Ireland | 1653927 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions of Dispersions Of Amorphous Drugs Mixed with Polymers | Other Solubilization | United States | 8703196 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Compositions Of Semi-Ordered Drugs And Polymers | Other Solubilization | United States | 8257739 |
| Pharma Biotech & Nutrition (LPBN) | Pharmaceutical Dosage Forms Comprising A Low-Solubility Drug And A Polymer | Other Solubilization | United States | 9445998 |
| Pharma Biotech & Nutrition (LPBN) | Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | European Patent Application | 3212169 |
| Pharma Biotech & Nutrition (LPBN) | Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | Japan | 6650933 |
| Pharma Biotech & Nutrition (LPBN) | REISSUE-Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | United States | RE47033 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Austria | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Belgium | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Canada | 2431274 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Switzerland | 694096 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Germany | 60115090.2 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Denmark | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Spain | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Finland | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | France | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | United Kingdom | 2375171 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | United Kingdom | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Italy | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Japan | 3854927 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Netherlands | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | Sweden | 1341928 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | United States | 6599711 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | United States | 6911319 |
| Pharma Biotech & Nutrition (LPBN) | Gel Staining Kit and Method | PROSIEVE® Products | European Patent Application | 3599244 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | China | ZL201280050243.5 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | China | ZL201710139782.0 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | Germany | 2744817 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | Spain | 2744817 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | France | 2744817 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | United Kingdom | 2744817 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | Japan | 6074428 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | Japan | 6475671 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | Netherlands | 2744817 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | United States | 9091694 |
| Pharma Biotech & Nutrition (LPBN) | Protein Detection | PROSIEVE® Products | United States | 9377467 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Austria | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Australia | 2002330860 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Belgium | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Brazil | PI0210681-7 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Switzerland | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | China | ZL02814296.9 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Cyprus | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Germany | 60233142.0 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Denmark | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Spain | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Finland | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | France | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | United Kingdom | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Ireland | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Italy | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Japan | 5039729 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Luxembourg | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Mexico | 254052 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Netherlands | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Portugal | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Sweden | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | Turkey | 1409984 |
| Pharma Biotech & Nutrition (LPBN) | Methods and Reagents for Detecting Endotoxin | PYROGENE™ rFc Assay | United States | 6849426 |
| Pharma Biotech & Nutrition (LPBN) | Dynamically Controlling an Automated System | PyroTec® Pro System | United States | 10768190 |
| Pharma Biotech & Nutrition (LPBN) | Dynamically Controlling an Automated System | PyroTec® Pro System | United States | 10928407 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | Switzerland | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | China | ZL201180039793.2 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | Germany | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | Spain | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | France | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | United Kingdom | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | Italy | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | Netherlands | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | Sweden | 2580313 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | United States | 9707703 |
| Pharma Biotech & Nutrition (LPBN) | Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | Switzerland | 1773416 |
| Pharma Biotech & Nutrition (LPBN) | Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | China | ZL200580022828.6 |
| Pharma Biotech & Nutrition (LPBN) | Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | Germany | 1773416 |
| Pharma Biotech & Nutrition (LPBN) | Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | France | 1773416 |
| Pharma Biotech & Nutrition (LPBN) | Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | United Kingdom | 1773416 |
| Pharma Biotech & Nutrition (LPBN) | Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | Japan | 4971981 |
| Pharma Biotech & Nutrition (LPBN) | Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | United States | 9101693 |
| Pharma Biotech & Nutrition (LPBN) | Compositions and Methods of Use for Extracts of Magnolianceae Plants | RELORA® Ingredient | United States | 6582735 |
| Pharma Biotech & Nutrition (LPBN) | Compositions and Methods of Use for Extracts of Magnolianceae Plants | RELORA® Ingredient | United States | 6814987 |
| Pharma Biotech & Nutrition (LPBN) | Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | Australia | 2013231673 |
| Pharma Biotech & Nutrition (LPBN) | Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | Japan | 6490662 |
| Pharma Biotech & Nutrition (LPBN) | Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | Singapore | 10201707481S |
| Pharma Biotech & Nutrition (LPBN) | Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | United States | 9393259 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | Switzerland | 3619188 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | Germany | 3619188 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | France | 3619188 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | United Kingdom | 3619188 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of Difluoromethylornithine | Small Molecules - API | Switzerland | 3634943 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of Difluoromethylornithine | Small Molecules - API | Germany | 3634943 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of Difluoromethylornithine | Small Molecules - API | France | 3634943 |
| Pharma Biotech & Nutrition (LPBN) | Method For Preparation Of Difluoromethylornithine | Small Molecules - API | United Kingdom | 3634943 |
| Pharma Biotech & Nutrition (LPBN) | Rotatory Ball That Spouts | Small Molecules - API | China | CN205517689U |
| Pharma Biotech & Nutrition (LPBN) | Self Seals Are Warded Off Glass And Are Repaired Bush | Small Molecules - API | China | CN205560114U |
| Pharma Biotech & Nutrition (LPBN) | Strong And High Hygroscopicity Powder Materials Of High Toxicity Throws Material Device | Small Molecules - API | China | CN205555443U |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Belgium | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Switzerland | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Germany | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Spain | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | France | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | United Kingdom | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Ireland | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Italy | 102016000098452 |
| Pharma Biotech & Nutrition (LPBN) | Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Italy | 3519100 |
| Pharma Biotech & Nutrition (LPBN) | Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Canada | 2862553 |
| Pharma Biotech & Nutrition (LPBN) | Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Switzerland | 2806856 |
| Pharma Biotech & Nutrition (LPBN) | Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Germany | 2806856 |
| Pharma Biotech & Nutrition (LPBN) | Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Italy | 1409966 |
| Pharma Biotech & Nutrition (LPBN) | Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Japan | 6158225 |
| Pharma Biotech & Nutrition (LPBN) | Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powdered Product | Small Molecules - Micronization | Switzerland | 2838661 |
| Pharma Biotech & Nutrition (LPBN) | Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powdered Product | Small Molecules - Micronization | Germany | 2838661 |
| Pharma Biotech & Nutrition (LPBN) | Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powdered Product | Small Molecules - Micronization | Italy | 1411465 |
| Pharma Biotech & Nutrition (LPBN) | Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powdered Product | Small Molecules - Micronization | United States | 9427743 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | Belgium | 1855652 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | Germany | 602006047398.2 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | France | 1855652 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | United Kingdom | 1855652 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | Ireland | 1855652 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | Portugal | 1855652 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | United States | 9265731 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | Germany | 602007041938.7 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | France | 2043610 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | United Kingdom | 2043610 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | Ireland | 2043610 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | Portugal | 2043610 |
| Pharma Biotech & Nutrition (LPBN) | Drying Of Drug-Containing Particles | Spray Drying | United States | 8834929 |
| Pharma Biotech & Nutrition (LPBN) | High-Temperature Spray Drying Process And Apparatus | Spray Drying | United States | 9248584 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Soild Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | United States | 6763607 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Using Pressure Nozzles | Spray Drying | United States | 7780988 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | Canada | 2472028 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | Japan | 4865989 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | United States | 6973741 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | United States | 8343550 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | United States | 8828443 |
| Pharma Biotech & Nutrition (LPBN) | Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | United States | 9339467 |
| Pharma Biotech & Nutrition (LPBN) | Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | Germany | 602004036819.9 |
| Pharma Biotech & Nutrition (LPBN) | Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | France | 1653928 |
| Pharma Biotech & Nutrition (LPBN) | Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | United Kingdom | 1653928 |
| Pharma Biotech & Nutrition (LPBN) | Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | Ireland | 1653928 |
| Pharma Biotech & Nutrition (LPBN) | Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | Portugal | 1653928 |
| Pharma Biotech & Nutrition (LPBN) | Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | Taiwan, Province of China | I290852 |
| Pharma Biotech & Nutrition (LPBN) | Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | United States | 10383941 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | United States | 9084944 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | United States | 9205345 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | United States | 9084976 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | United States | 9358478 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process | Spray Drying | Germany | 602010036172.1 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process | Spray Drying | European Patent Application | 3130396 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process | Spray Drying | France | 2411137 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process | Spray Drying | United Kingdom | 2411137 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process | Spray Drying | United States | 9724664 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process | Spray Drying | United States | 10300443 |
| Pharma Biotech & Nutrition (LPBN) | Spray-Drying Process | Spray Drying | United States | 10675602 |
| Pharma Biotech & Nutrition (LPBN) | Compositions Incorporating (-)-Hydroxycitric Acid, Chromium, and Gymnemic Acid, and Related Methods for Promoting Healthy Body Weight and Improving Related Health Factors | SuperCitraMax® Ingredient | Australia | 2002364213 |
| Pharma Biotech & Nutrition (LPBN) | Compositions Incorporating (-)-Hydroxycitric Acid, Chromium, and Gymnemic Acid, and Related Methods for Promoting Healthy Body Weight and Improving Related Health Factors | SuperCitraMax® Ingredient | New Zealand | 532550 |
| Pharma Biotech & Nutrition (LPBN) | Compositions Incorporating(-)-Hydroxycitric Acid, Chromium, and Gymnemic Acid, and Related Methods for Promoting Healthy Body Weight and Improving Related Health Factors | SuperCitraMax® Ingredient | South Africa | 2004/02687 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Supporting Weight Loss | SuperCitraMax® Ingredient | Australia | 2002305132 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Supporting Weight Loss | SuperCitraMax® Ingredient | New Zealand | 528681 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Supporting Weight Loss | SuperCitraMax® Ingredient | United States | 7335651 |
| Pharma Biotech & Nutrition (LPBN) | Method and Composition for Supporting Weight Loss | SuperCitraMax® Ingredient | South Africa | 2003/07594 |
| Pharma Biotech & Nutrition (LPBN) | Method for Preparing Hydroxycitric Acid Compositions, Dietary Supplements and Food Products Comprising the Same | SuperCitraMax® Ingredient | India | 208195 |
| Pharma Biotech & Nutrition (LPBN) | Improved Collagen Dispersion and Method of Producing Same | UC-II® Collagen | Korea, Republic of | 10-1611374 |
| Pharma Biotech & Nutrition (LPBN) | Improved Collagen Dispersion and Method of Producing Same | UC-II® Collagen | Taiwan, Province of China | I510500 |
| Pharma Biotech & Nutrition (LPBN) | Improved Collagen Dispersion and Method of Producing Same | UC-II® Collagen | United States | 8748499 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | Belgium | 1435906 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | Canada | 2459981 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | Germany | 1435906 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | Spain | 1435906 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | France | 1435906 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | United Kingdom | 1435906 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | Japan | 4800574 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | Netherlands | 1435906 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | United States | 7083820 |
| Pharma Biotech & Nutrition (LPBN) | Method for Producing Biologically Active Products | UC-II® Collagen | United States | 7846487 |
| Pharma Biotech & Nutrition (LPBN) | Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | Australia | 2014202041 |
| Pharma Biotech & Nutrition (LPBN) | Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | Canada | 2846644 |
| Pharma Biotech & Nutrition (LPBN) | Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | Korea, Republic of | 10-1664290 |
| Pharma Biotech & Nutrition (LPBN) | Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | Mexico | 347669 |
| Pharma Biotech & Nutrition (LPBN) | Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | Singapore | 11201403524R |
| Pharma Biotech & Nutrition (LPBN) | Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | United States | 9066926 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | ATE1155873 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Australia | 2013382370 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Belgium | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Czechia | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Denmark | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Spain | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Finland | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | France | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Ireland | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Italy | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Japan | 6698352 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Korea, Republic of | KR 10-2128959 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Norway | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Poland | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Sweden | 2970994 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Singapore | 11201507557U |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Turkey | TR 2019 14235 T4 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 9150870 |
| Pharma Biotech & Nutrition (LPBN) | Constitutive Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 10428123 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | 843821 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | 1231985 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Australia | 2013341049 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Belgium | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | China | ZL201380056279.9 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Czechia | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Denmark | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Spain | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Spain | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Finland | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | France | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | France | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Hong Kong | HK1208037 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Hungary | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Ireland | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Israel | 238420 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Italy | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Italy | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Japan | 6556625 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Korea, Republic of | 102079293 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Norway | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Poland | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Sweden | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Sweden | 3130598 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Singapore | 11201502745X |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | Turkey | 2912053 |
| Pharma Biotech & Nutrition (LPBN) | Expression Sequences | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 10160988 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Canada | 2803719 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | China | 103097542 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Spain | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | France | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | India | 321319 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Italy | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Japan | 5997140 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Poland | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | Sweden | 2591121 |
| Pharma Biotech & Nutrition (LPBN) | Production Cell Line | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 8962277 |
| Pharma Biotech & Nutrition (LPBN) | Promoter Variants | XS™ Technologies - Microbial Biopharmaceutical Services | Australia | 2016303026 |
| Pharma Biotech & Nutrition (LPBN) | Promoter Variants | XS™ Technologies - Microbial Biopharmaceutical Services | Japan | 6833812 |
| Pharma Biotech & Nutrition (LPBN) | Promoter Variants | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 10752907 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 10865416 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | 3132039 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | Belgium | 3132039 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 3132039 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | China | ZL201580032885.6 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 602015034267.4 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | France | 3132039 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 3132039 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 3132039 |
| Pharma Biotech & Nutrition (LPBN) | Recombinant Host Cell for Expressing Proteins of Interest | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 10590427 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | ATE1107543 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Australia | 2012320421 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Belgium | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Czechia | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Denmark | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Spain | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Finland | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | France | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Ireland | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Israel | 231859 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Italy | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Japan | 6113736 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Korea, Republic of | 10-1954389 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Korea, Republic of | KR 10-2128957 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Norway | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Poland | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Sweden | 2764016 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Turkey | TR2019 07915 T4 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Taiwan, Province of China | I560272 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 9512432 |
| Pharma Biotech & Nutrition (LPBN) | Regulatable Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 10301634 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Australia | 2011284844 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Belgium | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Canada | 2803654 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | China | ZL201180036765.5 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Czechia | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Denmark | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Eurasian Patent | 034074 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Spain | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Finland | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | France | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Hong Kong | 1184496 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Ireland | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Israel | 223864 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | India | 344138 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Italy | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Japan | 6071878 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Korea, Republic of | 10-1904140 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Korea, Republic of | 10-2022884 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Mexico | 352068 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Norway | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Poland | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Sweden | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of inducible promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Singapore | 187024 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Turkey | 2722390 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | Taiwan, Province of China | I515295 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 9464294 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 9970017 |
| Pharma Biotech & Nutrition (LPBN) | Regulation of Inducible Promoters | XS™ Technologies - Microbial Biopharmaceutical Services | South Africa | 2012/09268 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Austria | 578997 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Australia | 2010283807 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Belgium | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Canada | 2770557 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Switzerland | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | China | 201080035390.6 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Czechia | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Germany | 60 2009 010 275.3 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Denmark | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Eurasian Patent | 032045 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Spain | 2394668 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Finland | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | France | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United Kingdom | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Hong Kong | 1167677 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Ireland | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | India | 337600 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Italy | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Japan | 5794985 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Korea, Republic of | 10-1877286 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Mexico | 317816 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Netherlands | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Norway | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Poland | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Sweden | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Singapore | 178292 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Turkey | 2284273 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | Taiwan, Province of China | I 450965 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | United States | 9163247 |
| Pharma Biotech & Nutrition (LPBN) | Vector Comprising Mannoses Promoter and Mannose Promoter | XS™ Technologies - Microbial Biopharmaceutical Services | South Africa | 2012/00627 |
| Pharma Biotech & Nutrition (LPBN) | Automated Cell Culture System | Cocoon® Platform | United States | 9783768 |
Patent Portfolio - Specialty Ingredients
| Business Sector | Title | Country | Patent Number |
|---|---|---|---|
| Specialty Ingredients (LSI) | A COMPOSITION FOR IMPROVING SKIN CONDITION AND APPEARANCE | France | 2303010 |
| Specialty Ingredients (LSI) | A COMPOSITION FOR IMPROVING SKIN CONDITION AND APPEARANCE | Germany | 2303010 |
| Specialty Ingredients (LSI) | A COMPOSITION FOR IMPROVING SKIN CONDITION AND APPEARANCE | Italy | 2303010 |
| Specialty Ingredients (LSI) | A COMPOSITION FOR IMPROVING SKIN CONDITION AND APPEARANCE | Japan | 6223657 |
| Specialty Ingredients (LSI) | A COMPOSITION FOR IMPROVING SKIN CONDITION AND APPEARANCE | Japan | 6257052 |
| Specialty Ingredients (LSI) | A COMPOSITION FOR IMPROVING SKIN CONDITION AND APPEARANCE | United Kingdom | 2303010 |
| Specialty Ingredients (LSI) | A COMPOSITION FOR IMPROVING SKIN CONDITION AND APPEARANCE | United States | 9000033 |
| Specialty Ingredients (LSI) | A METHOD AND FORMULATION FOR THE TREATMENT OF TIMBER | Australia | 2019213415 |
| Specialty Ingredients (LSI) | A METHOD AND FORMULATION FOR THE TREATMENT OF TIMBER | New Zealand | 734108 |
| Specialty Ingredients (LSI) | A METHOD OF TREATING TIMBER | Australia | 2017101779 |
| Specialty Ingredients (LSI) | A METHOD OF TREATING WOOD | Australia | 2015101144 |
| Specialty Ingredients (LSI) | A METHOD OF TREATING WOOD | Australia | 2015101282 |
| Specialty Ingredients (LSI) | A SYNERGISTIC FUNGICIDAL COMPOSITION COMPRISING PYRIMETHANIL AND FLUAZINAM | Australia | 2014100898 |
| Specialty Ingredients (LSI) | A SYNERGISTIC FUNGICIDAL COMPOSITION COMPRISING PYRIMETHANIL AND FLUAZINAM | New Zealand | 601970 |
| Specialty Ingredients (LSI) | A TIMBER PRESERVATIVE FORMULATION | Australia | 2017101784 |
| Specialty Ingredients (LSI) | A WOOD PRESERVATIVE | New Zealand | 724922 |
| Specialty Ingredients (LSI) | A WOOD PRESERVATIVE FORMULATION | United States | 10201910 |
| Specialty Ingredients (LSI) | ACTIVATED DISINFECTANT HYDROGEN PEROXIDE COMPOSITIONS | United States | 10646607 |
| Specialty Ingredients (LSI) | ACTIVE HALOGEN ANTIMICROBIAL COMPOSITION AND METHOD OF USE | France | 2840893 |
| Specialty Ingredients (LSI) | ACTIVE HALOGEN ANTIMICROBIAL COMPOSITION AND METHOD OF USE | Germany | 2840893 |
| Specialty Ingredients (LSI) | ACTIVE HALOGEN ANTIMICROBIAL COMPOSITION AND METHOD OF USE | United Kingdom | 2840893 |
| Specialty Ingredients (LSI) | ACTIVE HALOGEN ANTIMICROBIAL COMPOSITION AND METHOD OF USE | United States | 9220272 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Australia | 2012330920 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Belgium | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Canada | 2854445 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Chile | 55451 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | China | ZL201280053925.1 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Denmark | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Finland | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | France | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Germany | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Ireland | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Japan | 6514269 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Latvia | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Netherlands | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | New Zealand | 624081 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Norway | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Poland | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Portugal | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Spain | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | Sweden | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | United Kingdom | 2775846 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | United States | 9603358 |
| Specialty Ingredients (LSI) | ADDITIVES FOR USE IN WOOD PRESERVATION | United States | 9961895 |
| Specialty Ingredients (LSI) | AMINE OXIDE WOOD PRESERVATIVES | United States | 6572788 |
| Specialty Ingredients (LSI) | AMMONIACAL COPPER ZINC ARSENATE CONCENTRATES AND METHODS OF PREPARATION | Canada | 2813773 |
| Specialty Ingredients (LSI) | AMMONIACAL COPPER ZINC ARSENATE CONCENTRATES AND METHODS OF PREPARATION | United States | 8911792 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL BISPYRIDINE AMINE COMPOSITIONS AND USES | United States | 9687432 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | Australia | 2010257341 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | Canada | 2797272 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | France | 2387883 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | Germany | 2387883 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | Israel | 166830 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | Italy | 2387883 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | Japan | 5570941 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | New Zealand | 538637 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | South Africa | 2005/01387 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | Spain | 2387883 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL COMPOSITIONS | United Kingdom | 2387883 |
| Specialty Ingredients (LSI) | ANTIMICROBIAL LUBRICANT FOR WOODFIBER-PLASTIC COMPOSITIONS | United States | 7582694 |
| Specialty Ingredients (LSI) | AQUEOUS COMPOSITION | Japan | 5820096 |
| Specialty Ingredients (LSI) | AUGMENTATION OF PYRITHIONE ACTIVITY OR A POLYVALENT METAL SALT OF PYRITHIONE ACTIVITY BY ZINC-CONTAINING LAYERED MATERIAL | Australia | 2004222254 |
| Specialty Ingredients (LSI) | AUGMENTATION OF PYRITHIONE ACTIVITY OR A POLYVALENT METAL SALT OF PYRITHIONE ACTIVITY BY ZINC-CONTAINING LAYERED MATERIAL | Canada | 2519433 |
| Specialty Ingredients (LSI) | AUGMENTATION OF PYRITHIONE ACTIVITY OR A POLYVALENT METAL SALT OF PYRITHIONE ACTIVITY BY ZINC-CONTAINING LAYERED MATERIAL | Mexico | 306018 |
| Specialty Ingredients (LSI) | BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS | Australia | 2013328924 |
| Specialty Ingredients (LSI) | BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS | Australia | 2017202791 |
| Specialty Ingredients (LSI) | BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS | Japan | 6444875 |
| Specialty Ingredients (LSI) | BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS | United States | 10433548 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Denmark | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | France | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Germany | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Greece | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Italy | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Japan | 5956400 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Korea, Republic of | 10-2033921 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Malaysia | 145917 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Netherlands | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Norway | 341341 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Singapore | 145370 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Sweden | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | Taiwan, Province of China | I394532 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | United Kingdom | 1998619 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | United States | 8372829 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | United States | 8481523 |
| Specialty Ingredients (LSI) | BIOCIDE COMPOSITION COMPRISING PYRITHIONE AND PYRROLE DERIVATIVES | United States | 7893047 |
| Specialty Ingredients (LSI) | BIOCIDES | United States | 9884822 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Austria | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Belgium | 1788869 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Belgium | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | China | 100563439 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | China | ZL201080036614.5 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Czechia | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Denmark | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | France | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Germany | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | India | 295224 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Israel | 218109 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Italy | 1788869 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Italy | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Japan | 5796012 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Korea, Republic of | 1211389 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Korea, Republic of | 10-1717804 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Netherlands | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Poland | 1788869 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Poland | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Spain | 1788869 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Spain | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Sweden | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | Switzerland | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | United Kingdom | 1788869 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | United Kingdom | 2467143 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | United States | 7854940 |
| Specialty Ingredients (LSI) | BROAD SPECTRUM PRESERVATION BLENDS | United States | 9610350 |
| Specialty Ingredients (LSI) | CARRIER SYSTEM FOR WOOD PRESERVATIVE FORMULATIONS | Australia | 2015101280 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | Brazil | PI0414768-5 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | China | 200480028463.3 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | France | 1675572 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | Germany | 602004033795.1 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | Italy | 1675572 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | Japan | 4664919 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | Korea, Republic of | 1106025 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | Spain | 1675572 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | United Kingdom | 1675572 |
| Specialty Ingredients (LSI) | COATED METAL PYRITHIONE PARTICLES FOR TREATMENT OF MICROORGANISMS | United States | 8980235 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | Brazil | 1120150021557 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | France | 2879496 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | Germany | 2879496 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | Italy | 2879496 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | Mexico | 358464 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | Poland | 2879496 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | Spain | 2879496 |
| Specialty Ingredients (LSI) | COMPOSITION AND METHOD FOR PREVENTING DISCOLORATION OF PYRITHIONE CONTAINING COMPOSITIONS | United Kingdom | 2879496 |
| Specialty Ingredients (LSI) | COMPOSITION AND USE | United States | 7226968 |
| Specialty Ingredients (LSI) | COMPOSITION COMPRISING A PARTICULATE ZINC MATERIAL, A PYRITHIONE OR A POLYVALENT METAL SALT OF A PYRITHIONE AND A GEL NETWORK | United States | 9381382 |
| Specialty Ingredients (LSI) | COMPOSITION COMPRISING ZINC-CONTAINING LAYERED MATERIAL WITH A HIGH RELATIVE ZINC LABILITY | United States | 8491877 |
| Specialty Ingredients (LSI) | COMPOSITION COMPRISING ZINC-CONTAINING LAYERED MATERIAL WITH A HIGH RELATIVE ZINC LABILITY | United States | 9381148 |
| Specialty Ingredients (LSI) | COMPOSITION CONTAINING AN EXTRACT OF A SEQUENTIAL OR SIMULTANEOUS FERMENTATION | Austria | 2282637 |
| Specialty Ingredients (LSI) | COMPOSITION CONTAINING AN EXTRACT OF A SEQUENTIAL OR SIMULTANEOUS FERMENTATION | Germany | 2282637 |
| Specialty Ingredients (LSI) | COMPOSITION FOR THE PREVENTION OF CORROSION IN ACIDIC CONDITIONS | United States | 10059872 |
| Specialty Ingredients (LSI) | COMPOSITIONS AND METHODS OF USE | New Zealand | 717571 |
| Specialty Ingredients (LSI) | COMPOSITIONS AND METHODS OF USE | South Africa | 2017/04942 |
| Specialty Ingredients (LSI) | COMPOSITIONS AND METHODS OF USE | United States | 10542753 |
| Specialty Ingredients (LSI) | COMPOSITIONS COMPRISING HYDROGEN PEROXIDE AND QUATERNARY AMMONIUM ACID COMPOUNDS FOR DISINFECTION, AND CLEANING | China | ZL201580007720.3 |
| Specialty Ingredients (LSI) | COMPOSITIONS COMPRISING HYDROGEN PEROXIDE AND QUATERNARY AMMONIUM ACID COMPOUNDS FOR DISINFECTION, AND CLEANING | France | 3102033 |
| Specialty Ingredients (LSI) | COMPOSITIONS COMPRISING HYDROGEN PEROXIDE AND QUATERNARY AMMONIUM ACID COMPOUNDS FOR DISINFECTION, AND CLEANING | Germany | 3102033 |
| Specialty Ingredients (LSI) | COMPOSITIONS COMPRISING HYDROGEN PEROXIDE AND QUATERNARY AMMONIUM ACID COMPOUNDS FOR DISINFECTION, AND CLEANING | Spain | 3102033 |
| Specialty Ingredients (LSI) | COMPOSITIONS COMPRISING HYDROGEN PEROXIDE AND QUATERNARY AMMONIUM ACID COMPOUNDS FOR DISINFECTION, AND CLEANING | United Kingdom | 3102033 |
| Specialty Ingredients (LSI) | COMPOSITIONS COMPRISING HYDROGEN PEROXIDE AND QUATERNARY AMMONIUM ACID COMPOUNDS FOR DISINFECTION, AND CLEANING | United States | 10568321 |
| Specialty Ingredients (LSI) | DEVICE FOR REMOVING AMMONIA NITROGEN IN WASTEWATER | China | CN202924811 |
| Specialty Ingredients (LSI) | DILUTABLE & READY-TO-USSE HOSPITAL STRENGTH DISINFECTANT DETERGENT WITH BIOCIDAL ACTIVITY IN FIVE MINUTE CONTACT TIME | United States | 10206392 |
| Specialty Ingredients (LSI) | DISCHARGING STABILIZING DEVICE FOR SEPARATING COLUMN | China | CN202921273 |
| Specialty Ingredients (LSI) | DISINFECTANT | Germany | 50109235.8-08 |
| Specialty Ingredients (LSI) | DISINFECTANT | Germany | 1671541 |
| Specialty Ingredients (LSI) | DISINFECTANT | Spain | 2260308 |
| Specialty Ingredients (LSI) | DISINFECTANT | Spain | 1671541 |
| Specialty Ingredients (LSI) | DISINFECTANT | United Kingdom | 1322156 |
| Specialty Ingredients (LSI) | DISINFECTANT | United Kingdom | 1671541 |
| Specialty Ingredients (LSI) | DISINFECTANT | United States | 6939840 |
| Specialty Ingredients (LSI) | DISINFECTANT COMPOSITION CONTAINING QUATERNARY AMMONIUM COMPOUNDS | United States | 10285400 |
| Specialty Ingredients (LSI) | DISINFECTANT COMPOSITION HAVING RESIDUAL BIOCIDAL PROPERTIES | United States | 10149471 |
| Specialty Ingredients (LSI) | DISINFECTANT COMPOSITION HAVING RESIDUAL BIOCIDAL PROPERTIES | United States | 10631537 |
| Specialty Ingredients (LSI) | DISINFECTING COMPOSITION AND WIPES WITH REDUCED CONTACT TIME | China | 106413761 |
| Specialty Ingredients (LSI) | DISINFECTING COMPOSITION AND WIPES WITH REDUCED CONTACT TIME | United States | 9655367 |
| Specialty Ingredients (LSI) | ENCAPSULATED WOOD PRESERVATIVES | United States | 9253977 |
| Specialty Ingredients (LSI) | ENHANCED PRESERVATIVE | United States | 10721934 |
| Specialty Ingredients (LSI) | EXTRUDED NON-WOOD FIBER PLASTIC COMPOSITES | United States | 7151125 |
| Specialty Ingredients (LSI) | FAST ACTING DISINFECTION COMPOSITION | China | 201580029923.2 |
| Specialty Ingredients (LSI) | FORMULATION AND METHOD FOR THE TREATMENT OF TIMBER | Australia | 2017202684 |
| Specialty Ingredients (LSI) | FORMULATION AND METHOD FOR THE TREATMENT OF TIMBER | New Zealand | 725908 |
| Specialty Ingredients (LSI) | FUNGICIDAL COMPOSITION COMPRISING TRIADIMEFON AND CYPROCONAZOLE, FOR PRESERVING GLUED WOOD PRODUCTS | Australia | 2011203019 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Austria | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Belgium | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | China | 201180049696.1 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Czechia | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Eurasian Patent | 023023 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Finland | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | France | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Germany | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Hong Kong | 1186457 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | India | 299130 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Italy | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Japan | 6000955 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Norway | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Poland | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Switzerland | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | Turkey | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | United Kingdom | 2627626 |
| Specialty Ingredients (LSI) | HALOGENATED DIETHYLTOLUENEDIAMINES | United States | 93404873 |
| Specialty Ingredients (LSI) | HERBICIDAL COMPOSITIONS | Australia | 2014203831 |
| Specialty Ingredients (LSI) | HERBICIDAL COMPOSITIONS | New Zealand | 627043 |
| Specialty Ingredients (LSI) | HOT WATER WASHING DEVICE OF PLATE-FRAME FILTER PRESS | China | CN202921039 |
| Specialty Ingredients (LSI) | HYDROGEN SULFIDE REMOVING DEVICE | China | CN202921315 |
| Specialty Ingredients (LSI) | IMPROVED FIRE RETARDANT | United States | 6,652,633 |
| Specialty Ingredients (LSI) | IMPROVED WOOD PRESERVATIVE FORMULATIONS | Australia | 2015215849 |
| Specialty Ingredients (LSI) | IMPROVEMENTS IN PRESERVATIVES FOR WOOD-BASED PRODUCTS | Australia | 2003288828 |
| Specialty Ingredients (LSI) | IMPROVEMENTS IN PRESERVATIVES FOR WOOD-BASED PRODUCTS | China | ZL200380106883.4 |
| Specialty Ingredients (LSI) | IMPROVEMENTS IN PRESERVATIVES FOR WOOD-BASED PRODUCTS | New Zealand | 523237 |
| Specialty Ingredients (LSI) | IN SITU PROCESS FOR PREPARING QUATERNARY AMMONIUM BICARBONATES AND QUATERNARY AMMONIUM CARBONATES. | United States | 6989459 |
| Specialty Ingredients (LSI) | IN SITU PROCESS FOR PREPARING QUATERNARY AMMONIUM BICARBONATES AND QUATERNARY AMMONIUM CARBONATES. | United States | 6784307 |
| Specialty Ingredients (LSI) | INSECTICIDAL COMPOSITION AND METHOD | Australia | 2015328781 |
| Specialty Ingredients (LSI) | INSECTICIDAL COMPOSITION AND METHOD | Australia | 2010237067 |
| Specialty Ingredients (LSI) | INSECTICIDAL COMPOSITION AND METHOD | New Zealand | 712998 |
| Specialty Ingredients (LSI) | INSECTICIDAL COMPOSITION AND METHOD | New Zealand | 576293 |
| Specialty Ingredients (LSI) | INSECTICIDAL COMPOSITION AND METHOD | United States | 8329310 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Australia | 2007267842 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Canada | 2653212 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | China | 101453899 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | France | 2742803 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | France | 3262941 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Germany | 2742803 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Germany | 3262941 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Italy | 2742803 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Italy | 3262941 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Japan | 5833053 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Malaysia | MY-154968-A |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Mexico | 307844 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | New Zealand | 572556 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Poland | 2742803 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Poland | 3262941 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Spain | 2742803 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | Spain | 3262941 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | United Kingdom | 2742803 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | United Kingdom | 3262941 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | United States | 9717250 |
| Specialty Ingredients (LSI) | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS | United States | 9723842 |
| Specialty Ingredients (LSI) | KIT FOR ON-THE-SHELF SALE | Australia | 2019100114 |
| Specialty Ingredients (LSI) | LIQUID LAUNDRY DETERGENT COMPOSITION FOR CLOTHING | United States | 10435652 |
| Specialty Ingredients (LSI) | METABOLIZED CONDITIONED GROWTH MEDIUM AND METHODS OF USE | United States | 9408881 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | France | 1296966 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | Germany | 60145942.3 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | Japan | 5107496 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | Korea, Republic of | 0873944 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | Netherlands | 1296966 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | Switzerland | 1296966 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | Taiwan, Province of China | 184786 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | United Kingdom | 1296966 |
| Specialty Ingredients (LSI) | METHOD AND COMPOSITIONS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN METAL WORKING FLUIDS | United States | 6861395 |
| Specialty Ingredients (LSI) | METHOD FOR DETERMINING BIOCIDES WITHIN WOOD | Australia | 2005201412 |
| Specialty Ingredients (LSI) | METHOD FOR DETERMINING BIOCIDES WITHIN WOOD | New Zealand | 532151 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Austria | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Belgium | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Canada | 2950972 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | China | 201580025257.5 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Czechia | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Denmark | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Finland | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | France | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Germany | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Hong Kong | 1230161 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Hungary | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Ireland | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Italy | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Japan | 6203431 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Korea, Republic of | 10-1763552 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Mexico | 361611 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Netherlands | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Poland | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Spain | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Sweden | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | Switzerland | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | United Kingdom | 3126344 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS CATALYSIS | United States | 9771367 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Austria | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Belgium | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Canada | 2966791 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | China | 201580060494.5 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Czechia | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Finland | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | France | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Germany | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Hong Kong | 1237759 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Italy | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Japan | 6240364 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Korea, Republic of | 10-1810378 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Netherlands | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | Switzerland | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | United Kingdom | 3215476 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HOMOGENEOUS CATALYSIS | United States | 9809596 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Australia | 2014259506 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Canada | 2877532 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | China | ZL201480001266.6 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | China | 201610584770.4 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | France | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Germany | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Hong Kong | 1214240 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Hong Kong | 1227843 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Israel | 235115 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Italy | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Japan | 5989873 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Japan | 5813276 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Korea, Republic of | 1530836 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Netherlands | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Spain | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Sweden | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | Switzerland | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | United Kingdom | 2841415 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF IMIDODISULFURYL COMPOUNDS | United States | 9546136 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF N-BUTYL NITRITE | China | 201680053036.3 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF N-BUTYL NITRITE | Germany | 3310752 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF N-BUTYL NITRITE | Japan | 6449519 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF N-BUTYL NITRITE | Korea, Republic of | 10-1874776 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF N-BUTYL NITRITE | Switzerland | 3310752 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARATION OF N-BUTYL NITRITE | United States | 10125087 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | France | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | Germany | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | Italy | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | Japan | 6559133 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | Netherlands | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | Spain | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | Sweden | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | Switzerland | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR PREPARING FIBER-REINFORCED PARTS BASED ON CYANATE ESTER/EPOXY BLENDS | United Kingdom | 3077449 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Australia | 2003243419 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Austria | 626706 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Brazil | PI0317589-8 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Canada | 2507978 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | China | 101239747 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | China | ZL 03825677.0 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | France | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Germany | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Hong Kong | 1087094 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Hong Kong | 1124304 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | India | 218892 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Italy | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Japan | 5551120 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Mexico | 266579 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | New Zealand | 540823 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Norway | 333931 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Poland | PAT.218746 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Slovenia | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | South Africa | 2005/4876 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Spain | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Sweden | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Switzerland | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | Turkey | 201313100 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | United Kingdom | 1578695 |
| Specialty Ingredients (LSI) | METHOD FOR REMOVAL OF BIOFILM | United States | 7407590 |
| Specialty Ingredients (LSI) | METHOD OF INHIBITING CORROSION USING A COMPOSITION OF QUATERNARY AMMONIUM SALTS CONTAINING NON-HALOGEN ANIONS. | United States | 9394617 |
| Specialty Ingredients (LSI) | METHOD OF PREPARING QUATERNARY AMMONIUM HYDROXIDE. | United States | 7057070 |
| Specialty Ingredients (LSI) | METHOD OF PREPARING WOOD PRESERVATIVE FORMULATIONS | Australia | 2015101283 |
| Specialty Ingredients (LSI) | METHOD OF SCAVENGING HYDROGEN SULFIDE AND/OR SULFHYDRYL COMPOUNDS | Australia | 2013306052 |
| Specialty Ingredients (LSI) | METHOD OF SCAVENGING HYDROGEN SULFIDE AND/OR SULFHYDRYL COMPOUNDS | Mexico | 361962 |
| Specialty Ingredients (LSI) | METHOD OF SCAVENGING HYDROGEN SULFIDE AND/OR SULFHYDRYL COMPOUNDS | Singapore | 11201501042W |
| Specialty Ingredients (LSI) | METHOD OF SCAVENGING HYDROGEN SULFIDE AND/OR SULFHYDRYL COMPOUNDS | United States | 9752083 |
| Specialty Ingredients (LSI) | METHODS FOR PRODUCING COPPER ETHANOLAMINE SOLUTIONS | Australia | 2004293437 |
| Specialty Ingredients (LSI) | METHODS FOR PRODUCING COPPER ETHANOLAMINE SOLUTIONS | Canada | 2565169 |
| Specialty Ingredients (LSI) | METHODS FOR PRODUCING COPPER ETHANOLAMINE SOLUTIONS | United Kingdom | 1692145 |
| Specialty Ingredients (LSI) | METHODS FOR PRODUCING COPPER ETHANOLAMINE SOLUTIONS | United States | 7273944 |
| Specialty Ingredients (LSI) | NON-SPHERICAL AND NON-PLATELET CRYSTALLINE FORMS OF ZINC PYRITHIONE | China | 00130989.7 |
| Specialty Ingredients (LSI) | NON-SPHERICAL AND NON-PLATELET CRYSTALLINE FORMS OF ZINC PYRITHIONE | Korea, Republic of | 0870254 |
| Specialty Ingredients (LSI) | NON-SPHERICAL AND NON-PLATELET CRYSTALLINE FORMS OF ZINC PYRITHIONE | United Kingdom | 2355458 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | France | 2299830 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | Germany | 2299830 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | Italy | 2299830 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | Japan | 5687193 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | United Kingdom | 2299830 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | United States | 9376659 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | United States | 9901538 |
| Specialty Ingredients (LSI) | PERSONAL CARE COMPOSITION CONTAINING "YEAST/RESVERATROL FERMENT" EXTRACT | United States | 9744121 |
| Specialty Ingredients (LSI) | POLYIMIDE OLIGOMERS | United States | 8901274 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Belgium | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | China | 201080006177.2 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Denmark | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | France | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Germany | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | India | 294049 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Italy | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Mexico | 328286 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Netherlands | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Spain | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Sweden | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | Switzerland | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | United Kingdom | 2391662 |
| Specialty Ingredients (LSI) | PREPARATION OF A PYRITHIONE SALT DISPERSION USABLE IN URETHANE APPLICATIONS | United States | 8901203 |
| Specialty Ingredients (LSI) | PRESERVATIVE BLENDS CONTAINING IODINE CONTAINING COMPOUNDS | United States | 6946427 |
| Specialty Ingredients (LSI) | PRESERVATIVE COMPOSITION FOR INDUSTRIAL USES | Japan | 5108264 |
| Specialty Ingredients (LSI) | PRESERVATIVE COMPOSITION FOR INDUSTRIAL USES | Korea, Republic of | 10-1431288 |
| Specialty Ingredients (LSI) | PRESERVATIVE COMPOSITION FOR WET WIPES | United States | 10271551 |
| Specialty Ingredients (LSI) | PRESERVATIVE CONCENTRATE FOR THE TREATMENT OF TIMBER | Australia | 2017101780 |
| Specialty Ingredients (LSI) | PRESERVATIVE FORMULATIONS FOR TREATING WOOD | Australia | 2015101281 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | Australia | 2012311460 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | Canada | 2849344 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | Denmark | 2758347 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | Mexico | 351425 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | Netherlands | 2758347 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | Norway | 2758347 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | United Kingdom | 2758347 |
| Specialty Ingredients (LSI) | PROCESS AND COMPOSITION FOR THE REMOVAL OF HYDROGEN SULFIDE FROM INDUSTRIAL PROCESS FLUIDS | United States | 9334182 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | China | ZL1380025889.2 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | France | 2834218 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | Germany | 2834218 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | India | 299647 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | Japan | 6148326 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | Korea, Republic of | 10-2063030 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | Spain | 2834218 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | United Kingdom | 2834218 |
| Specialty Ingredients (LSI) | PROCESS FOR PREPARING ALKALI METAL PYRITHIONE AND ITS POLYVALENT METAL COMPLEXES FROM PYRIDINE OXIDE | United States | 9079857 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | Canada | 2876281 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | China | ZL201380037175.3 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | France | 2872473 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | Germany | 2872473 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | Hong Kong | 1205097 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | Japan | 6284933 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | Netherlands | 2872473 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | Switzerland | 2872473 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | United Kingdom | 2872473 |
| Specialty Ingredients (LSI) | PROCESS FOR THE PRODUCTION OF METHYLBUTINOL | United States | 9284243 |
| Specialty Ingredients (LSI) | PROCESSES FOR PREPARING LINEAR POLYGLYCEROLS AND POLYGLYCEROL ESTERS | United States | 6620904 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Austria | 420224 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Finland | 1649079 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Germany | 602004018931.6-08 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Italy | 1649079 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Korea, Republic of | 1135915 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Netherlands | 1649079 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Poland | 1649079 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Slovakia | 1649079 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Spain | 2320997 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | Switzerland | 1649079 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM CARBONATES AND BICARBONATES AS ANTICORROSIVE AGENTS | United Kingdom | 1649079 |
| Specialty Ingredients (LSI) | QUATERNARY AMMONIUM SALTS CONTAINING NON-HALOGEN ANIONS AS ANTICORROSIVE AGENTS | United States | 9080064 |
| Specialty Ingredients (LSI) | REDUCED DRYING CARRIER FORMULATION | United States | 9045681 |
| Specialty Ingredients (LSI) | RIBBON TYPE STIRRING DEVICE | China | CN202921197 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | Australia | 2010229060 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | Canada | 2755647 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | China | ZL201080018489.5 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | France | 2410842 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | Germany | 2410842 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | Japan | 5855710 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | Japan | 5580876 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | South Africa | 2011006842 |
| Specialty Ingredients (LSI) | SANITIZER FORMULATIONS | United Kingdom | 2410842 |
| Specialty Ingredients (LSI) | STABILIZED ISOTHIAZOLONE-CONTAINING COMPOSITIONS | United States | 6566382 |
| Specialty Ingredients (LSI) | STABLE COMPOSITION FOR CONTROLLING BIOLOGICAL GROWTH AND METHOD FOR USING SAME IN OIL FIELD APPLICATIONS | United States | 9750258 |
| Specialty Ingredients (LSI) | STERILIZING DETERGENT COMPOSITION FOR BATHROOM | Japan | 5654892 |
| Specialty Ingredients (LSI) | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | Australia | 2017225057 |
| Specialty Ingredients (LSI) | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | France | 3042562 |
| Specialty Ingredients (LSI) | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | Germany | 3042562 |
| Specialty Ingredients (LSI) | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | Japan | 6469581 |
| Specialty Ingredients (LSI) | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | New Zealand | 708588 |
| Specialty Ingredients (LSI) | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | Sweden | 3042562 |
| Specialty Ingredients (LSI) | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | United Kingdom | 3042562 |
| Specialty Ingredients (LSI) | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS | United States | 8784910 |
| Specialty Ingredients (LSI) | SYNERGISTIC FUNGICIDAL COMPOSITIONS | Australia | 2013201498 |
| Specialty Ingredients (LSI) | SYNERGISTIC FUNGICIDAL COMPOSITIONS | Australia | 2015101115 |
| Specialty Ingredients (LSI) | SYNERGISTIC FUNGICIDAL COMPOSITIONS | Australia | 2014100897 |
| Specialty Ingredients (LSI) | SYNERGISTIC FUNGICIDAL COMPOSITIONS | New Zealand | 594861 |
| Specialty Ingredients (LSI) | SYNERGISTIC FUNGICIDAL COMPOSITIONS AND METHODS OF USE | United States | 9439429 |
| Specialty Ingredients (LSI) | SYNERGISTIC FUNGICIDAL COMPOSITIONS AND METHODS OF USE | United States | 9826740 |
| Specialty Ingredients (LSI) | SYNERGISTIC HERBICIDAL COMPOSITION | New Zealand | 584359 |
| Specialty Ingredients (LSI) | SYNERGISTIC HERBICIDAL COMPOSITIONS COMPRISING DIFLUFENICAN AND FLUMETSULAM | Australia | 2011224112 |
| Specialty Ingredients (LSI) | SYNERGISTIC HERBICIDAL COMPOSITIONS COMPRISING DIFLUFENICAN AND FLUMETSULAM | Australia | 2003201298 |
| Specialty Ingredients (LSI) | SYNERGISTIC HERBICIDAL COMPOSITIONS COMPRISING DIFLUFENICAN AND FLUMETSULAM | New Zealand | 588247 |
| Specialty Ingredients (LSI) | SYNERGISTIC HERBICIDAL COMPOSITIONS COMPRISING DIFLUFENICAN AND FLUMETSULAM | New Zealand | 517784 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Australia | 2014301021 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Brazil | 0913389-5 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Brazil | 112015032601-3 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | China | 200980129152.9 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | China | 201480036200.0 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Eurasian Patent | 021050 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | France | 3013311 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | France | 2296614 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Germany | 3013311 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Germany | 60 2009 004 788.4 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | India | 282631 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Israel | 243177 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | Japan | 5990344 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | United Kingdom | 3013311 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | United Kingdom | 2296614 |
| Specialty Ingredients (LSI) | SYNERGISTIC PRESERVATIVE BLENDS | United States | 9060952 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | France | 2293670 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | Germany | 2293670 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | India | 279960 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | Italy | 2293670 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | Netherlands | 2293670 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | Poland | 2293670 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | Spain | 2293670 |
| Specialty Ingredients (LSI) | TOPICAL PYRITHIONE COMPOSITIONS AND METHODS FOR TREATMENT OF NAIL FUNGUS | United Kingdom | 2293670 |
| Specialty Ingredients (LSI) | ULTRA LOW LOSS DIELECTRIC THERMOSETTING RESIN COMPOSITIONS AND HIGH PREFORMANCE LAMINATES MANUFACTURED THEREFROM | Korea, Republic of | 10-1819949 |
| Specialty Ingredients (LSI) | ULTRA LOW LOSS DIELECTRIC THERMOSETTING RESIN COMPOSITIONS AND HIGH PREFORMANCE LAMINATES MANUFACTURED THEREFROM | Taiwan, Province of China | I617594 |
| Specialty Ingredients (LSI) | ULTRA LOW LOSS DIELECTRIC THERMOSETTING RESIN COMPOSITIONS AND HIGH PREFORMANCE LAMINATES MANUFACTURED THEREFROM | United States | 9439284 |
| Specialty Ingredients (LSI) | ULTRA LOW LOSS DIELECTRIC THERMOSETTING RESIN COMPOSITIONS AND HIGH PREFORMANCE LAMINATES MANUFACTURED THEREFROM | United States | 9332637 |
| Specialty Ingredients (LSI) | ULTRAFILTRATION DEVICE | China | CN202924800 |
| Specialty Ingredients (LSI) | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | Australia | 2007203439 |
| Specialty Ingredients (LSI) | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | Canada | 2481088 |
| Specialty Ingredients (LSI) | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | China | 627609 |
| Specialty Ingredients (LSI) | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | Hong Kong | 1080747 |
| Specialty Ingredients (LSI) | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | Mexico | 286183 |
| Specialty Ingredients (LSI) | VIRUCIDAL DISINFECTANT | Germany | 1469729 |
| Specialty Ingredients (LSI) | VIRUCIDAL DISINFECTANT | Spain | 1469729 |
| Specialty Ingredients (LSI) | VIRUCIDAL DISINFECTANT | United Kingdom | 1469729 |
| Specialty Ingredients (LSI) | VIRUCIDAL DISINFECTANT | United States | 8221733 |
| Specialty Ingredients (LSI) | VISCOSITY BUILDING COMPOSITION FOR PERSONAL CARE PRODUCTS | United States | 10064809 |
| Specialty Ingredients (LSI) | VISCOSITY BUILDING COMPOSITION FOR PERSONAL CARE PRODUCTS | United States | 9867769 |
| Specialty Ingredients (LSI) | WATER-SOLUBLE COMPOSITION TO BE IMPREGNATED TO FIBER SHEET | China | ZL201310028226.8 |
| Specialty Ingredients (LSI) | WATER-SOLUBLE COMPOSITION TO BE IMPREGNATED TO FIBER SHEET | Indonesia | IDP0053249 |
| Specialty Ingredients (LSI) | WATER-SOLUBLE COMPOSITION TO BE IMPREGNATED TO FIBER SHEET | Japan | 5845098 |
| Specialty Ingredients (LSI) | WATER-SOLUBLE COMPOSITION TO BE IMPREGNATED TO FIBER SHEET | Taiwan, Province of China | I603698 |
| Specialty Ingredients (LSI) | WET WIPE CONCENTRATE | United States | 10117818 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITION | Canada | 2714681 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITION | United States | 8414931 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITION | United States | 8293282 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Australia | 2011268757 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Canada | 2803092 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | China | ZL201180031591.3 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Denmark | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Finland | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | France | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Ireland | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Japan | 6590409 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Netherlands | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | New Zealand | 600636 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Norway | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Portugal | 105766 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Spain | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | Sweden | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | United Kingdom | 2481526 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | United Kingdom | 2582234 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | United Kingdom | 2554623 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | United Kingdom | 2549423 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | United States | 9023483 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE COMPOSITIONS USEFUL FOR TREATING COPPER-TOLERANT FUNGI | United States | 9023483 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS | Australia | 2013200225 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS | Australia | 2007253048 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS | New Zealand | 596157 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS | New Zealand | 573995 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS COMPRISING ISOTHIAZOLONES WHICH PROVIDE PROTECTIN AGAINST SURFACE STAINING | Australia | 2011239731 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS COMPRISING ISOTHIAZOLONES WHICH PROVIDE PROTECTIN AGAINST SURFACE STAINING | Canada | 2796022 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS COMPRISING ISOTHIAZOLONES WHICH PROVIDE PROTECTIN AGAINST SURFACE STAINING | China | 201180028807.0 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS COMPRISING ISOTHIAZOLONES WHICH PROVIDE PROTECTIN AGAINST SURFACE STAINING | Japan | 5952262 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVE FORMULATIONS COMPRISING ISOTHIAZOLONES WHICH PROVIDE PROTECTIN AGAINST SURFACE STAINING | New Zealand | 602919 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVES | Australia | 2006220419 |
| Specialty Ingredients (LSI) | WOOD PRESERVATIVES | New Zealand | 567062 |
Trademark Portfolio - Pharma Biotech & Nutrition
| Business Sector | Title | Country | Trademark Number | |
|---|---|---|---|---|
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | China | 8085918 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | China | 8085917 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | China | 8085916 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | European Union | 1040412 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | Germany | 30 2009 050 887.9 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | Japan | 1040412 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | Korea, Republic of | 1040412 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | Madrid Protocol | 1040412 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | Singapore | 1040412 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | Switzerland | 604959 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | United Kingdom | UK00801040412 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | United States | 3976607 | |
| Pharma Biotech & Nutrition (LPBN) | 4D-NUCLEOFECTOR | United States | 3976607 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO | Canada | TMA594851 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO | United States | 2964802 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO & Design | Canada | TMA606108 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO & Design | European Union | 1360557 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO & Design | Madrid Protocol | 1360557 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO & Design | Switzerland | 1360557 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO & Design | United Kingdom | UK00801360557 | |
| Pharma Biotech & Nutrition (LPBN) | 7-KETO & Design | United States | 2675783 | |
| Pharma Biotech & Nutrition (LPBN) | 96-WELL SHUTTLE | China | 891232 | |
| Pharma Biotech & Nutrition (LPBN) | 96-WELL SHUTTLE | European Union | 891232 | |
| Pharma Biotech & Nutrition (LPBN) | 96-WELL SHUTTLE | Germany | 30552368 | |
| Pharma Biotech & Nutrition (LPBN) | 96-WELL SHUTTLE | Japan | 891232 | |
| Pharma Biotech & Nutrition (LPBN) | 96-WELL SHUTTLE | Madrid Protocol | 891232 | |
| Pharma Biotech & Nutrition (LPBN) | 96-WELL SHUTTLE | United Kingdom | UK00800891232 | |
| Pharma Biotech & Nutrition (LPBN) | ABUSOLVE | European Union | 4424479 | |
| Pharma Biotech & Nutrition (LPBN) | ABUSOLVE | United Kingdom | UK00904424479 | |
| Pharma Biotech & Nutrition (LPBN) | ACCUGENE | European Union | 1366585 | |
| Pharma Biotech & Nutrition (LPBN) | ACCUGENE | Madrid Protocol | 1366585 | |
| Pharma Biotech & Nutrition (LPBN) | ACCUGENE | United Kingdom | UK00801366585 | |
| Pharma Biotech & Nutrition (LPBN) | ACCUGENE & Design | United States | 1957961 | |
| Pharma Biotech & Nutrition (LPBN) | ALL COLOR CAPSULES | United States | 5577613 | |
| Pharma Biotech & Nutrition (LPBN) | ALLER-7 | Canada | TMA651466 | |
| Pharma Biotech & Nutrition (LPBN) | ALLER-7 | European Union | 018001494 | |
| Pharma Biotech & Nutrition (LPBN) | ALLER-7 | India | 4032595 | |
| Pharma Biotech & Nutrition (LPBN) | ALLER-7 | United Kingdom | UK00918001494 | |
| Pharma Biotech & Nutrition (LPBN) | ALLER-7 | United States | 2883022 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | Canada | 555973 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | China | 921576 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | European Union | 001254218 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | Japan | 4479396 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | Korea, Republic of | 921576 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | Madrid Protocol | 921576 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | United Kingdom | UK00901254218 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | United States | 2787139 | |
| Pharma Biotech & Nutrition (LPBN) | AMAXA | United States | 2640104 | |
| Pharma Biotech & Nutrition (LPBN) | ARROWS - CURVED (Coni-Snap Sprinkle) | European Union | 12255022 | |
| Pharma Biotech & Nutrition (LPBN) | ARROWS - CURVED (Coni-Snap Sprinkle) | United Kingdom | UK00912255022 | |
| Pharma Biotech & Nutrition (LPBN) | ARROWS - CURVED (Coni-Snap Sprinkle) | United States | 4902312 | |
| Pharma Biotech & Nutrition (LPBN) | AUTHORIZED RESELLER M MODA & Design | Brazil | 831127562 | |
| Pharma Biotech & Nutrition (LPBN) | AUTHORIZED RESELLER M MODA & Design | European Union | 1095422 | |
| Pharma Biotech & Nutrition (LPBN) | AUTHORIZED RESELLER M MODA & Design | India | 2200645 | |
| Pharma Biotech & Nutrition (LPBN) | AUTHORIZED RESELLER M MODA & Design | Japan | 1095422 | |
| Pharma Biotech & Nutrition (LPBN) | AUTHORIZED RESELLER M MODA & Design | Madrid Protocol | 1095422 | |
| Pharma Biotech & Nutrition (LPBN) | AUTHORIZED RESELLER M MODA & Design | Singapore | T1116239G | |
| Pharma Biotech & Nutrition (LPBN) | AUTHORIZED RESELLER M MODA & Design | United Kingdom | UK00801095422 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Australia | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Brazil | 917904958 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Brazil | 917905059 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | European Union | 018097826 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | India | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Japan | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Korea, Republic of | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Madrid Protocol | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | New Zealand | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Russian Federation | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Singapore | 1487777 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | Switzerland | 740990 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | United Kingdom | UK00918097826 | |
| Pharma Biotech & Nutrition (LPBN) | BACTHERA | United States | 6062366 | |
| Pharma Biotech & Nutrition (LPBN) | BEBM | United States | 1790002 | |
| Pharma Biotech & Nutrition (LPBN) | BEGM | United States | 1790008 | |
| Pharma Biotech & Nutrition (LPBN) | BEND RESEARCH | United States | 4124543 | |
| Pharma Biotech & Nutrition (LPBN) | BIOWHITTAKER | European Union | 011490001 | |
| Pharma Biotech & Nutrition (LPBN) | BIOWHITTAKER | United Kingdom | UK00911490001 | |
| Pharma Biotech & Nutrition (LPBN) | BIOWHITTAKER | United States | 4334146 | |
| Pharma Biotech & Nutrition (LPBN) | BUILT ON QUALITY. BACKED BY SCIENCE. | United States | 6165060 | |
| Pharma Biotech & Nutrition (LPBN) | BULLETKIT | European Union | 003997319 | |
| Pharma Biotech & Nutrition (LPBN) | BULLETKIT | Germany | 39403221 | |
| Pharma Biotech & Nutrition (LPBN) | BULLETKIT | United Kingdom | UK00903997319 | |
| Pharma Biotech & Nutrition (LPBN) | BULLETKIT | United States | 1789993 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Algeria | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Argentina | 2221181 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Australia | 433683 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Australia | 1167658 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Austria | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Austria | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Bangladesh | 22936 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Belarus | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Benelux | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Benelux | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Bolivia, Plurinational State of | 77255 C | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Bosnia & Herzegovina | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Brazil | 828925445 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Brazil | 828925453 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Brazil | 828925437 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Brazil | 790372215 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Brazil | 828925461 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Bulgaria | 15428 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Bulgaria | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Bulgaria | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Canada | TMA283614 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Canada | TMA730,565 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Chile | 793131 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | China | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | China | 230192 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | China | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Colombia | 106080 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Croatia | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Croatia | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Cuba | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Czechia | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Czechia | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Denmark | VR 002057 1998 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Ecuador | 2390-1985 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Egypt | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Egypt | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | El Salvador | 12Book88 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Estonia | 15835 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | European Union | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Finland | 212224 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | France | N 1489718 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | France | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | France | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Germany | 2037022 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Germany | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Germany | 30641156 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Germany | 1032440 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Greece | 135630 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Guatemala | 41046 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Hong Kong | 1987B2263 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Hungary | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Hungary | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Iceland | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Iceland | V0029097 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | India | 1522264 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | India | 1522263 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | India | 1522265 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | India | 443594 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Indonesia | IDM000109035 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Indonesia | IDM000171964 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Indonesia | IDM000171963 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Indonesia | IDM000171962 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Ireland | 218710 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Israel | 116673 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Italy | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Italy | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Japan | 1650953 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Japan | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Jordan | 23809 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Korea, Democratic People's Republic of | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Korea, Republic of | 4002082880000 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Latvia | M31217 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Lebanon | 146352 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Liechtenstein | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Liechtenstein | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Lithuania | 23936 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Macedonia, The Former Yugoslav Republic of | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Macedonia, The Former Yugoslav Republic of | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Madrid Protocol | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Madrid Protocol | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Madrid Protocol | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Malaysia | 85004299 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Mexico | 1023932 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Mexico | 1847364 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Mexico | 336388 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Mexico | 1020911 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Mexico | 290781 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Monaco | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Mongolia | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Montenegro | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Morocco | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Morocco | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | New Zealand | 161210 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Nicaragua | 11601 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Norway | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Norway | 190540 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Pakistan | 87706 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Panama | 96735 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Paraguay | 344540 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Peru | PI0087699 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Philippines | 42003008990 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Poland | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Portugal | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Portugal | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Romania | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Romania | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Russian Federation | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Russian Federation | 72166 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | San Marino | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Serbia | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Serbia | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Singapore | T9800044J | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Slovakia | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Slovakia | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Slovenia | 359713 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Slovenia | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | South Africa | 1985/7098 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Spain | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Sri Lanka | 50667 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Sudan | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Sudan | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Sudan | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Sweden | 332449 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Switzerland | 372682 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Switzerland | 914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Switzerland | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Taiwan, Province of China | 1334196 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Taiwan, Province of China | 342671 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Thailand | 37121 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Thailand | 284274 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Thailand | KOR33838 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Thailand | 296720 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Turkey | 95992 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Ukraine | 8855 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Ukraine | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | United Kingdom | 2028537 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | United Kingdom | UK00800914930 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | United States | 1174776 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | United States | 3877206 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Uruguay | 433801 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL | Viet Nam | 603692 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL - BEYOND THE CAPSULE | China | 1529543 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL - BEYOND THE CAPSULE | European Union | 01821391 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL - BEYOND THE CAPSULE | Madrid Protocol | 1529543 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL - BEYOND THE CAPSULE | Russian Federation | 1529543 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL - BEYOND THE CAPSULE | United Kingdom | 1529543 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL - BEYOND THE CAPSULE | United Kingdom | UK00918212391 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSUGEL (Katakana Characters) | Japan | 2423087 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULE CONCIERGE | China | 1545239 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULE CONCIERGE | European Union | "1545239 | " |
| Pharma Biotech & Nutrition (LPBN) | CAPSULE CONCIERGE | Madrid Protocol | 1545239 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULE CONCIERGE | United Kingdom | UK00801545239 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULE CONCIERGE | United States | 6176839 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULE CONCIERGE | United States | 6246459 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULECADDY | European Union | 1510121 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULECADDY | Madrid Protocol | 1510121 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULECADDY | United Kingdom | UK00801510121 | |
| Pharma Biotech & Nutrition (LPBN) | CAPSULECADDY | United States | 6031338 | |
| Pharma Biotech & Nutrition (LPBN) | CARDIASLIM | Brazil | 911377409 | |
| Pharma Biotech & Nutrition (LPBN) | CARDIASLIM | Canada | TMA1028318 | |
| Pharma Biotech & Nutrition (LPBN) | CARDIASLIM | Mexico | 1689236 | |
| Pharma Biotech & Nutrition (LPBN) | CARDIASLIM | United States | 4280541 | |
| Pharma Biotech & Nutrition (LPBN) | CARDIASLIM | United States | 4280541 | |
| Pharma Biotech & Nutrition (LPBN) | CARDIASLIM & Design | United States | 5354535 | |
| Pharma Biotech & Nutrition (LPBN) | CARNICHROME | Canada | 570057 | |
| Pharma Biotech & Nutrition (LPBN) | CARNICHROME | Mexico | 724459 | |
| Pharma Biotech & Nutrition (LPBN) | CARNICHROME | Switzerland | 490212 | |
| Pharma Biotech & Nutrition (LPBN) | CARNICHROME | Taiwan, Province of China | 01720558 | |
| Pharma Biotech & Nutrition (LPBN) | CARNICHROME | United States | 2656114 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Argentina | 2352223 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Austria | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Benelux | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Brazil | 819124168 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Canada | TMA434962 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Chile | 760478 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | China | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Colombia | 190446 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Czechia | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Denmark | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Ecuador | 414798 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Finland | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | France | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Germany | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Greece | 148418 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Hungary | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Indonesia | 562792 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Iran, Islamic Republic of | 99594 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Ireland | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Italy | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Japan | 3169521 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Korea, Republic of | 436514 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Madrid Protocol | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Malaysia | 9302185 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Norway | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Peru | 25577 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Poland | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Portugal | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Romania | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Russian Federation | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Singapore | T9302318C | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Slovakia | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Slovenia | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | South Africa | 199817043 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Spain | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Sweden | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Switzerland | 399345 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Taiwan, Province of China | 615884 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Thailand | 29627 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Ukraine | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | United Kingdom | 1530377 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | United States | 1835611 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Venezuela, Bolivarian Republic of | 198946 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIFEED | Viet Nam | 598163 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Argentina | 2351643 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Austria | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Benelux | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Brazil | 819124150 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Canada | TMA434961 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Chile | 761162 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | China | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Colombia | 160445 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Czechia | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Ecuador | 332597 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | European Union | 1262922 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | France | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Germany | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Greece | 145419 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Hungary | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | India | 1267477 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Indonesia | 562731 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Iran, Islamic Republic of | 99595 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Italy | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Japan | 3169522 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Korea, Republic of | 436513 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Madrid Protocol | 1267477 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Madrid Protocol | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Malaysia | 93002184 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Myanmar | 482602018 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Peru | 25576 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Philippines | 4-1993-060241 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Poland | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Portugal | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Romania | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Russian Federation | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Singapore | T9302319A | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Slovakia | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | South Africa | 1998/17044 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Spain | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Switzerland | 399346 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Taiwan, Province of China | 615885 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Thailand | 29628 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Ukraine | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | United Kingdom | UK00801262922 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | United Kingdom | 1530265 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | United States | 1831509 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Venezuela, Bolivarian Republic of | 198945 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING | Viet Nam | 598164 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING & Design | Madrid Protocol | 1262922 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING & Design | United States | 5069638 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING & Design (Chinese Characters) | China | 9240055 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING & Design (Chinese Characters) | China | 9239757 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING (Chinese Characters) | Taiwan, Province of China | 1056676 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING (Chinese Characters) | Taiwan, Province of China | 1059007 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIKING (Katakana Characters) | Japan | 6175050 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Austria | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Benelux | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Canada | 578192 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Chile | 915696 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Chile | 913874 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | China | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Czechia | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | France | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Germany | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Greece | 145417 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Hungary | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Iran, Islamic Republic of | 99601 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Italy | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Japan | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Korea, Republic of | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Madrid Protocol | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Poland | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Portugal | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Romania | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Russian Federation | 0705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Slovenia | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Spain | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Switzerland | 456924 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPASS | Ukraine | 705361 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Albania | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Algeria | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Argentina | 2220527 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Argentina | 2220526 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Australia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Austria | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Bahrain | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Belarus | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Benelux | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Bolivia, Plurinational State of | 163683 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Bolivia, Plurinational State of | 168942 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Bosnia & Herzegovina | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Botswana | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Brazil | 910172692 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Brazil | 901610437 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Brazil | 829137858 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Brazil | 829137840 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Bulgaria | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Canada | 1031309 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Canada | TMA821933 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Canada | TMA834673 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Chile | 866964 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Chile | 806618 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | China | 1292229 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | China | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | China | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Colombia | 391517 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Colombia | 341186 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Colombia | 341187 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Costa Rica | 247111 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Croatia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Cyprus | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Czechia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Denmark | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Dominican Republic | 240996 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Ecuador | SENADI_2020_TI_25759 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Egypt | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Egypt | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Estonia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | European Union | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | European Union | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | European Union | 014709497 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Finland | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | France | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Georgia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Georgia | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Germany | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Greece | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Hong Kong | 301290050 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Hungary | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | India | 1292229 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | India | 1791245 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | India | 1546665 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Indonesia | IDM000281150 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Indonesia | IDM000276881 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Indonesia | IDM000276880 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Iran, Islamic Republic of | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Ireland | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Israel | 219398 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Israel | 219397 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Israel | 219396 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Italy | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Japan | 1292229 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Japan | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Kazakhstan | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Kazakhstan | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Korea, Republic of | 1292229 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Korea, Republic of | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Kosovo | 20973 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Latvia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Liechtenstein | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Lithuania | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Macedonia, The Former Yugoslav Republic of | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Macedonia, The Former Yugoslav Republic of | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Madrid Protocol | 1292229 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Madrid Protocol | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Madrid Protocol | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Malaysia | 7005908 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Malaysia | 7005907 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Malaysia | 9002382 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Mexico | 1292229 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Mexico | 999574 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Mexico | 1099635 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Mexico | 1053497 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Montenegro | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Morocco | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Morocco | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Namibia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Namibia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Namibia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | New Zealand | 802464 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | New Zealand | 766054 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Norway | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Pakistan | 262209 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Pakistan | 261,956 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Pakistan | 261,955 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Peru | 486 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Philippines | 42009001930 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Poland | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Portugal | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Romania | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Russian Federation | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Russian Federation | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Saudi Arabia | 116025 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Saudi Arabia | 116026 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Serbia | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Serbia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Singapore | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Singapore | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Slovakia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Slovenia | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | South Africa | 2009/03064 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | South Africa | 2009/03063 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Spain | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Sweden | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Switzerland | 682,929 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Switzerland | 556613 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Switzerland | 595659 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Syrian Arab Republic | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Syrian Arab Republic | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Taiwan, Province of China | 1320416 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Taiwan, Province of China | 1408397 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Thailand | 171115655 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Thailand | 278449 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Thailand | 321970 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Thailand | 279480 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Turkey | 200409750 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Turkey | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Turkey | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Ukraine | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Ukraine | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | United Kingdom | WO0000000923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | United Kingdom | UK00801042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | United Kingdom | UK00914709497 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | United Kingdom | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | United Kingdom | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | United States | 4836564 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | United States | 3402122 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Uruguay | 400048 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Viet Nam | 1292229 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Viet Nam | 1042829 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE | Viet Nam | 923115 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Australia | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Brazil | 908464614 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Brazil | 908464649 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Brazil | 908464738 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Brazil | 908464703 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Brazil | 908464584 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Canada | TMA941,621 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | China | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Colombia | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | European Union | 012023354 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Germany | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Hong Kong | 301288684 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | India | 1791248 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Japan | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Korea, Republic of | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Madrid Protocol | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Malaysia | 2016059329 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Malaysia | 2016059327 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Mexico | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | New Zealand | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Paraguay | 422254 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Paraguay | 422253 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Peru | 14851 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Russian Federation | 488528 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Russian Federation | 488537 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Switzerland | 585474 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Thailand | 171102429 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Thailand | 161101440 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Turkey | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | Ukraine | 1014293 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | United Kingdom | UK00912023354 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | United States | 4836563 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | United States | 4027560 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE & Design | United States | 4836923 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE BUILT ON QUALITY. BACKED BY SCIENCE | European Union | 014309091 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE BUILT ON QUALITY. BACKED BY SCIENCE | Switzerland | 679672 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE BUILT ON QUALITY. BACKED BY SCIENCE | United Kingdom | UK00914309091 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE MUSCLEGUARD | European Union | 015079148 | |
| Pharma Biotech & Nutrition (LPBN) | CARNIPURE MUSCLEGUARD | United Kingdom | UK00915079148 | |
| Pharma Biotech & Nutrition (LPBN) | CELLMATE | United Kingdom | 1421705 | |
| Pharma Biotech & Nutrition (LPBN) | CFS 1200 | European Union | 018092637 | |
| Pharma Biotech & Nutrition (LPBN) | CFS 1200 | United Kingdom | UK00918092637 | |
| Pharma Biotech & Nutrition (LPBN) | CFS 1200 | United States | 5971573 | |
| Pharma Biotech & Nutrition (LPBN) | CFS 1500 | European Union | 018092658 | |
| Pharma Biotech & Nutrition (LPBN) | CFS 1500 | United Kingdom | UK00918092658 | |
| Pharma Biotech & Nutrition (LPBN) | CFS 1500 | United States | 5971575 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | China | 1369192 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | European Union | 1369192 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | Japan | 1369192 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | Korea, Republic of | 1369192 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | Madrid Protocol | 1369192 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | Switzerland | 715732 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | United Kingdom | UK00801369192 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV | United States | 5547865 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | China | 1368482 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | European Union | 1368482 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | Japan | 1368482 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | Korea, Republic of | 1368482 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | Madrid Protocol | 1368482 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | Singapore | 1368482 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | Switzerland | 720058 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | United Kingdom | UK00801368482 | |
| Pharma Biotech & Nutrition (LPBN) | CHOK1SV GS-KO | United States | 5420763 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Canada | TMA594244 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Colombia | 598559 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | European Union | 3600293 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Korea, Republic of | 40-1341025 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Mexico | 1121824 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Mexico | 1121825 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | New Zealand | 222713 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | New Zealand | 222712 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Singapore | T9305095D | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Singapore | T9305096B | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Taiwan, Province of China | 1052842 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | Taiwan, Province of China | 1080401 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | United Kingdom | UK00903600293 | |
| Pharma Biotech & Nutrition (LPBN) | CHROMEMATE | United States | 1627865 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Australia | 651200 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Benelux | 557461 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Brazil | 818559314 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Canada | TMA479729 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | China | 14028249 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | China | 14028250 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Czechia | 264318 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Denmark | VR199406548 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | European Union | 3600351 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Germany | 2912744 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Hong Kong | 199915958A | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Israel | 96665 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Italy | 1111544 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Japan | 4155163 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Japan | 4311582 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Japan | 4091521 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Japan | 4155162 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Korea, Republic of | 40-357720 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Malaysia | 95004319 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Mexico | 796096 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Mexico | 742218 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Mexico | 531270 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | New Zealand | 237963 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Poland | 184151 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Singapore | T94/06574B | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | South Africa | 95/0740 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | Taiwan, Province of China | 685601 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | United Kingdom | 1577297 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | United Kingdom | UK00903600351 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX | United States | 2563916 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX & Design | United States | 2710696 | |
| Pharma Biotech & Nutrition (LPBN) | CITRIMAX (Katakana Characters) | Japan | 4335719 | |
| Pharma Biotech & Nutrition (LPBN) | CLONETICS | European Union | 003997293 | |
| Pharma Biotech & Nutrition (LPBN) | CLONETICS | United Kingdom | UK00903997293 | |
| Pharma Biotech & Nutrition (LPBN) | CLONETICS | United States | 2744944 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | Australia | 1447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | Australia | 1375927 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | Canada | TMA848616 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | China | 37708191 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | European Union | 1447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | European Union | 009295007 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | India | 1447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | Israel | 1447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | Madrid Protocol | 1447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | Singapore | 1447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | Switzerland | 1447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | United Kingdom | UK00909295007 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | United Kingdom | UK00801447955 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | United States | 5825316 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON | United States | 4350511 | |
| Pharma Biotech & Nutrition (LPBN) | COCOON ORCHARD | European Union | 018326741 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | Canada | 1092810 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | Canada | 1092809 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | European Union | 017998920 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | European Union | 017927766 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | United Kingdom | UK00917927766 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | United Kingdom | UK00917998920 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | United States | 5910192 | |
| Pharma Biotech & Nutrition (LPBN) | COLORISTA | United States | 5735495 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Argentina | 2488481 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Australia | 325298 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Bolivia, Plurinational State of | 54513-A | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Brazil | 790012740 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Canada | TMA248658 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Chile | 888197 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Costa Rica | 56001 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | El Salvador | 106 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | India | 166777 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Indonesia | IDM000243922 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Japan | 1527539 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Korea, Republic of | 208290 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Malaya | M/081428 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | New Zealand | 126423 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Nicaragua | 10550 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Singapore | T7979137C | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Thailand | 85921 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Uruguay | 156003 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP | Venezuela, Bolivarian Republic of | F099111 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Armenia | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Austria | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Belarus | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Benelux | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Bosnia & Herzegovina | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | China | 230193 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Colombia | 131992 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Croatia | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Czechia | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Denmark | VR 001348 1981 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Egypt | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | European Union | 7420342 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Finland | 81974 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | France | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Germany | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Hong Kong | 300984790 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Hungary | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Italy | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Japan | 2669478 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Kazakhstan | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Kyrgyzstan | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Macedonia, The Former Yugoslav Republic of | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Madrid Protocol | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Malaysia | 2000/10109 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Mexico | 399496 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Moldova, Republic of | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Pakistan | 89538 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Portugal | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Romania | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Russian Federation | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Serbia | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Serbia & Montenegro | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Singapore | T8304354H | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Slovakia | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Slovenia | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | South Africa | 1980/05682 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Spain | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Sweden | 173808 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Switzerland | 2P-297434 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Taiwan, Province of China | 479629 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Tajikistan | 44617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Ukraine | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | United Kingdom | 1139546 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | United Kingdom | UK00907420342 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | United States | 1172814 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP | Uzbekistan | 444617 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP (Katakana Characters) | Japan | 2669479 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP CAPSUGEL | Indonesia | IDM000448641 | |
| Pharma Biotech & Nutrition (LPBN) | CONI-SNAP CAPSUGEL | Malaysia | 10091 | |
| Pharma Biotech & Nutrition (LPBN) | CONISNAP SUPRO | Canada | TMA345834 | |
| Pharma Biotech & Nutrition (LPBN) | CYTAIR | Benelux | 425530 | |
| Pharma Biotech & Nutrition (LPBN) | CYTAIR | France | 1393057 | |
| Pharma Biotech & Nutrition (LPBN) | CYTAIR | Germany | 1117645 | |
| Pharma Biotech & Nutrition (LPBN) | CYTAIR | Switzerland | 2P-355955 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Canada | TMA747790 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | European Union | 8214785 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Finland | 201387 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | France | 94530989 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Germany | 2098565 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Indonesia | IDM000091479 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Italy | 1613184 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Japan | 5331072 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Malaysia | 2000/10112 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Norway | 170394 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | Spain | 787407 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | United Kingdom | UK00908214785 | |
| Pharma Biotech & Nutrition (LPBN) | DBCAPS | United States | 1993968 | |
| Pharma Biotech & Nutrition (LPBN) | DELIVERING THE MEDICINES OF TOMORROW, TODAY | Japan | 1345743 | |
| Pharma Biotech & Nutrition (LPBN) | DELIVERING THE MEDICINES OF TOMORROW, TODAY | Madrid Protocol | 1345743 | |
| Pharma Biotech & Nutrition (LPBN) | DELIVERING THE MEDICINES OF TOMORROW, TODAY | Switzerland | 1345743 | |
| Pharma Biotech & Nutrition (LPBN) | DELIVERING THE MEDICINES OF TOMORROW, TODAY | United States | 5228273 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | Australia | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | China | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | European Union | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | India | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | Japan | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | Madrid Protocol | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | New Zealand | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | Russian Federation | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | Singapore | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | Taiwan, Province of China | 02022152 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | Turkey | 1468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | United Kingdom | UK00801468980 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS | United States | 5863290 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Brazil | 831060018 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Canada | TMA847,001 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | China | 19504907 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | European Union | 9984221 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Hong Kong | 302362815 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | India | 1454680 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Indonesia | IDM000472557 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Japan | 5462523 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Madrid Protocol | 1454680 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Malaysia | 2012014785 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Russian Federation | 606599 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Singapore | 1454680 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Taiwan, Province of China | 1588275 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | Thailand | 171122242 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | United Kingdom | UK00909984221 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design | United States | 4169138 | |
| Pharma Biotech & Nutrition (LPBN) | DRCAPS & Design (Color) | Turkey | 201853957 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Australia | 1472340 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Brazil | 913932604 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Canada | TMA1004721 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | China | 1472340 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | European Union | 018020146 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | European Union | 1296021 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | India | 1472340 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Japan | 1296021 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Japan | 1472340 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Madrid Protocol | 1296021 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Madrid Protocol | 1472340 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Mexico | 1296021 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | Russian Federation | 1472340 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | United Kingdom | UK00801296021 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | United Kingdom | UK00918020146 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | United States | 4991824 | |
| Pharma Biotech & Nutrition (LPBN) | DUOCAP | United States | 6240397 | |
| Pharma Biotech & Nutrition (LPBN) | EASY ACCESS | United States | 4223333 | |
| Pharma Biotech & Nutrition (LPBN) | E-BIOTICS | Brazil | 919541674 | |
| Pharma Biotech & Nutrition (LPBN) | E-BIOTICS | Brazil | 919541666 | |
| Pharma Biotech & Nutrition (LPBN) | E-BIOTICS | European Union | 018219663 | |
| Pharma Biotech & Nutrition (LPBN) | E-BIOTICS | Madrid Protocol | 1533070 | |
| Pharma Biotech & Nutrition (LPBN) | E-BIOTICS | United Kingdom | UK00918219663 | |
| Pharma Biotech & Nutrition (LPBN) | E-BIOTICS | United Kingdom | 1533070 | |
| Pharma Biotech & Nutrition (LPBN) | EBM | European Union | 003997145 | |
| Pharma Biotech & Nutrition (LPBN) | EBM | United Kingdom | UK00903997145 | |
| Pharma Biotech & Nutrition (LPBN) | EBM | United States | 1789992 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | China | 1398944 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | European Union | 017722315 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | India | 1398944 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | Ireland | 258872 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | Korea, Republic of | 1398944 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | Madrid Protocol | 1398944 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | Singapore | 1398944 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | Switzerland | 717765 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | United Kingdom | UK00917722315 | |
| Pharma Biotech & Nutrition (LPBN) | ECHO | United States | 6142276 | |
| Pharma Biotech & Nutrition (LPBN) | EGM | European Union | 003997103 | |
| Pharma Biotech & Nutrition (LPBN) | EGM | United Kingdom | UK00903997103 | |
| Pharma Biotech & Nutrition (LPBN) | EGM | United States | 1789991 | |
| Pharma Biotech & Nutrition (LPBN) | ENDOTOXIN EXPERTISE AT YOUR FINGERTIPS | United States | 5198939 | |
| Pharma Biotech & Nutrition (LPBN) | ENERGIZE. RECOVER. REPEAT. | United States | 5042690 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | European Union | 1299115 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | India | 1299115 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | Israel | 1299115 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | Japan | 1299115 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | Madrid Protocol | 1299115 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | United Kingdom | UK00801299115 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | United States | 5519969 | |
| Pharma Biotech & Nutrition (LPBN) | ENTRINSIC | United States | 5257327 | |
| Pharma Biotech & Nutrition (LPBN) | EPIBASE | Benelux | 714221 | |
| Pharma Biotech & Nutrition (LPBN) | EPIBASE | European Union | 006618177 | |
| Pharma Biotech & Nutrition (LPBN) | EPIBASE | United Kingdom | UK00906618177 | |
| Pharma Biotech & Nutrition (LPBN) | EPIBASE | United States | 4060274 | |
| Pharma Biotech & Nutrition (LPBN) | ESF9 | European Union | 017722281 | |
| Pharma Biotech & Nutrition (LPBN) | ESF9 | Switzerland | 717707 | |
| Pharma Biotech & Nutrition (LPBN) | ESF9 | United Kingdom | UK00917722281 | |
| Pharma Biotech & Nutrition (LPBN) | FASTLANE | United States | 1646544 | |
| Pharma Biotech & Nutrition (LPBN) | FASTLANE | United States | 2872844 | |
| Pharma Biotech & Nutrition (LPBN) | FBM | United States | 1790007 | |
| Pharma Biotech & Nutrition (LPBN) | FGM | United States | 1790006 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Argentina | 2373265 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Argentina | 2373264 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Australia | 1336901 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Belarus | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Canada | TMA1005949 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Chile | 880206 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | China | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | China | 1020824 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Colombia | 397624 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Colombia | 397625 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Egypt | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | European Union | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | European Union | 1020824 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Georgia | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Hong Kong | 301415772 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Japan | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Kazakhstan | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Madrid Protocol | 1020824 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Madrid Protocol | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Mexico | 1188626 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Morocco | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | New Zealand | 811816 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Russian Federation | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Russian Federation | 1020824 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Serbia | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Singapore | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Switzerland | 586088 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Switzerland | 582176 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Taiwan, Province of China | 1409696 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Turkey | 1020824 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Turkey | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Ukraine | 1020824 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | Ukraine | 1020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | United Kingdom | UK00801020888 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | United Kingdom | UK00801020824 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID | United States | 2238437 | |
| Pharma Biotech & Nutrition (LPBN) | FIBERAID & Design | Canada | TMA1005921 | |
| Pharma Biotech & Nutrition (LPBN) | FLASHGEL | European Union | 004294757 | |
| Pharma Biotech & Nutrition (LPBN) | FLASHGEL | United Kingdom | UK00904294757 | |
| Pharma Biotech & Nutrition (LPBN) | FLASHGEL | United States | 3152117 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | European Union | 1091502 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | Germany | 1091502 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | Japan | 1091502 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | Madrid Protocol | 1091502 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | Switzerland | 613687 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | United Kingdom | 1091502 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | United Kingdom | UK00811091502 | |
| Pharma Biotech & Nutrition (LPBN) | FLOWPLATE | United States | 4159710 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | Australia | 1522558 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | European Union | 018104427 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | Madrid Protocol | 1522558 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | New Zealand | 1522558 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | Russian Federation | 1522558 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | Switzerland | 1522558 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | United Kingdom | UK00918104427 | |
| Pharma Biotech & Nutrition (LPBN) | FOOD COLORED CAPSULES & Design | United States | 6160955 | |
| Pharma Biotech & Nutrition (LPBN) | GS | European Union | 1501568 | |
| Pharma Biotech & Nutrition (LPBN) | GS | Madrid Protocol | 1501568 | |
| Pharma Biotech & Nutrition (LPBN) | GS | Singapore | 1501568 | |
| Pharma Biotech & Nutrition (LPBN) | GS | Switzerland | 744845 | |
| Pharma Biotech & Nutrition (LPBN) | GS | United Kingdom | UK00801501568 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | China | 1472593 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | European Union | 018057787 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | India | 1472593 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | Israel | 1472593 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | Japan | 1472593 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | Madrid Protocol | 1472593 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | Singapore | 1472593 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | Switzerland | 1472593 | |
| Pharma Biotech & Nutrition (LPBN) | GS DISCOVERY | United Kingdom | UK00918057787 | |
| Pharma Biotech & Nutrition (LPBN) | GS GENE EXPRESSION SYSTEM | European Union | 1334739 | |
| Pharma Biotech & Nutrition (LPBN) | GS GENE EXPRESSION SYSTEM | Japan | 1334739 | |
| Pharma Biotech & Nutrition (LPBN) | GS GENE EXPRESSION SYSTEM | Madrid Protocol | 1334739 | |
| Pharma Biotech & Nutrition (LPBN) | GS GENE EXPRESSION SYSTEM | Singapore | 1334739 | |
| Pharma Biotech & Nutrition (LPBN) | GS GENE EXPRESSION SYSTEM | Switzerland | 694401 | |
| Pharma Biotech & Nutrition (LPBN) | GS GENE EXPRESSION SYSTEM | United Kingdom | UK00801334739 | |
| Pharma Biotech & Nutrition (LPBN) | GS GENE EXPRESSION SYSTEM | United States | 5253431 | |
| Pharma Biotech & Nutrition (LPBN) | GS KNOCKOUT | European Union | 1369191 | |
| Pharma Biotech & Nutrition (LPBN) | GS KNOCKOUT | Madrid Protocol | 1369191 | |
| Pharma Biotech & Nutrition (LPBN) | GS KNOCKOUT | Switzerland | 755920 | |
| Pharma Biotech & Nutrition (LPBN) | GS KNOCKOUT | United Kingdom | UK00801369191 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | China | 1436448 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | European Union | 1436448 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | India | 1436448 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | Madrid Protocol | 1436448 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | Singapore | 1436448 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | Switzerland | 727313 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | United Kingdom | 1436448 | |
| Pharma Biotech & Nutrition (LPBN) | GS PIGGYBAC | United Kingdom | UK00801436448 | |
| Pharma Biotech & Nutrition (LPBN) | GS SYSTEM | European Union | 1335391 | |
| Pharma Biotech & Nutrition (LPBN) | GS SYSTEM | India | 1335391 | |
| Pharma Biotech & Nutrition (LPBN) | GS SYSTEM | Madrid Protocol | 1335391 | |
| Pharma Biotech & Nutrition (LPBN) | GS SYSTEM | Singapore | 1335391 | |
| Pharma Biotech & Nutrition (LPBN) | GS SYSTEM | Switzerland | 694,402 | |
| Pharma Biotech & Nutrition (LPBN) | GS SYSTEM | United Kingdom | UK00801335391 | |
| Pharma Biotech & Nutrition (LPBN) | GS SYSTEM | United States | 5388853 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | China | 1340400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | European Union | 1340400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | India | 1340400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | Japan | 1,340,400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | Madrid Protocol | 1340400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | Singapore | 1340400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | Switzerland | 1,340,400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | United Kingdom | UK00801340400 | |
| Pharma Biotech & Nutrition (LPBN) | GS XCEED | United States | 4271475 | |
| Pharma Biotech & Nutrition (LPBN) | GSV9 | China | 1559439 | |
| Pharma Biotech & Nutrition (LPBN) | GSV9 | Madrid Protocol | 1559439 | |
| Pharma Biotech & Nutrition (LPBN) | GSV9 | United Kingdom | 1559439 | |
| Pharma Biotech & Nutrition (LPBN) | GTG | United States | 2524654 | |
| Pharma Biotech & Nutrition (LPBN) | HEALTHCARE CONTINUUM | European Union | 016630221 | |
| Pharma Biotech & Nutrition (LPBN) | HEALTHCARE CONTINUUM | United Kingdom | UK00916630221 | |
| Pharma Biotech & Nutrition (LPBN) | HMß | Hungary | 772056 | |
| Pharma Biotech & Nutrition (LPBN) | HMß | Poland | 772056 | |
| Pharma Biotech & Nutrition (LPBN) | HMß | Spain | 772056 | |
| Pharma Biotech & Nutrition (LPBN) | HORSESHOE CRAB DNA HELIX & Design | United States | 4135650 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | European Union | 1437268 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | European Union | 016804676 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | Madrid Protocol | 1437268 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | Singapore | 1437268 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | Switzerland | 707753 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | Switzerland | 1437268 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | United Kingdom | UK00916804676 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX | United Kingdom | UK00801437268 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX - THE AGILE ADVANTAGE | European Union | 016804668 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX - THE AGILE ADVANTAGE | Japan | 1360428 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX - THE AGILE ADVANTAGE | Madrid Protocol | 1360428 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX - THE AGILE ADVANTAGE | Singapore | 1360428 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX - THE AGILE ADVANTAGE | Switzerland | 707754 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX - THE AGILE ADVANTAGE | United Kingdom | UK00916804668 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX - THE AGILE ADVANTAGE | United Kingdom | 1360428 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX & Design | European Union | 1447128 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX & Design | Japan | 1447128 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX & Design | Madrid Protocol | 1447128 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX & Design | Singapore | 1447128 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX & Design | Switzerland | 1447128 | |
| Pharma Biotech & Nutrition (LPBN) | IBEX & Design | United Kingdom | UK00801447128 | |
| Pharma Biotech & Nutrition (LPBN) | IMMUNENHANCER | United States | 3770187 | |
| Pharma Biotech & Nutrition (LPBN) | IMMUNOTUNING & Design | Benelux | 749396 | |
| Pharma Biotech & Nutrition (LPBN) | INTERHEALTH NUTRACEUTICALS | United States | 2547696 | |
| Pharma Biotech & Nutrition (LPBN) | ISOGEL | United States | 1217161 | |
| Pharma Biotech & Nutrition (LPBN) | KBM | European Union | 003997095 | |
| Pharma Biotech & Nutrition (LPBN) | KBM | Germany | 39403133 | |
| Pharma Biotech & Nutrition (LPBN) | KBM | United Kingdom | UK00903997095 | |
| Pharma Biotech & Nutrition (LPBN) | KBM | United States | 1789990 | |
| Pharma Biotech & Nutrition (LPBN) | KGM | European Union | 003997129 | |
| Pharma Biotech & Nutrition (LPBN) | KGM | United Kingdom | UK00903997129 | |
| Pharma Biotech & Nutrition (LPBN) | KGM | United States | 3070262 | |
| Pharma Biotech & Nutrition (LPBN) | KINETIC-QCL | European Union | 003997467 | |
| Pharma Biotech & Nutrition (LPBN) | KINETIC-QCL | United Kingdom | UK00903997467 | |
| Pharma Biotech & Nutrition (LPBN) | KINETIC-QCL | United States | 1815650 | |
| Pharma Biotech & Nutrition (LPBN) | L7 | European Union | 1199597 | |
| Pharma Biotech & Nutrition (LPBN) | L7 | Madrid Protocol | 1199597 | |
| Pharma Biotech & Nutrition (LPBN) | L7 | United Kingdom | UK00801199597 | |
| Pharma Biotech & Nutrition (LPBN) | L7 | United States | 4672996 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | Brazil | 917634705 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | Brazil | 917634624 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | Canada | 1015879 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | European Union | 013962972 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | India | 4219694 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | Madrid Protocol | 1286864 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | Mexico | 1286864 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | United Kingdom | UK00913962972 | |
| Pharma Biotech & Nutrition (LPBN) | LARAFEED | United States | 2681803 | |
| Pharma Biotech & Nutrition (LPBN) | LATITUDE | European Union | 001020353 | |
| Pharma Biotech & Nutrition (LPBN) | LATITUDE | Japan | 4326124 | |
| Pharma Biotech & Nutrition (LPBN) | LATITUDE | United Kingdom | UK00901020353 | |
| Pharma Biotech & Nutrition (LPBN) | LATITUDE | United States | 2427388 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE | India | 1048763 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE | Japan | 4783707 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE | Madrid Protocol | 839750 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE | Mexico | 863239 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE (Chinese Characters) | China | 829141 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE (Chinese Characters) | Hong Kong | 300229310 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE (Chinese Characters) | Madrid Protocol | 829141 | |
| Pharma Biotech & Nutrition (LPBN) | L-CARNIPURE (Chinese Characters) | Switzerland | 522845 | |
| Pharma Biotech & Nutrition (LPBN) | LEMS | European Union | 018079627 | |
| Pharma Biotech & Nutrition (LPBN) | LEMS | United Kingdom | UK00918079627 | |
| Pharma Biotech & Nutrition (LPBN) | LEMS | United States | 2662510 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Argentina | 2734023 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Argentina | 2550436 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Australia | 908274 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Austria | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Bangladesh | 23719 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Belarus | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Benelux | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Benelux | 413089 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Bosnia & Herzegovina | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Brazil | 812083733 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Canada | 737533 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Chile | 936995 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | China | 5229563 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Colombia | 264436 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Egypt | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | European Union | CTM005018461 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | France | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Germany | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Greece | 147607 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Hong Kong | 300231803 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | India | 1434202 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | India | 439844 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Indonesia | IDM00091459 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Italy | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Italy | 362015000028218 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Japan | 5074104 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Jordan | 66463 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Kazakhstan | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Korea, Republic of | 4001309130000 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Madrid Protocol | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Malaysia | 10116 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Mexico | 846012 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Mexico | 952327 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Montenegro | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | New Zealand | 765198 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Norway | 216646 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Pakistan | 86859 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Philippines | 42011000522 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Russian Federation | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Serbia | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Singapore | T0711925C | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | South Africa | 200818388 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Spain | 2322739 M7 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Spain | 1142926 M7 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Sweden | 356890 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Switzerland | 3P-290135 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Taiwan, Province of China | 479631 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Taiwan, Province of China | 1260271 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Thailand | KOR256642 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Thailand | KOR256643 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Thailand | KOR30502 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Tunisia | TN/E/2011/00087 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Turkey | 2009 34199 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Ukraine | 433836 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | United Kingdom | UK00905018461 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | United Kingdom | 1244950 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | United States | 3362544 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | United States | 1408173 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS | Viet Nam | 4-0125719-000 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Australia | 1103246 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Bulgaria | 68231 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Canada | 1293303 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | European Union | 5022264 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | India | 1433117 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Indonesia | IDM000318738 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Japan | 5000536 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Mexico | 930344 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Russian Federation | 680531 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Taiwan, Province of China | 1245958 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Thailand | KOR256640 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | Thailand | 256641 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | United Kingdom | UK00905022264 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS & Design | United States | 3362545 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS (Katakana Characters) | Japan | 4998635 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS VISIBLE LIQUID CAPSULE & Design | Brazil | 828264970 | |
| Pharma Biotech & Nutrition (LPBN) | LICAPS VISIBLE LIQUID CAPSULE & Design | China | 5217441 | |
| Pharma Biotech & Nutrition (LPBN) | LIPIDEX | European Union | 11967221 | |
| Pharma Biotech & Nutrition (LPBN) | LIPIDEX | Japan | 5632732 | |
| Pharma Biotech & Nutrition (LPBN) | LIPIDEX | Mexico | 1463695 | |
| Pharma Biotech & Nutrition (LPBN) | LIPIDEX | United Kingdom | UK00911967221 | |
| Pharma Biotech & Nutrition (LPBN) | LONGDA | China | 23278856 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Algeria | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Algeria | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Argentina | 2092149 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Argentina | 2086001 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Argentina | 2048862 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Australia | 254463 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Australia | 254461 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Australia | 137886 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Australia | 1552324 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Austria | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Austria | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Austria | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Benelux | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Benelux | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Benelux | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Bolivia, Plurinational State of | 142507 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Bosnia & Herzegovina | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Bosnia & Herzegovina | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Brazil | 912246804 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Brazil | 911504958 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Brazil | 911505024 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Brazil | 2299542 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Brazil | 2316056 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Brazil | 911504940 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Bulgaria | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Bulgaria | 8718 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Canada | 1056266 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Canada | TMDA18816 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Chile | 1006164 formerly 660912 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Chile | 1078442 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Chile | 1237313 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | China | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | China | 70084 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | China | 70083 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | China | 70083 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | China | 70087 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Colombia | 575596 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Colombia | 465446 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Croatia | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Croatia | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Croatia | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Cuba | 110949 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Cuba | 108923 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Czechia | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Czechia | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Czechia | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Denmark | 195802173 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Denmark | 197202552 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Ecuador | 3399-13 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Egypt | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Egypt | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Egypt | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Estonia | 6825 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Estonia | 8620 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | European Union | 001101898 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | European Union | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Finland | 34238 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | France | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | France | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | France | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Georgia | 425 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Georgia | 426 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Germany | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Germany | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Germany | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Germany | 923914 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Ghana | 18491 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Ghana | 18494 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Greece | 23071 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Hong Kong | 19721562AA | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Hong Kong | 19721448AA | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Hungary | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Hungary | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Hungary | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 291427 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 185939 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 185938 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 185937 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 185936 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 291431 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 291430 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 291428 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | India | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Indonesia | IDM000788821 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Indonesia | IDM000117275 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Indonesia | IDM000117276 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Indonesia | IDM000652535 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Ireland | 62415 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Ireland | 79971 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 16687 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 16686 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 16685 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 16684 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 34451 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 34454 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 34452 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 34456 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Israel | 16688 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Italy | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Italy | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Italy | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Japan | 3157933 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Japan | 1417754 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Japan | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Japan | 1365518 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Japan | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Japan | 1267891 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Kazakhstan | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Korea, Democratic People's Republic of | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Korea, Democratic People's Republic of | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Korea, Republic of | 347510 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Korea, Republic of | 356223 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Latvia | 14932 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Latvia | 19144 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Liechtenstein | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Liechtenstein | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Liechtenstein | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Lithuania | 6196 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Lithuania | 6197 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Macau | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Macau | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Macedonia, The Former Yugoslav Republic of | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Macedonia, The Former Yugoslav Republic of | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Macedonia, The Former Yugoslav Republic of | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Madrid Protocol | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Madrid Protocol | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Madrid Protocol | 1155028 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Madrid Protocol | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Madrid Protocol | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Malaysia | 95007459 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Malaysia | 2016066899 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Malaysia | 95007458 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Malaysia | 2016066900 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Mexico | 94769 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Monaco | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Montenegro | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Montenegro | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Montenegro | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Morocco | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Morocco | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Morocco | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | New Zealand | 98524 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | New Zealand | 98526 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | New Zealand | 98523 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | New Zealand | 98527 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Nigeria | 64988 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Nigeria | 64990 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Nigeria | 65882 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Nigeria | 38356 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Nigeria | 38354 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Norway | 52323 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Pakistan | 29520 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Pakistan | 29519 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Pakistan | 60077 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Pakistan | 60076 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Pakistan | 60078 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Pakistan | 66453 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Pakistan | 66452 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Peru | 248025 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Peru | 9533 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Philippines | 42011006254 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Philippines | 4201700003219 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Poland | R49,553 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Portugal | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Portugal | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Portugal | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Romania | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Romania | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Romania | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Russian Federation | 44307 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Russian Federation | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | San Marino | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | San Marino | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | San Marino | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Serbia | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Serbia | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Serbia | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Singapore | T9503516B | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Singapore | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Singapore | T9503517J | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Slovakia | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Slovakia | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Slovakia | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Slovenia | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Slovenia | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Slovenia | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | South Africa | 743585 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | South Africa | 743582 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | South Africa | 743581 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | South Africa | 743583 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | South Africa | 743586 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | South Africa | 743587 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | South Africa | 743584 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Spain | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Spain | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Spain | 138182 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Sri Lanka | 73905 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Sri Lanka | 73906 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Sweden | 17002 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Sweden | 101915 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Switzerland | 1262560 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Switzerland | 651968 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Switzerland | P364350 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Taiwan, Province of China | 719101 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Taiwan, Province of China | 738761 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Tunisia | 381034 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Tunisia | EE030193 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Turkey | 77180 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | United Kingdom | UK00901101898 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | United Kingdom | 985126 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | United Kingdom | 813597 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | United Kingdom | 777775 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | United States | 956300 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | United States | 4922144 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | United States | 4483125 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | F071498 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | F071496 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | F071495 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | 71499 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | F071500 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | 79427F | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | 72345 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Venezuela, Bolivarian Republic of | 71497 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA | Viet Nam | 265860 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA - DELIVERING THE MEDICINES OF TOMORROW, TODAY | European Union | 016315905 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA - DELIVERING THE MEDICINES OF TOMORROW, TODAY | United Kingdom | UK00916315905 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA - SMARTER THAN YOU THINK | European Union | 018194245 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA - SMARTER THAN YOU THINK | United Kingdom | UK00918194245 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Australia | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Australia | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Azerbaijan | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Belarus | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Brazil | 912246715 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Brazil | 912246782 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Brazil | 912246731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Brazil | 912246758 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Canada | TMA936561 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Canada | TMA929787 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Chile | 1245987 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 23075516 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5202933 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5202932 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 1422434 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5202934 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5202935 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5148117 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5148119 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5148118 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5148353 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | China | 5148855 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Colombia | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Colombia | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | European Union | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | European Union | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Iceland | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | India | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | India | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Japan | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Japan | 5819625 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Korea, Republic of | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Madrid Protocol | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Madrid Protocol | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | New Zealand | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Russian Federation | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Russian Federation | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Russian Federation | 30018 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Russian Federation | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Singapore | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Singapore | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Switzerland | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Switzerland | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Switzerland | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Switzerland | P351,562 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Taiwan, Province of China | 1873338 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Turkey | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Turkey | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Ukraine | 1330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Ukraine | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Ukraine | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | United Kingdom | UK00801330731 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | United Kingdom | UK00801204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | United States | 5222498 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | United States | 4639815 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Uzbekistan | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA & Design | Uzbekistan | 1204258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA (Chinese Characters) | China | 1074148 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA (Katakana Characters) | Japan | 1947974 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA (Taiwanese Characters) | Thailand | Kor61032 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | Brazil | 919150845 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | Brazil | 919150497 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | China | 1492721 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | European Union | 1492721 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | Madrid Protocol | 1492721 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | Switzerland | 1492721 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | United Kingdom | UK00801492721 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA ENGINE | United States | 6082076 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA -THE HEALTHCARE CONTINUUM | European Union | 016630238 | |
| Pharma Biotech & Nutrition (LPBN) | LONZA -THE HEALTHCARE CONTINUUM | United Kingdom | UK00916630238 | |
| Pharma Biotech & Nutrition (LPBN) | LONZEAL | China | 10268258 | |
| Pharma Biotech & Nutrition (LPBN) | LONZEAL | China | 10268260 | |
| Pharma Biotech & Nutrition (LPBN) | LONZEAL | China | 10268262 | |
| Pharma Biotech & Nutrition (LPBN) | LONZEAL | China | 10268259 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | China | 1467038 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | European Union | 017912858 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | Madrid Protocol | 1467038 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | Russian Federation | 1467038 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | Thailand | KOR203999 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | Turkey | "1467038 | " |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | United Kingdom | UK00917912858 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC | United States | 5359392 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC & Design | Canada | 1067740 | |
| Pharma Biotech & Nutrition (LPBN) | L-OPTIZINC & Design | United States | 5373862 | |
| Pharma Biotech & Nutrition (LPBN) | LUCETTA | European Union | 1068000 | |
| Pharma Biotech & Nutrition (LPBN) | LUCETTA | Germany | 302009057018 | |
| Pharma Biotech & Nutrition (LPBN) | LUCETTA | Madrid Protocol | 1068000 | |
| Pharma Biotech & Nutrition (LPBN) | LUCETTA | United Kingdom | UK00801068000 | |
| Pharma Biotech & Nutrition (LPBN) | LUCETTA | United States | 4152218 | |
| Pharma Biotech & Nutrition (LPBN) | M & Design | United States | 3676260 | |
| Pharma Biotech & Nutrition (LPBN) | M MODA & Design | Brazil | 830964347 | |
| Pharma Biotech & Nutrition (LPBN) | M MODA & Design | European Union | 1079896 | |
| Pharma Biotech & Nutrition (LPBN) | M MODA & Design | Japan | 1079896 | |
| Pharma Biotech & Nutrition (LPBN) | M MODA & Design | Madrid Protocol | 1079896 | |
| Pharma Biotech & Nutrition (LPBN) | M MODA & Design | Singapore | T1108693C | |
| Pharma Biotech & Nutrition (LPBN) | M MODA & Design | United Kingdom | UK00801079896 | |
| Pharma Biotech & Nutrition (LPBN) | M MODA & Design | United States | 4212373 | |
| Pharma Biotech & Nutrition (LPBN) | M MODA MORE SCIENCE. LESS PAPER. & Design | United States | 4117511 | |
| Pharma Biotech & Nutrition (LPBN) | MADE BETTER. BY SCIENCE. | Madrid Protocol | 1505340 | |
| Pharma Biotech & Nutrition (LPBN) | MADE BETTER. BY SCIENCE. | United States | 6120583 | |
| Pharma Biotech & Nutrition (LPBN) | MAST | European Union | 016421695 | |
| Pharma Biotech & Nutrition (LPBN) | MAST | United Kingdom | UK00916421695 | |
| Pharma Biotech & Nutrition (LPBN) | MAST | United States | 5796717 | |
| Pharma Biotech & Nutrition (LPBN) | MAST & Design | United States | 6263580 | |
| Pharma Biotech & Nutrition (LPBN) | MBM | United States | 1803996 | |
| Pharma Biotech & Nutrition (LPBN) | MDE | United States | 2609983 | |
| Pharma Biotech & Nutrition (LPBN) | MEBM | United States | 1790005 | |
| Pharma Biotech & Nutrition (LPBN) | MEGM | United States | 1790003 | |
| Pharma Biotech & Nutrition (LPBN) | METAPHOR | Germany | 2099302 | |
| Pharma Biotech & Nutrition (LPBN) | METAPHOR | Japan | 3154191 | |
| Pharma Biotech & Nutrition (LPBN) | METAPHOR | United Kingdom | 1543788 | |
| Pharma Biotech & Nutrition (LPBN) | METAPHOR | United States | 2590772 | |
| Pharma Biotech & Nutrition (LPBN) | MGM | United States | 1789997 | |
| Pharma Biotech & Nutrition (LPBN) | Misc. (Straight Arrows) Design | European Union | 018320710 | |
| Pharma Biotech & Nutrition (LPBN) | MISCELLAENOUS DESIGN | China | 5959762 | |
| Pharma Biotech & Nutrition (LPBN) | MODA | India | 2153155 | |
| Pharma Biotech & Nutrition (LPBN) | MODA | United States | 4134297 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | Brazil | 830964371 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | Canada | 858846 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | China | 1080008 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | European Union | 1080008 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | India | 1279966 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | Japan | 1080008 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | Madrid Protocol | 1080008 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | Singapore | T1108709C | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | United Kingdom | UK00801080008 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-EM | United States | 4130823 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-ES | European Union | 018065343 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-ES | United Kingdom | UK00918065343 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-ES | United States | 6004099 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | Brazil | 830964380 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | Canada | 860551 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | China | 1080007 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | European Union | 1080007 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | India | 1097091 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | Japan | 1080007 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | Madrid Protocol | 1080007 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | Singapore | T1108708E | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | United Kingdom | UK00801080007 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-FDC | United States | 4134296 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | Brazil | 830964355 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | Canada | TMA896,365 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | China | 1080354 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | European Union | 1080354 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | Japan | 1080354 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | Madrid Protocol | 1080354 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | Singapore | T1109088D | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | United Kingdom | UK00801080354 | |
| Pharma Biotech & Nutrition (LPBN) | MODA-VIP | United States | 4361816 | |
| Pharma Biotech & Nutrition (LPBN) | MORE SCIENCE. LESS PAPER. | Australia | 1079810 | |
| Pharma Biotech & Nutrition (LPBN) | MORE SCIENCE. LESS PAPER. | European Union | 1079810 | |
| Pharma Biotech & Nutrition (LPBN) | MORE SCIENCE. LESS PAPER. | Japan | 1079810 | |
| Pharma Biotech & Nutrition (LPBN) | MORE SCIENCE. LESS PAPER. | Madrid Protocol | 1079810 | |
| Pharma Biotech & Nutrition (LPBN) | MORE SCIENCE. LESS PAPER. | Singapore | T1108680A | |
| Pharma Biotech & Nutrition (LPBN) | MORE SCIENCE. LESS PAPER. | United Kingdom | UK00801079810 | |
| Pharma Biotech & Nutrition (LPBN) | MORE SCIENCE. LESS PAPER. | United States | 4057717 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | China | 19126322A | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | China | 19126322 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | France | 164320056 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | Israel | 1483895 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | Italy | 302017000007980 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | Madrid Protocol | 1483895 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | Spain | 3637237 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | Turkey | 1483895 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD | United Kingdom | UK00003193556 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD WITH CARNIPURE | Brazil | 910950369 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD WITH CARNIPURE | Brazil | 910950440 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD WITH CARNIPURE | China | 1303763 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD WITH CARNIPURE | China | 30286653 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD WITH CARNIPURE | European Union | 015326499 | |
| Pharma Biotech & Nutrition (LPBN) | MUSCLEGUARD WITH CARNIPURE | United Kingdom | UK00915326499 | |
| Pharma Biotech & Nutrition (LPBN) | MYCOALERT | European Union | 2829653 | |
| Pharma Biotech & Nutrition (LPBN) | MYCOALERT | Japan | 4755050 | |
| Pharma Biotech & Nutrition (LPBN) | MYCOALERT | United Kingdom | UK00902829653 | |
| Pharma Biotech & Nutrition (LPBN) | MYCOALERT | United States | 2889813 | |
| Pharma Biotech & Nutrition (LPBN) | NHEPS | European Union | 000650788 | |
| Pharma Biotech & Nutrition (LPBN) | NHEPS | United Kingdom | UK00900650788 | |
| Pharma Biotech & Nutrition (LPBN) | NIAMAX | Australia | 1146302 | |
| Pharma Biotech & Nutrition (LPBN) | NIAMAX | Canada | TMA753635 | |
| Pharma Biotech & Nutrition (LPBN) | NIAMAX | China | 5755862 | |
| Pharma Biotech & Nutrition (LPBN) | NIAMAX | Indonesia | IDM000168795 | |
| Pharma Biotech & Nutrition (LPBN) | NIAMAX | Japan | 5062592 | |
| Pharma Biotech & Nutrition (LPBN) | NIAMAX | Mexico | 965199 | |
| Pharma Biotech & Nutrition (LPBN) | NIAMAX | United States | 2988157 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | China | 5148602 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | China | 5148601 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | European Union | 004880548 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | Germany | 30546724 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | Japan | 901419 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | Madrid Protocol | 901419 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | United Kingdom | UK00904880548 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOCUVETTE | United States | 3288423 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Australia | 993426 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Canada | 779810 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | China | 5756356 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | China | 5756355 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | European Union | 993426 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Japan | 993426 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Korea, Republic of | 40-0772176 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Madrid Protocol | 993426 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Madrid Protocol | 975413 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Switzerland | 993426 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | Taiwan, Province of China | 1960224 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | United Kingdom | UK00800993426 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTION | United States | 5864847 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Australia | 897952 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Australia | 1174412 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Canada | 585865 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Canada | 714310 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | China | 5756359 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | China | 5756358 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | China | 5756357 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | European Union | 002497188 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Germany | 30137839 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Germany | 30634963 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Japan | 919120 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Japan | 4653888 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Korea, Republic of | 919120 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Madrid Protocol | 919120 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Switzerland | 498570 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Switzerland | 556835 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | Taiwan, Province of China | 1957071 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | United Kingdom | UK00902497188 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | United States | 2792329 | |
| Pharma Biotech & Nutrition (LPBN) | NUCLEOFECTOR | United States | 3431457 | |
| Pharma Biotech & Nutrition (LPBN) | NUKLEOFEKTION | Canada | 583207 | |
| Pharma Biotech & Nutrition (LPBN) | NUKLEOFEKTION | European Union | 002065175 | |
| Pharma Biotech & Nutrition (LPBN) | NUKLEOFEKTION | Germany | 30058774 | |
| Pharma Biotech & Nutrition (LPBN) | NUKLEOFEKTION | Japan | 4536859 | |
| Pharma Biotech & Nutrition (LPBN) | NUSIEVE | Germany | 1147524 | |
| Pharma Biotech & Nutrition (LPBN) | NUSIEVE | Japan | 2307463 | |
| Pharma Biotech & Nutrition (LPBN) | NUSIEVE | United States | 1333903 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | Canada | TMA831,501 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | China | 5963487 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | European Union | 5780762 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | Mexico | 982950 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | Russian Federation | 425765 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | Switzerland | 559685 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | Thailand | 273846 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | Ukraine | 135992 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | United Kingdom | UK00905780762 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS | United States | 3463352 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANCAPS (Katakana Characters) | Japan | 5088624 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | Australia | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | Brazil | 916295346 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | Brazil | 916295303 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | China | 37632125 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | China | 44620703 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | European Union | 017984165 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | India | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | Israel | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | Korea, Republic of | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | Madrid Protocol | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | New Zealand | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | Switzerland | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | United Kingdom | UK00917984165 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | United Kingdom | 1439955 | |
| Pharma Biotech & Nutrition (LPBN) | OCEANIX | United States | 5998730 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | Brazil | 819929700 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | Dominican Republic | 106376 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | European Union | 3600483 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | India | 3807806 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | India | 3807806 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | New Zealand | 222715 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | New Zealand | 222714 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | Singapore | T9305097J | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | Taiwan, Province of China | 1052841 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | Taiwan, Province of China | 1090496 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | United Kingdom | UK00903600483 | |
| Pharma Biotech & Nutrition (LPBN) | OPTIZINC | United States | 2516452 | |
| Pharma Biotech & Nutrition (LPBN) | ORGANICAPS | European Union | 002893097 | |
| Pharma Biotech & Nutrition (LPBN) | ORGANICAPS | Madrid Protocol | 1557089 | |
| Pharma Biotech & Nutrition (LPBN) | ORGANICAPS | Russian Federation | 1557089 | |
| Pharma Biotech & Nutrition (LPBN) | ORGANICAPS | United Kingdom | UK00902893097 | |
| Pharma Biotech & Nutrition (LPBN) | ORGANICAPS | United Kingdom | 1557089 | |
| Pharma Biotech & Nutrition (LPBN) | PAGER | Australia | 752784 | |
| Pharma Biotech & Nutrition (LPBN) | PAGER | European Union | 000727743 | |
| Pharma Biotech & Nutrition (LPBN) | PAGER | United Kingdom | UK00900727743 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | Canada | TMA592,107 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | France | 023156411 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | Germany | 30216209 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | India | 1091408 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | Japan | 4641730 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | Mexico | 746091 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | United Kingdom | 2296671 | |
| Pharma Biotech & Nutrition (LPBN) | PCCAPS | United States | 2678299 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | Canada | TMA861607 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | China | 1130766 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | European Union | 6345491 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | Japan | 4148265 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | Switzerland | 565677 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | Thailand | kor307126 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | United Kingdom | UK00906345491 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS | United States | 3978429 | |
| Pharma Biotech & Nutrition (LPBN) | PEARLCAPS (Chinese Characters) | China | 1032648 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Argentina | 2732002 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Brazil | 840719685 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Canada | TMA900,440 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | China | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Colombia | 491657 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Costa Rica | 224181 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Ecuador | 3447-13 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Egypt | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | European Union | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Hong Kong | 302279296 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Iceland | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | India | 2345147 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Indonesia | IDM000440925 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Israel | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Japan | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Jordan | 125268 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Korea, Republic of | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Lebanon | 143706 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Macedonia, The Former Yugoslav Republic of | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Madrid Protocol | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Malaysia | 2012009997 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Mexico | 1784478 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Monaco | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Morocco | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Paraguay | 382468 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Peru | 193224 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Philippines | 4-2012-006691 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Russian Federation | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Saudi Arabia | 145490 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | South Africa | 2012/14662 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Taiwan, Province of China | 1572068 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Thailand | TMA406,333 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Tunisia | TN/E/2012/01096 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Turkey | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Ukraine | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | United Kingdom | UK00801128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | United States | 4311553 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Uruguay | 437159 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS | Viet Nam | 1128631 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Argentina | 2859621 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Australia | 1523311 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Brazil | 840229399 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Canada | TMA900,439 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | China | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Colombia | 491656 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Costa Rica | 224081 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Croatia | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Ecuador | 3446-13 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Egypt | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | European Union | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Hong Kong | 302279287 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Iceland | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | India | 2345148 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Israel | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Japan | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Jordan | 125162 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Korea, Republic of | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Lebanon | 143685 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Macedonia, The Former Yugoslav Republic of | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Madrid Protocol | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Malaysia | 2012009996 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Monaco | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Montenegro | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Morocco | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | New Zealand | 960013 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Norway | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Paraguay | 390626 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Peru | 193342 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Philippines | 4-2012-006693 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Russian Federation | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Saudi Arabia | 1445/43 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Serbia | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Singapore | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | South Africa | 2012/14663 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Switzerland | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Taiwan, Province of China | 1572067 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Thailand | TM398,915 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Tunisia | TN/E/2012/1083 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Turkey | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Ukraine | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | United Kingdom | UK00801133047 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | United States | 4323037 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Uruguay | 437158 | |
| Pharma Biotech & Nutrition (LPBN) | PLANTCAPS & Design | Viet Nam | 1133047 | |
| Pharma Biotech & Nutrition (LPBN) | POIETICS | European Union | 003999018 | |
| Pharma Biotech & Nutrition (LPBN) | POIETICS | United Kingdom | UK00903999018 | |
| Pharma Biotech & Nutrition (LPBN) | POWERCHO | Canada | 664675 | |
| Pharma Biotech & Nutrition (LPBN) | POWERCHO | European Union | 004423877 | |
| Pharma Biotech & Nutrition (LPBN) | POWERCHO | United Kingdom | UK00904423877 | |
| Pharma Biotech & Nutrition (LPBN) | POWERCHO | United States | 3687485 | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | Brazil | 831127554 | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | European Union | 1095421 | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | India | 2200646 | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | Japan | 1095421 | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | Madrid Protocol | 1095421 | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | Singapore | T1116238I | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | United Kingdom | UK00801095421 | |
| Pharma Biotech & Nutrition (LPBN) | POWERED BY M MODA & Design | United States | 4130853 | |
| Pharma Biotech & Nutrition (LPBN) | POWERFEED | China | 30932995 | |
| Pharma Biotech & Nutrition (LPBN) | POWERFEED | European Union | 014035381 | |
| Pharma Biotech & Nutrition (LPBN) | POWERFEED | United Kingdom | UK00914035381 | |
| Pharma Biotech & Nutrition (LPBN) | POWERFEED | United States | 4967588 | |
| Pharma Biotech & Nutrition (LPBN) | PPILIGHT | United States | 3628865 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Brazil | 829749187 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Canada | TMA555,633 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | China | 1115330 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | China | 1104642 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Denmark | VR 004946 1995 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Finland | 201298 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | France | 95574598 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Germany | 39533653 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Iceland | 402/1997 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | India | 1038115 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Italy | 1648393 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Mexico | 498850 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Mexico | 498849 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Norway | 178440 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Sweden | 313197 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | Taiwan, Province of China | 959,631 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | United Kingdom | 2022970 | |
| Pharma Biotech & Nutrition (LPBN) | PRESS-FIT | United States | 2099915 | |
| Pharma Biotech & Nutrition (LPBN) | PROCHO | European Union | 1525928 | |
| Pharma Biotech & Nutrition (LPBN) | PROCHO | Madrid Protocol | 1525928 | |
| Pharma Biotech & Nutrition (LPBN) | PROCHO | United Kingdom | 1525928 | |
| Pharma Biotech & Nutrition (LPBN) | PROCHO | United Kingdom | UK00801525928 | |
| Pharma Biotech & Nutrition (LPBN) | PROCHO | United States | 6168012 | |
| Pharma Biotech & Nutrition (LPBN) | PROSIEVE | Benelux | 477671 | |
| Pharma Biotech & Nutrition (LPBN) | PROSIEVE | Canada | 392118 | |
| Pharma Biotech & Nutrition (LPBN) | PROSIEVE | France | 1599205 | |
| Pharma Biotech & Nutrition (LPBN) | PROSIEVE | Germany | 1172966 | |
| Pharma Biotech & Nutrition (LPBN) | PROSIEVE | Japan | 2472372 | |
| Pharma Biotech & Nutrition (LPBN) | PROSIEVE | United Kingdom | 1428824 | |
| Pharma Biotech & Nutrition (LPBN) | PROSIEVE | United States | 2443434 | |
| Pharma Biotech & Nutrition (LPBN) | PROTYKIN | United States | 2178636 | |
| Pharma Biotech & Nutrition (LPBN) | PYROCELL | China | 1544516 | |
| Pharma Biotech & Nutrition (LPBN) | PYROCELL | European Union | 1544516 | |
| Pharma Biotech & Nutrition (LPBN) | PYROCELL | Madrid Protocol | 1544516 | |
| Pharma Biotech & Nutrition (LPBN) | PYROCELL | United Kingdom | UK00801544516 | |
| Pharma Biotech & Nutrition (LPBN) | PYROCELL | United Kingdom | 1544516 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENE | China | 12,255,653 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENE | European Union | 003997442 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENE | United Kingdom | UK00903997442 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENE | United States | 2803730 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Benelux | 355815 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Brazil | 7201338 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Canada | TMA204309 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Chile | 875051 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | China | 12255654 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | European Union | 003997301 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | France | 1257628 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Germany | 931264 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Japan | 3249829 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Sweden | 166731 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | Switzerland | 404941 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | United Kingdom | UK00903997301 | |
| Pharma Biotech & Nutrition (LPBN) | PYROGENT | United States | 999468 | |
| Pharma Biotech & Nutrition (LPBN) | PYROSPERSE | European Union | 003997277 | |
| Pharma Biotech & Nutrition (LPBN) | PYROSPERSE | Germany | 1019789 | |
| Pharma Biotech & Nutrition (LPBN) | PYROSPERSE | United Kingdom | UK00903997277 | |
| Pharma Biotech & Nutrition (LPBN) | PYROSPERSE | United Kingdom | UK00001147727 | |
| Pharma Biotech & Nutrition (LPBN) | PYROSPERSE | United States | 1204201 | |
| Pharma Biotech & Nutrition (LPBN) | PYROTEC | European Union | 009974619 | |
| Pharma Biotech & Nutrition (LPBN) | PYROTEC | Japan | 5471497 | |
| Pharma Biotech & Nutrition (LPBN) | PYROTEC | United Kingdom | UK00909974619 | |
| Pharma Biotech & Nutrition (LPBN) | PYROTEC | United States | 4170229 | |
| Pharma Biotech & Nutrition (LPBN) | PYROWAVE | United States | 4914541 | |
| Pharma Biotech & Nutrition (LPBN) | QC INSIDER | European Union | 013902754 | |
| Pharma Biotech & Nutrition (LPBN) | QC INSIDER | United Kingdom | UK00913902754 | |
| Pharma Biotech & Nutrition (LPBN) | QC INSIDER | United States | 5208337 | |
| Pharma Biotech & Nutrition (LPBN) | QC INSIDER - ENDOTOXIN EXPERTISE AT YOUR FINGERTIPS | United States | 5078794 | |
| Pharma Biotech & Nutrition (LPBN) | QCL-1000 | European Union | 003997475 | |
| Pharma Biotech & Nutrition (LPBN) | QCL-1000 | United Kingdom | UK00903997475 | |
| Pharma Biotech & Nutrition (LPBN) | QCL-1000 | United States | 1325248 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | China | 1520014 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | European Union | 018191654 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | Madrid Protocol | 1520014 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | Russian Federation | 1520014 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | Switzerland | 1520014 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | United Kingdom | 1520014 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | United Kingdom | UK00918191654 | |
| Pharma Biotech & Nutrition (LPBN) | REDICAPS | United States | 6132850 | |
| Pharma Biotech & Nutrition (LPBN) | RELIANT | Japan | 4227269 | |
| Pharma Biotech & Nutrition (LPBN) | RELIANT | United Kingdom | 1543713 | |
| Pharma Biotech & Nutrition (LPBN) | RELIANT | United States | 2768601 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | Australia | 1354925 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | Canada | TMA774212 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | European Union | 1354925 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | European Union | 2411015 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | United Kingdom | UK00902411015 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | United Kingdom | 1354925 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | United Kingdom | UK00801354925 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA | United States | 2589375 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA & Design | Canada | 1034508 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA & Design | Madrid Protocol | 1354925 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA & Design | New Zealand | 1354925 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA & Design | South Africa | 2017/19168 | |
| Pharma Biotech & Nutrition (LPBN) | RELORA & Design | United States | 5373658 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Australia | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Brazil | 828068704 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Canada | TMA990956 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | European Union | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Finland | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Germany | 30576273 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Japan | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Korea, Republic of | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Madrid Protocol | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Mexico | 919491 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Russian Federation | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Switzerland | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | Turkey | 0910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | United Kingdom | UK00800910842 | |
| Pharma Biotech & Nutrition (LPBN) | RELORIA | United States | 5425607 | |
| Pharma Biotech & Nutrition (LPBN) | RESELUTE | United Kingdom | 1249165 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Argentina | 2403474 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Argentina | 2403473 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Australia | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Belarus | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Benelux | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Brazil | 830435794 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Brazil | 830435760 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Canada | TMA811212 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Chile | 900441 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | China | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Colombia | 404473 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Colombia | 404472 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Egypt | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | European Union | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Georgia | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | India | 1881459 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Indonesia | IDM000311740 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Israel | 224572 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Israel | 224569 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Japan | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Kazakhstan | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Korea, Republic of | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Madrid Protocol | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Mexico | 1189228 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Mexico | 1143316 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Morocco | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | New Zealand | 815045 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Norway | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Pakistan | 274,294 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Pakistan | 274293 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Philippines | 42009011151 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Russian Federation | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Serbia | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Singapore | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | South Africa | 2009/21713 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | South Africa | 200921714 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Switzerland | 589121 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Taiwan, Province of China | 1442977 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Thailand | 328565 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Turkey | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | Ukraine | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | United Kingdom | 1025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | United Kingdom | UK00801025325 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID | United States | 3734734 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | Australia | 1853780 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | Canada | 1042508 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | China | 1203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | European Union | 1203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | India | 1203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | Madrid Protocol | 1203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | Mexico | 1203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | Russian Federation | 1203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | Switzerland | 1203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | United Kingdom | UK00801203945 | |
| Pharma Biotech & Nutrition (LPBN) | RESISTAID & Design | United States | 4588868 | |
| Pharma Biotech & Nutrition (LPBN) | SCIENCE IN MOTION | European Union | 017948030 | |
| Pharma Biotech & Nutrition (LPBN) | SCIENCE IN MOTION | United Kingdom | UK00917948030 | |
| Pharma Biotech & Nutrition (LPBN) | SCL & Design | China | 335686 | |
| Pharma Biotech & Nutrition (LPBN) | SEA PLAQUE & Design | Canada | 188403 | |
| Pharma Biotech & Nutrition (LPBN) | SEA PLAQUE & Design | Italy | 979795 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPLAQUE | Canada | 563611 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPLAQUE | European Union | 005039029 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPLAQUE | Japan | 4481198 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPLAQUE | United Kingdom | UK00905039029 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPLAQUE | United States | 2630141 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPREP | United States | 1263315 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPURE | European Union | 005272646 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPURE | India | 2238900 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPURE | Japan | 5030018 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPURE | United Kingdom | UK00905272646 | |
| Pharma Biotech & Nutrition (LPBN) | SEAPURE | United States | 4174635 | |
| Pharma Biotech & Nutrition (LPBN) | SEDITOL | Australia | 1371632 | |
| Pharma Biotech & Nutrition (LPBN) | SEDITOL | Canada | TMA667489 | |
| Pharma Biotech & Nutrition (LPBN) | SEDITOL | United Kingdom | 2377796 | |
| Pharma Biotech & Nutrition (LPBN) | SEDITOL | United States | 2961524 | |
| Pharma Biotech & Nutrition (LPBN) | SENTINEL APART | United States | 5056310 | |
| Pharma Biotech & Nutrition (LPBN) | SFAAV | European Union | 018057783 | |
| Pharma Biotech & Nutrition (LPBN) | SFAAV | United Kingdom | UK00918057783 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | European Union | 3543204 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | Japan | 4781818 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | Mexico | 880579 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | New Zealand | 704561 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | Norway | 224942 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | Switzerland | P-518182 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | Thailand | 202576 | |
| Pharma Biotech & Nutrition (LPBN) | SGCAPS | United Kingdom | UK00903543204 | |
| Pharma Biotech & Nutrition (LPBN) | SIMPLIFIH | China | 1519842 | |
| Pharma Biotech & Nutrition (LPBN) | SIMPLIFIH | European Union | 1519842 | |
| Pharma Biotech & Nutrition (LPBN) | SIMPLIFIH | Madrid Protocol | 1519842 | |
| Pharma Biotech & Nutrition (LPBN) | SIMPLIFIH | Switzerland | 1519842 | |
| Pharma Biotech & Nutrition (LPBN) | SIMPLIFIH | United Kingdom | UK00801519842 | |
| Pharma Biotech & Nutrition (LPBN) | SIMPLIFIH | United States | 5957752 | |
| Pharma Biotech & Nutrition (LPBN) | SIMPLYLOAD | United States | 2887793 | |
| Pharma Biotech & Nutrition (LPBN) | SINGLEQUOTS | European Union | 003997343 | |
| Pharma Biotech & Nutrition (LPBN) | SINGLEQUOTS | Germany | 39403222 | |
| Pharma Biotech & Nutrition (LPBN) | SINGLEQUOTS | United Kingdom | UK00903997343 | |
| Pharma Biotech & Nutrition (LPBN) | SINGLEQUOTS | United States | 1790001 | |
| Pharma Biotech & Nutrition (LPBN) | SKBM | United States | 1790000 | |
| Pharma Biotech & Nutrition (LPBN) | SKGM | European Union | 003997137 | |
| Pharma Biotech & Nutrition (LPBN) | SKGM | United Kingdom | UK00903997137 | |
| Pharma Biotech & Nutrition (LPBN) | SKGM | United States | 1790004 | |
| Pharma Biotech & Nutrition (LPBN) | SMBM | United States | 1789995 | |
| Pharma Biotech & Nutrition (LPBN) | SMGM | European Union | 003997111 | |
| Pharma Biotech & Nutrition (LPBN) | SMGM | United Kingdom | UK00903997111 | |
| Pharma Biotech & Nutrition (LPBN) | SMGM | United States | 1789996 | |
| Pharma Biotech & Nutrition (LPBN) | SPRINKLE & Design | China | 1407900 | |
| Pharma Biotech & Nutrition (LPBN) | SPRINKLE & Design | European Union | 017221599 | |
| Pharma Biotech & Nutrition (LPBN) | SPRINKLE & Design | Madrid Protocol | 1407900 | |
| Pharma Biotech & Nutrition (LPBN) | SPRINKLE & Design | Singapore | 1407900 | |
| Pharma Biotech & Nutrition (LPBN) | SPRINKLE & Design | United Kingdom | UK00917221599 | |
| Pharma Biotech & Nutrition (LPBN) | SPRINKLE & Design | United States | 5609255 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX | Croatia | Z20030773 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX | Egypt | 353140 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX | Hong Kong | 303003506 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX | Japan | 4900793 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX | Korea, Republic of | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX | Taiwan, Province of China | 1438480 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX | United States | 3102316 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Canada | 1087946 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | China | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | China | 1340824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | European Union | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | India | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | India | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Madrid Protocol | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Switzerland | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Switzerland | 1370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Taiwan, Province of China | 1263194 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Taiwan, Province of China | 1263333 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Taiwan, Province of China | 1263115 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | Taiwan, Province of China | 1262416 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | United Kingdom | UK00801370824 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX & Design | United States | 5379358 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER CITRIMAX CLINICAL STRENGTH | United States | 3330536 | |
| Pharma Biotech & Nutrition (LPBN) | SUPER DIET CITRIMAX HYDROXYCITRIC ACID | Japan | 4264438 | |
| Pharma Biotech & Nutrition (LPBN) | SUPRO | China | 2019934 | |
| Pharma Biotech & Nutrition (LPBN) | SUPRO | Taiwan, Province of China | 962537 | |
| Pharma Biotech & Nutrition (LPBN) | SYTRINOL | Canada | TMA641536 | |
| Pharma Biotech & Nutrition (LPBN) | SYTRINOL | European Union | 7281711 | |
| Pharma Biotech & Nutrition (LPBN) | SYTRINOL | United Kingdom | UK00907281711 | |
| Pharma Biotech & Nutrition (LPBN) | SYTRINOL | United States | 3078476 | |
| Pharma Biotech & Nutrition (LPBN) | SYTRINOL HEALTHY HEART & Design | United States | 5354611 | |
| Pharma Biotech & Nutrition (LPBN) | SYTRINOL HEALTHY HEART & Design | TMA1070065 | ||
| Pharma Biotech & Nutrition (LPBN) | TAPIOCAPS | Brazil | 912215666 | |
| Pharma Biotech & Nutrition (LPBN) | TAPIOCAPS & Design | Brazil | 911212973 | |
| Pharma Biotech & Nutrition (LPBN) | THE AGILE ADVANTAGE | European Union | 016807471 | |
| Pharma Biotech & Nutrition (LPBN) | THE AGILE ADVANTAGE | Switzerland | 707755 | |
| Pharma Biotech & Nutrition (LPBN) | THE AGILE ADVANTAGE | United Kingdom | UK00916807471 | |
| Pharma Biotech & Nutrition (LPBN) | THE HEALTHCARE CONTINUUM | China | 1412569 | |
| Pharma Biotech & Nutrition (LPBN) | THE HEALTHCARE CONTINUUM | India | 1412569 | |
| Pharma Biotech & Nutrition (LPBN) | THE HEALTHCARE CONTINUUM | Japan | 1412569 | |
| Pharma Biotech & Nutrition (LPBN) | THE HEALTHCARE CONTINUUM | Madrid Protocol | 1412569 | |
| Pharma Biotech & Nutrition (LPBN) | THE HEALTHCARE CONTINUUM | Switzerland | 1412569 | |
| Pharma Biotech & Nutrition (LPBN) | THE HEALTHCARE CONTINUUM | United States | 5476927 | |
| Pharma Biotech & Nutrition (LPBN) | THERAPEAK | China | 1544473 | |
| Pharma Biotech & Nutrition (LPBN) | THERAPEAK | European Union | 010039279 | |
| Pharma Biotech & Nutrition (LPBN) | THERAPEAK | Madrid Protocol | 1544473 | |
| Pharma Biotech & Nutrition (LPBN) | THERAPEAK | Taiwan, Province of China | 02123922 | |
| Pharma Biotech & Nutrition (LPBN) | THERAPEAK | United Kingdom | UK00910039279 | |
| Pharma Biotech & Nutrition (LPBN) | THERAPEAK | United States | 4070761 | |
| Pharma Biotech & Nutrition (LPBN) | TOXILIGHT | European Union | 002829539 | |
| Pharma Biotech & Nutrition (LPBN) | TOXILIGHT | Japan | 4755052 | |
| Pharma Biotech & Nutrition (LPBN) | TOXILIGHT | United Kingdom | UK00902829539 | |
| Pharma Biotech & Nutrition (LPBN) | TOXILIGHT | United States | 2894447 | |
| Pharma Biotech & Nutrition (LPBN) | TREE | Madrid Protocol | 1564428 | |
| Pharma Biotech & Nutrition (LPBN) | TRIPOLE | Benelux | 719367 | |
| Pharma Biotech & Nutrition (LPBN) | T-VIVO | European Union | 01821154 | |
| Pharma Biotech & Nutrition (LPBN) | T-VIVO | Taiwan, Province of China | 02121044 | |
| Pharma Biotech & Nutrition (LPBN) | T-VIVO | United Kingdom | UK00918271154 | |
| Pharma Biotech & Nutrition (LPBN) | UC-FLEX | Australia | 1939139 | |
| Pharma Biotech & Nutrition (LPBN) | UC-FLEX | China | 32116448 | |
| Pharma Biotech & Nutrition (LPBN) | UC-FLEX | European Union | 017926994 | |
| Pharma Biotech & Nutrition (LPBN) | UC-FLEX | India | 3884918 | |
| Pharma Biotech & Nutrition (LPBN) | UC-FLEX | Singapore | 40201813295Q | |
| Pharma Biotech & Nutrition (LPBN) | UC-FLEX | United Kingdom | UK00917926994 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Argentina | 2575403 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Argentina | 2575404 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Australia | 891950 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Brazil | 905220030 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Canada | TMA645413 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Chile | 1099060 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | China | 10586972 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | China | 14003568 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Colombia | 456715 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Colombia | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Egypt | 353138 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | European Union | 2328235 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Hong Kong | 302675179 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | India | 2362933 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Indonesia | IDM000454551 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Indonesia | IDM000422661 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Israel | 1436593 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Israel | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Japan | 5157376 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Jordan | 161654 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Kazakhstan | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Korea, Republic of | 40-1173775 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Korea, Republic of | 40-1221005 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Korea, Republic of | 40-542473 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Lebanon | 168550 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Madrid Protocol | 1436593 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Madrid Protocol | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Malaysia | 01013773 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Malaysia | 01013774 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Mexico | 729618 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Mexico | 729619 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | New Zealand | 647743 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | New Zealand | 647742 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Norway | 1436593 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Norway | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | OAPI | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Pakistan | 174945 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Paraguay | 398105 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Paraguay | 398104 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Philippines | 42017017533 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Philippines | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Russian Federation | 486950 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Singapore | T1311696A | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | South Africa | 2001/21752 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | South Africa | 2001/21751 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Switzerland | 1436593 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Taiwan, Province of China | 1260326 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Taiwan, Province of China | 1021512 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Thailand | KOR171004 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Thailand | KOR170487 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Turkey | 200937920 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Ukraine | 1503876 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Ukraine | 1436593 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | United Kingdom | UK00902328235 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | United Kingdom | 2276044 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | United States | 2929146 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Uruguay | 432398 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II | Viet Nam | 206802 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | ARIPO (TM) | AP/M/2017/002932 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Australia | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Botswana | AP/M/2017/002932 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Brazil | 911881743 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Brazil | 911881824 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Canada | 1035269 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | China | G1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | European Union | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | India | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Indonesia | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Israel | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Japan | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Korea, Republic of | 40-1173776 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Liberia | AP/M/2017/002932 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Madrid Protocol | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Malaysia | 2017072385 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Myanmar | 4/3344/2020 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Russian Federation | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | South Africa | 201712119 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | South Africa | 201712120 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Switzerland | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Taiwan, Province of China | 02088008 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Turkey | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Ukraine | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | United Kingdom | UK00801331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | United States | 5309425 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Viet Nam | 1331483 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Zimbabwe | AP/M/2017/002932 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II & Design | Zimbabwe | AP/M/2017/002932 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | Australia | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | China | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | European Union | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | India | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | Madrid Protocol | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | Russian Federation | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | Taiwan, Province of China | 02123787 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | Turkey | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | United Kingdom | UK00801539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II Logo (with Runner design) | United Kingdom | 1539770 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II PLUS | Japan | 4726993 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA | China | 1540213 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA | European Union | 1540213 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA | Madrid Protocol | 1540213 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA | Singapore | 1540213 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA | United Kingdom | UK00801540213 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA Logo (with Runner design) | China | 1539812 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA Logo (with Runner design) | Madrid Protocol | 1539812 | |
| Pharma Biotech & Nutrition (LPBN) | UC-II ULTRA Logo (with Runner design) | Singapore | 1539812 | |
| Pharma Biotech & Nutrition (LPBN) | ULTRA 8 | Brazil | 829958282 | |
| Pharma Biotech & Nutrition (LPBN) | ULTRA 8 | Canada | TMA808,919 | |
| Pharma Biotech & Nutrition (LPBN) | ULTRA 8 | Japan | 5317342 | |
| Pharma Biotech & Nutrition (LPBN) | ULTRA III | European Union | 017901343 | |
| Pharma Biotech & Nutrition (LPBN) | ULTRA III | United Kingdom | UK00917901343 | |
| Pharma Biotech & Nutrition (LPBN) | ULTRA III | United States | 2050291 | |
| Pharma Biotech & Nutrition (LPBN) | ULTRADOMA | United States | 5085157 | |
| Pharma Biotech & Nutrition (LPBN) | V Logo | Malaysia | 6018126 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Argentina | 2371637 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Australia | 832682 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Benelux | R 649521 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Brazil | 823727629 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Canada | TMA555961 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | China | 1584357 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Ecuador | 8004 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | European Union | 2404788 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | France | 013097124 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Hong Kong | 300569205 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Iceland | 3972008 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | India | 372987 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Indonesia | IDM000257238 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Japan | 4341410 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Korea, Republic of | 4005040920000 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Malaysia | 00005927 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Mexico | 1867434 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | New Zealand | 613886 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Norway | 246230 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Russian Federation | 639447 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Singapore | T0620458C | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | South Africa | 2006/01417 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Spain | 2134517 M1 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Switzerland | P-513690 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Thailand | 130140 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Turkey | 2007/55163 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Ukraine | 255660 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | United Kingdom | UK00902404788 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | United Kingdom | 2154117 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | United States | 2707336 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS | Viet Nam | 43851 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Argentina | 2240423 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Australia | 1117910 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Bosnia & Herzegovina | BAZ0812253 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Brazil | 828521093 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Canada | TMA737,701 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Chile | 895527 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | China | 5416374 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | China | 4485378 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Costa Rica | 205804 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Dominican Republic | 173304 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Ecuador | 1262 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | European Union | 2417384 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | European Union | 2400505 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Hong Kong | 300569214 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | India | 1461350 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Indonesia | IDM000150065 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Israel | 229626 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Kenya | 63441 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Mexico | 939227 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Monaco | 27409 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Norway | 259411 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Russian Federation | 368240 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Saudi Arabia | 106131 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Serbia | 58599 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Singapore | T06/20460E | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | South Africa | 2006/01418 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Switzerland | 592688 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Taiwan, Province of China | 1177093 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Taiwan, Province of China | 1250333 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Thailand | KOR227021 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Thailand | KOR259089 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Turkey | 200850336 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Ukraine | 104776 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | United Kingdom | UK00902417384 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | United Kingdom | UK00902400505 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | United States | 2598057 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS & Design | Viet Nam | 86173 | |
| Pharma Biotech & Nutrition (LPBN) | VCAPS PLUS (Katakana Characters) | Japan | 5205601 | |
| Pharma Biotech & Nutrition (LPBN) | VIALIGHT | European Union | 2829588 | |
| Pharma Biotech & Nutrition (LPBN) | VIALIGHT | Japan | 4755054 | |
| Pharma Biotech & Nutrition (LPBN) | VIALIGHT | United Kingdom | UK00902829588 | |
| Pharma Biotech & Nutrition (LPBN) | VIALIGHT | United States | 2894444 | |
| Pharma Biotech & Nutrition (LPBN) | WHITE OPAL | European Union | 018052548 | |
| Pharma Biotech & Nutrition (LPBN) | WHITE OPAL | United Kingdom | UK00918052548 | |
| Pharma Biotech & Nutrition (LPBN) | WINKQCL | China | 12,255,556 | |
| Pharma Biotech & Nutrition (LPBN) | WINKQCL | European Union | 003997335 | |
| Pharma Biotech & Nutrition (LPBN) | WINKQCL | United Kingdom | UK00903997335 | |
| Pharma Biotech & Nutrition (LPBN) | WINKQCL | United States | 2148831 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | Australia | 1161757 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | Canada | TMA592,119 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | China | 5928568 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | China | 5928569 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | China | 5928570 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | European Union | 2206142 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | India | 921029 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | Japan | 765278 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | Madrid Protocol | 765278 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | Switzerland | 609454 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | United Kingdom | 2269316 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | United Kingdom | UK00902206142 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE | United States | 2954067 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE & Design | United States | 3418979 | |
| Pharma Biotech & Nutrition (LPBN) | XCELODOSE (Katakana Characters) | Japan | 4937172 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOHOOD | China | 6702256 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOHOOD | European Union | 018092663 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOHOOD | Japan | 5422684 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOHOOD | United Kingdom | UK00918092663 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOHOOD | United States | 5950081 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOLAB | European Union | 008458002 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOLAB | United Kingdom | UK00908458002 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOLAB | United States | 5965575 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOPROTECT | China | 8833384 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOPROTECT | European Union | 009501248 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOPROTECT | Japan | 5424599 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOPROTECT | Switzerland | 611000 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOPROTECT | United Kingdom | UK00909501248 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOPROTECT | United States | 5950080 | |
| Pharma Biotech & Nutrition (LPBN) | XCELOTAPPER | Japan | 6264609 | |
| Pharma Biotech & Nutrition (LPBN) | XPRESS-FIT | Brazil | 829749195 | |
| Pharma Biotech & Nutrition (LPBN) | XPRESS-FIT | United States | 3477984 | |
| Pharma Biotech & Nutrition (LPBN) | XS | European Union | 1369101 | |
| Pharma Biotech & Nutrition (LPBN) | XS | Israel | 1369101 | |
| Pharma Biotech & Nutrition (LPBN) | XS | Madrid Protocol | 1369101 | |
| Pharma Biotech & Nutrition (LPBN) | XS | Singapore | 1369101 | |
| Pharma Biotech & Nutrition (LPBN) | XS | Switzerland | 708217 | |
| Pharma Biotech & Nutrition (LPBN) | XS | United Kingdom | UK00801369101 | |
| Pharma Biotech & Nutrition (LPBN) | XS | United States | 5440762 | |
| Pharma Biotech & Nutrition (LPBN) | XS PIGGYBAC | China | 1466215 | |
| Pharma Biotech & Nutrition (LPBN) | XS PIGGYBAC | European Union | 1466215 | |
| Pharma Biotech & Nutrition (LPBN) | XS PIGGYBAC | Madrid Protocol | 1466215 | |
| Pharma Biotech & Nutrition (LPBN) | XS PIGGYBAC | Singapore | 1466215 | |
| Pharma Biotech & Nutrition (LPBN) | XS PIGGYBAC | Switzerland | 729214 | |
| Pharma Biotech & Nutrition (LPBN) | XS PIGGYBAC | United Kingdom | 1466215 | |
| Pharma Biotech & Nutrition (LPBN) | XS PIGGYBAC | United Kingdom | UK00801466215 | |
| Pharma Biotech & Nutrition (LPBN) | XS TECHNOLOGIES | Switzerland | 580888 | |
| Pharma Biotech & Nutrition (LPBN) | XTREME | European Union | 010039287 | |
| Pharma Biotech & Nutrition (LPBN) | XTREME | United Kingdom | UK00910039287 | |
| Pharma Biotech & Nutrition (LPBN) | XTREME | United States | 4196785 | |
| Pharma Biotech & Nutrition (LPBN) | X-VIVO | China | 21033107 | |
| Pharma Biotech & Nutrition (LPBN) | X-VIVO | European Union | 010039253 | |
| Pharma Biotech & Nutrition (LPBN) | X-VIVO | United Kingdom | UK00910039253 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | Australia | 1469164 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | European Union | 018061855 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | Japan | 1469164 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | Korea, Republic of | 1469164 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | Madrid Protocol | 1469164 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | New Zealand | 1469164 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | Switzerland | 1469164 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | United Kingdom | UK00918061855 | |
| Pharma Biotech & Nutrition (LPBN) | ZEPHYR | United States | 5957730 | |
| Pharma Biotech & Nutrition (LPBN) | ZMA | Turkey | 2019/121940 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | Brazil | 913139998 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | China | 1363565 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | European Union | 1363565 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | India | 1363565 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | Japan | 1363565 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | Madrid Protocol | 1363565 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | South Africa | 201721638 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | United Kingdom | UK00801363565 | |
| Pharma Biotech & Nutrition (LPBN) | ZYCHROME | United States | 4115366 |
Trademark Portfolio - Specialty Ingredients
| Business Sector | Title | Country | Trademark Number |
|---|---|---|---|
| Specialty Ingredients (LSI) | ABZORBE | Australia | 1314339 |
| Specialty Ingredients (LSI) | ACQ PROTECT | United States | 5312462 |
| Specialty Ingredients (LSI) | ACRAWAX | Benelux | 86137 |
| Specialty Ingredients (LSI) | ACRAWAX | Brazil | 821128620 |
| Specialty Ingredients (LSI) | ACRAWAX | Canada | 121592 |
| Specialty Ingredients (LSI) | ACRAWAX | China | 10021753 |
| Specialty Ingredients (LSI) | ACRAWAX | Denmark | VR198100206 |
| Specialty Ingredients (LSI) | ACRAWAX | European Union | 1232792 |
| Specialty Ingredients (LSI) | ACRAWAX | France | 1282178 |
| Specialty Ingredients (LSI) | ACRAWAX | Germany | 858023 |
| Specialty Ingredients (LSI) | ACRAWAX | India | 1164111 |
| Specialty Ingredients (LSI) | ACRAWAX | India | 1163466 |
| Specialty Ingredients (LSI) | ACRAWAX | Japan | 735346 |
| Specialty Ingredients (LSI) | ACRAWAX | Madrid Protocol | 1232792 |
| Specialty Ingredients (LSI) | ACRAWAX | Russian Federation | 1232792 |
| Specialty Ingredients (LSI) | ACRAWAX | Spain | 375111 |
| Specialty Ingredients (LSI) | ACRAWAX | Sweden | 136356 |
| Specialty Ingredients (LSI) | ACRAWAX | Sweden | 754997 |
| Specialty Ingredients (LSI) | ACRAWAX | Switzerland | 302149 |
| Specialty Ingredients (LSI) | ACRAWAX | Turkey | 1232792 |
| Specialty Ingredients (LSI) | ACRAWAX | United Kingdom | 796740 |
| Specialty Ingredients (LSI) | ACRAWAX | United States | 724068 |
| Specialty Ingredients (LSI) | ADVANCE GOLD | New Zealand | 1009588 |
| Specialty Ingredients (LSI) | AGRISOTE | France | 194531889 |
| Specialty Ingredients (LSI) | AGRISOTE | Germany | 30 2019 004 987.6 |
| Specialty Ingredients (LSI) | AGRISOTE | Portugal | 620701 |
| Specialty Ingredients (LSI) | AGRISOTE | Spain | 4008097 |
| Specialty Ingredients (LSI) | AGRISOTE | United Kingdom | 3375530 |
| Specialty Ingredients (LSI) | AKLAME | New Zealand | 262085 |
| Specialty Ingredients (LSI) | AKOLIDINE | China | 1289978 |
| Specialty Ingredients (LSI) | AKOLIDINE | European Union | 1289978 |
| Specialty Ingredients (LSI) | AKOLIDINE | India | 1289978 |
| Specialty Ingredients (LSI) | AKOLIDINE | Madrid Protocol | 1289978 |
| Specialty Ingredients (LSI) | AKOLIDINE | Switzerland | 1289978 |
| Specialty Ingredients (LSI) | AKOLIDINE | United States | 4620524 |
| Specialty Ingredients (LSI) | ALDO | China | 10021752 |
| Specialty Ingredients (LSI) | ALDO | India | 2238945 |
| Specialty Ingredients (LSI) | ALDO | Turkey | 2016/78106 |
| Specialty Ingredients (LSI) | ALDO | United States | 436919 |
| Specialty Ingredients (LSI) | ALDOSPERSE | China | 10,021,751 |
| Specialty Ingredients (LSI) | ALDOSPERSE | India | 2238940 |
| Specialty Ingredients (LSI) | ALDOSPERSE | India | 1165057 |
| Specialty Ingredients (LSI) | ALDOSPERSE | Spain | 434423 |
| Specialty Ingredients (LSI) | ALDOSPERSE | United States | 1721232 |
| Specialty Ingredients (LSI) | ALLITRON | Australia | 1230038 |
| Specialty Ingredients (LSI) | ALLITRON | Australia | 1224789 |
| Specialty Ingredients (LSI) | ALPASSO | New Zealand | 800598 |
| Specialty Ingredients (LSI) | AMBOL | New Zealand | 275466 |
| Specialty Ingredients (LSI) | AMBOL | New Zealand | 275464 |
| Specialty Ingredients (LSI) | AMBOL | New Zealand | 275463 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Austria | 560944 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Brazil | 818402580 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Canada | 407646 |
| Specialty Ingredients (LSI) | AMPHOTERGE | China | 11127165 |
| Specialty Ingredients (LSI) | AMPHOTERGE | China | 10021750 |
| Specialty Ingredients (LSI) | AMPHOTERGE | France | 560944 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Germany | 560944 |
| Specialty Ingredients (LSI) | AMPHOTERGE | India | 1162909 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Italy | 560944 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Japan | 2439376 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Madrid Protocol | 560944 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Spain | 560944 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Switzerland | 378804 |
| Specialty Ingredients (LSI) | AMPHOTERGE | Turkey | 2016/8098 |
| Specialty Ingredients (LSI) | AMPHOTERGE | United Kingdom | 1403054 |
| Specialty Ingredients (LSI) | AMPHOTERGE | United States | 1373328 |
| Specialty Ingredients (LSI) | ANAPEX | Chile | 1317270 |
| Specialty Ingredients (LSI) | ANAPEX | Colombia | 633609 |
| Specialty Ingredients (LSI) | ANTIBLU | Australia | 1003865 |
| Specialty Ingredients (LSI) | ANTIBLU | Austria | 115216 |
| Specialty Ingredients (LSI) | ANTIBLU | Benelux | 432287 |
| Specialty Ingredients (LSI) | ANTIBLU | Canada | TMA672873 |
| Specialty Ingredients (LSI) | ANTIBLU | Chile | 832910 |
| Specialty Ingredients (LSI) | ANTIBLU | China | 4383865 |
| Specialty Ingredients (LSI) | ANTIBLU | China | 4383853 |
| Specialty Ingredients (LSI) | ANTIBLU | China | 4383854 |
| Specialty Ingredients (LSI) | ANTIBLU | Japan | 4951289 |
| Specialty Ingredients (LSI) | ANTIBLU | Korea, Republic of | 40-1060954 |
| Specialty Ingredients (LSI) | ANTIBLU | Malaysia | 04018483 |
| Specialty Ingredients (LSI) | ANTIBLU | Malaysia | 04018484 |
| Specialty Ingredients (LSI) | ANTIBLU | Malaysia | 4018482 |
| Specialty Ingredients (LSI) | ANTIBLU | New Zealand | 720709 |
| Specialty Ingredients (LSI) | ANTIBLU | Portugal | 232707 |
| Specialty Ingredients (LSI) | ANTIBLU | Singapore | T0420734H |
| Specialty Ingredients (LSI) | ANTIBLU | Singapore | T0420732A |
| Specialty Ingredients (LSI) | ANTIBLU | Singapore | T0420731C |
| Specialty Ingredients (LSI) | ANTIBLU | South Africa | 200421578 |
| Specialty Ingredients (LSI) | ANTIBLU | South Africa | 200213895 |
| Specialty Ingredients (LSI) | ANTIBLU | South Africa | 58473 |
| Specialty Ingredients (LSI) | ANTIBLU | South Africa | 2002/13894 |
| Specialty Ingredients (LSI) | ANTIBLU | Sweden | 204098 |
| Specialty Ingredients (LSI) | ANTIBLU | Taiwan, Province of China | 1188144 |
| Specialty Ingredients (LSI) | ANTIBLU | Thailand | 171104159 |
| Specialty Ingredients (LSI) | ANTIBLU | Ukraine | 239279 |
| Specialty Ingredients (LSI) | ANTIBLU | United States | 2,902,171 |
| Specialty Ingredients (LSI) | ANTIBLU | Uruguay | 399895 |
| Specialty Ingredients (LSI) | ANTIBLU | Viet Nam | 285535 |
| Specialty Ingredients (LSI) | ANTIBLU (Chinese Characters) | China | 8927226 |
| Specialty Ingredients (LSI) | ANTIBLU 246 | New Zealand | 269500 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Belarus | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Bulgaria | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Czechia | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Estonia | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | European Union | 3898715 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Madrid Protocol | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Romania | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Russian Federation | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Turkey | 846246 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Ukraine | 169913 |
| Specialty Ingredients (LSI) | ANTIBLU SELECT | Viet Nam | 846246 |
| Specialty Ingredients (LSI) | ANTIBORER | South Africa | 200213892 |
| Specialty Ingredients (LSI) | ANTIBORER | South Africa | 200213893 |
| Specialty Ingredients (LSI) | APEX | New Zealand | 974064 |
| Specialty Ingredients (LSI) | AQUAFRAME | Australia | 1366790 |
| Specialty Ingredients (LSI) | AQUATEK | New Zealand | 298066 |
| Specialty Ingredients (LSI) | AQUICAPS | New Zealand | 759343 |
| Specialty Ingredients (LSI) | ARCH | Argentina | 2568917 |
| Specialty Ingredients (LSI) | ARCH | Argentina | 2568919 |
| Specialty Ingredients (LSI) | ARCH | Argentina | 2444956 |
| Specialty Ingredients (LSI) | ARCH | Australia | 790320 |
| Specialty Ingredients (LSI) | ARCH | Brazil | 821560808 |
| Specialty Ingredients (LSI) | ARCH | Brazil | 821560760 |
| Specialty Ingredients (LSI) | ARCH | Canada | TMA769176 |
| Specialty Ingredients (LSI) | ARCH | Chile | 894016 |
| Specialty Ingredients (LSI) | ARCH | Colombia | 229343 |
| Specialty Ingredients (LSI) | ARCH | Colombia | 229600 |
| Specialty Ingredients (LSI) | ARCH | Colombia | 229599 |
| Specialty Ingredients (LSI) | ARCH | Congo | 7212/99 |
| Specialty Ingredients (LSI) | ARCH | Ecuador | 2213-10 |
| Specialty Ingredients (LSI) | ARCH | Ecuador | 3200-00 |
| Specialty Ingredients (LSI) | ARCH | El Salvador | 172 BOOK 128 |
| Specialty Ingredients (LSI) | ARCH | El Salvador | 192 BOOK 133 |
| Specialty Ingredients (LSI) | ARCH | European Union | 001135185 |
| Specialty Ingredients (LSI) | ARCH | European Union | 583302 |
| Specialty Ingredients (LSI) | ARCH | Guatemala | 105070 |
| Specialty Ingredients (LSI) | ARCH | Guatemala | 104627 |
| Specialty Ingredients (LSI) | ARCH | Honduras | 82210 |
| Specialty Ingredients (LSI) | ARCH | Hong Kong | 7434/1999 |
| Specialty Ingredients (LSI) | ARCH | India | 851126 |
| Specialty Ingredients (LSI) | ARCH | India | 851121 |
| Specialty Ingredients (LSI) | ARCH | Indonesia | IDM00276104 |
| Specialty Ingredients (LSI) | ARCH | Indonesia | IDM000192078 |
| Specialty Ingredients (LSI) | ARCH | Indonesia | IDM000312981 |
| Specialty Ingredients (LSI) | ARCH | Israel | 114274 |
| Specialty Ingredients (LSI) | ARCH | Jamaica | 34711 |
| Specialty Ingredients (LSI) | ARCH | Jamaica | 34699 |
| Specialty Ingredients (LSI) | ARCH | Japan | 4803572 |
| Specialty Ingredients (LSI) | ARCH | Japan | 4935652 |
| Specialty Ingredients (LSI) | ARCH | Kenya | 48700 |
| Specialty Ingredients (LSI) | ARCH | Kenya | 48699 |
| Specialty Ingredients (LSI) | ARCH | Korea, Republic of | 490806 |
| Specialty Ingredients (LSI) | ARCH | Malaysia | 99004343 |
| Specialty Ingredients (LSI) | ARCH | Malaysia | 99004346 |
| Specialty Ingredients (LSI) | ARCH | Malaysia | 99004347 |
| Specialty Ingredients (LSI) | ARCH | Malaysia | 97013056 |
| Specialty Ingredients (LSI) | ARCH | Malaysia | 07007559 |
| Specialty Ingredients (LSI) | ARCH | Maldives | N/A |
| Specialty Ingredients (LSI) | ARCH | Mexico | 688050 |
| Specialty Ingredients (LSI) | ARCH | Mexico | 648319 |
| Specialty Ingredients (LSI) | ARCH | New Zealand | 309430 |
| Specialty Ingredients (LSI) | ARCH | New Zealand | 309429 |
| Specialty Ingredients (LSI) | ARCH | Panama | 99986 |
| Specialty Ingredients (LSI) | ARCH | Paraguay | 328853 |
| Specialty Ingredients (LSI) | ARCH | Paraguay | 328852 |
| Specialty Ingredients (LSI) | ARCH | Peru | 63449 |
| Specialty Ingredients (LSI) | ARCH | Peru | 58086 |
| Specialty Ingredients (LSI) | ARCH | Philippines | 4-2004-003781 |
| Specialty Ingredients (LSI) | ARCH | Russian Federation | 385803 |
| Specialty Ingredients (LSI) | ARCH | Singapore | T99/03542F |
| Specialty Ingredients (LSI) | ARCH | Singapore | T97/09517J |
| Specialty Ingredients (LSI) | ARCH | South Africa | 1999/05611 |
| Specialty Ingredients (LSI) | ARCH | South Africa | 1999/05610 |
| Specialty Ingredients (LSI) | ARCH | Switzerland | 471484 |
| Specialty Ingredients (LSI) | ARCH | Switzerland | 449645 |
| Specialty Ingredients (LSI) | ARCH | Taiwan, Province of China | 824999 |
| Specialty Ingredients (LSI) | ARCH | Taiwan, Province of China | 959132 |
| Specialty Ingredients (LSI) | ARCH | Thailand | Kor129697 |
| Specialty Ingredients (LSI) | ARCH | Thailand | Kor74221 |
| Specialty Ingredients (LSI) | ARCH | Thailand | Kor211621 |
| Specialty Ingredients (LSI) | ARCH | Turkey | 99/003935 |
| Specialty Ingredients (LSI) | ARCH | Ukraine | 235280 |
| Specialty Ingredients (LSI) | ARCH | United States | 2,639,997 |
| Specialty Ingredients (LSI) | ARCH | United States | 3756675 |
| Specialty Ingredients (LSI) | ARCH | Venezuela, Bolivarian Republic of | P-227021 |
| Specialty Ingredients (LSI) | ARCH | Venezuela, Bolivarian Republic of | P227018 |
| Specialty Ingredients (LSI) | ARCH | Viet Nam | 131687 |
| Specialty Ingredients (LSI) | ARCH & Design | Australia | 1378720 |
| Specialty Ingredients (LSI) | ARCH & Design | Brazil | 821724169 |
| Specialty Ingredients (LSI) | ARCH & Design | Canada | TMA768226 |
| Specialty Ingredients (LSI) | ARCH & Design | Canada | TMA844122 |
| Specialty Ingredients (LSI) | ARCH & Design | Chile | 804858 |
| Specialty Ingredients (LSI) | ARCH & Design | China | 8662120 |
| Specialty Ingredients (LSI) | ARCH & Design | China | 8662115 |
| Specialty Ingredients (LSI) | ARCH & Design | China | 8662116 |
| Specialty Ingredients (LSI) | ARCH & Design | Dominican Republic | 106160 |
| Specialty Ingredients (LSI) | ARCH & Design | Dominican Republic | 105673 |
| Specialty Ingredients (LSI) | ARCH & Design | Dominican Republic | 105621 |
| Specialty Ingredients (LSI) | ARCH & Design | El Salvador | 194 BOOK 110 |
| Specialty Ingredients (LSI) | ARCH & Design | European Union | 1165877 |
| Specialty Ingredients (LSI) | ARCH & Design | Guatemala | 153883 |
| Specialty Ingredients (LSI) | ARCH & Design | Hong Kong | 300871984 |
| Specialty Ingredients (LSI) | ARCH & Design | India | 855716 |
| Specialty Ingredients (LSI) | ARCH & Design | Indonesia | IDM000192076 |
| Specialty Ingredients (LSI) | ARCH & Design | Indonesia | IDM000312980 |
| Specialty Ingredients (LSI) | ARCH & Design | Indonesia | IDM000429025 |
| Specialty Ingredients (LSI) | ARCH & Design | Israel | 200220 |
| Specialty Ingredients (LSI) | ARCH & Design | Israel | 200216 |
| Specialty Ingredients (LSI) | ARCH & Design | Israel | 200222 |
| Specialty Ingredients (LSI) | ARCH & Design | Israel | 200221 |
| Specialty Ingredients (LSI) | ARCH & Design | Jamaica | 34712 |
| Specialty Ingredients (LSI) | ARCH & Design | Jamaica | 34703 |
| Specialty Ingredients (LSI) | ARCH & Design | Japan | 4935653 |
| Specialty Ingredients (LSI) | ARCH & Design | Kenya | 61272 |
| Specialty Ingredients (LSI) | ARCH & Design | Korea, Republic of | 486653 |
| Specialty Ingredients (LSI) | ARCH & Design | Korea, Republic of | 490807 |
| Specialty Ingredients (LSI) | ARCH & Design | Malaysia | 07007558 |
| Specialty Ingredients (LSI) | ARCH & Design | Malaysia | 99004336 |
| Specialty Ingredients (LSI) | ARCH & Design | Malaysia | 99004338 |
| Specialty Ingredients (LSI) | ARCH & Design | Malaysia | 99004340 |
| Specialty Ingredients (LSI) | ARCH & Design | Maldives | N/A |
| Specialty Ingredients (LSI) | ARCH & Design | Mexico | 1250105 |
| Specialty Ingredients (LSI) | ARCH & Design | Mexico | 1250106 |
| Specialty Ingredients (LSI) | ARCH & Design | Mexico | 1321757 |
| Specialty Ingredients (LSI) | ARCH & Design | New Zealand | 309437 |
| Specialty Ingredients (LSI) | ARCH & Design | New Zealand | 309436 |
| Specialty Ingredients (LSI) | ARCH & Design | Panama | 163056 |
| Specialty Ingredients (LSI) | ARCH & Design | Panama | 163051 |
| Specialty Ingredients (LSI) | ARCH & Design | Panama | 163050 |
| Specialty Ingredients (LSI) | ARCH & Design | Panama | 163048 |
| Specialty Ingredients (LSI) | ARCH & Design | Panama | 163047 |
| Specialty Ingredients (LSI) | ARCH & Design | Peru | 130098 |
| Specialty Ingredients (LSI) | ARCH & Design | Peru | 130094 |
| Specialty Ingredients (LSI) | ARCH & Design | Peru | 130093 |
| Specialty Ingredients (LSI) | ARCH & Design | Peru | 130097 |
| Specialty Ingredients (LSI) | ARCH & Design | Philippines | 4-2004-003782 |
| Specialty Ingredients (LSI) | ARCH & Design | Russian Federation | 385804 |
| Specialty Ingredients (LSI) | ARCH & Design | Singapore | T99/05843D |
| Specialty Ingredients (LSI) | ARCH & Design | South Africa | 2010/18178 |
| Specialty Ingredients (LSI) | ARCH & Design | South Africa | 2010/18177 |
| Specialty Ingredients (LSI) | ARCH & Design | Sri Lanka | 139315 |
| Specialty Ingredients (LSI) | ARCH & Design | Sri Lanka | 139311 |
| Specialty Ingredients (LSI) | ARCH & Design | Sri Lanka | 139312 |
| Specialty Ingredients (LSI) | ARCH & Design | Switzerland | 564198 |
| Specialty Ingredients (LSI) | ARCH & Design | Taiwan, Province of China | 959133 |
| Specialty Ingredients (LSI) | ARCH & Design | Taiwan, Province of China | 940847 |
| Specialty Ingredients (LSI) | ARCH & Design | Thailand | Kor129696 |
| Specialty Ingredients (LSI) | ARCH & Design | Thailand | Kor211622 |
| Specialty Ingredients (LSI) | ARCH & Design | United States | 2,582,682 |
| Specialty Ingredients (LSI) | ARCH & Design | United States | 3756674 |
| Specialty Ingredients (LSI) | ARCH & Design | Venezuela, Bolivarian Republic of | P-224188 |
| Specialty Ingredients (LSI) | ARCH & Design | Venezuela, Bolivarian Republic of | P-224190 |
| Specialty Ingredients (LSI) | ARCH & Design | Venezuela, Bolivarian Republic of | P-224187 |
| Specialty Ingredients (LSI) | ARCH & Design | Venezuela, Bolivarian Republic of | P224190 |
| Specialty Ingredients (LSI) | ARCH & Design | Viet Nam | 131688 |
| Specialty Ingredients (LSI) | ASSURE | New Zealand | 601852 |
| Specialty Ingredients (LSI) | ATOMIC | New Zealand | 744641 |
| Specialty Ingredients (LSI) | AUTO-TREATER | European Union | 2175016 |
| Specialty Ingredients (LSI) | AUTO-TREATER | Latvia | M50356 |
| Specialty Ingredients (LSI) | AUTO-TREATER | Norway | 214567 |
| Specialty Ingredients (LSI) | AXCELA | Argentina | 2899686 |
| Specialty Ingredients (LSI) | AXCELA | Australia | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | Brazil | 910276307 |
| Specialty Ingredients (LSI) | AXCELA | China | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | Colombia | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | European Union | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | Korea, Republic of | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | Madrid Protocol | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | New Zealand | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | Peru | 245566 |
| Specialty Ingredients (LSI) | AXCELA | Russian Federation | 1127274 |
| Specialty Ingredients (LSI) | AXCELA | Taiwan, Province of China | 1846609 |
| Specialty Ingredients (LSI) | AXCELA | United States | 4692727 |
| Specialty Ingredients (LSI) | AXCELA & Design | Brazil | 910276404 |
| Specialty Ingredients (LSI) | AXCELA & Design | European Union | 014811004 |
| Specialty Ingredients (LSI) | AXCELA & Design | Guatemala | 232075 |
| Specialty Ingredients (LSI) | AXCELA (Korean Characters) | Korea, Republic of | 40-1174574 |
| Specialty Ingredients (LSI) | AXIS | New Zealand | 655025 |
| Specialty Ingredients (LSI) | AXIS | New Zealand | 655026 |
| Specialty Ingredients (LSI) | AZOLYTE | Australia | 1210430 |
| Specialty Ingredients (LSI) | AZOLYTE | New Zealand | 779644 |
| Specialty Ingredients (LSI) | AZOTEK | Australia | 1418813 |
| Specialty Ingredients (LSI) | AZOTEK | New Zealand | 839891 |
| Specialty Ingredients (LSI) | AZURE | South Africa | N/A |
| Specialty Ingredients (LSI) | AZURE AQUA | Australia | 1367943 |
| Specialty Ingredients (LSI) | AZURE AQUA | Australia | 1359237 |
| Specialty Ingredients (LSI) | AZURE AQUA | China | 8736103 |
| Specialty Ingredients (LSI) | AZURE AQUA | China | 8736104 |
| Specialty Ingredients (LSI) | AZURE AQUA | China | 8736105 |
| Specialty Ingredients (LSI) | AZURE AQUA | China | 8732030 |
| Specialty Ingredients (LSI) | AZURE AQUA | New Zealand | 822354 |
| Specialty Ingredients (LSI) | AZURE AQUA | New Zealand | 826092 |
| Specialty Ingredients (LSI) | B3 FRESH | Australia | 1488674 |
| Specialty Ingredients (LSI) | B3 FRESH | Brazil | 917905148 |
| Specialty Ingredients (LSI) | B3 FRESH | European Union | 1488674 |
| Specialty Ingredients (LSI) | B3 FRESH | Madrid Protocol | 1488674 |
| Specialty Ingredients (LSI) | B3 FRESH | New Zealand | 1488674 |
| Specialty Ingredients (LSI) | B3 FRESH | Switzerland | 1488674 |
| Specialty Ingredients (LSI) | BARAMINE | Australia | IR1123453 |
| Specialty Ingredients (LSI) | BARAMINE | Belarus | IR1123453 |
| Specialty Ingredients (LSI) | BARAMINE | China | 1123453 |
| Specialty Ingredients (LSI) | BARAMINE | European Union | 010952869 |
| Specialty Ingredients (LSI) | BARAMINE | Madrid Protocol | 1123453 |
| Specialty Ingredients (LSI) | BARAMINE | Malaysia | 2017067968 |
| Specialty Ingredients (LSI) | BARAMINE | New Zealand | 1123453 |
| Specialty Ingredients (LSI) | BARAMINE | Russian Federation | 1123453 |
| Specialty Ingredients (LSI) | BARAMINE | Taiwan, Province of China | 1911274 |
| Specialty Ingredients (LSI) | BARAMINE | Turkey | 1123453 |
| Specialty Ingredients (LSI) | BARAMINE | Ukraine | 1123453 |
| Specialty Ingredients (LSI) | BARAMINE | United States | 4334261 |
| Specialty Ingredients (LSI) | BARCHLOR | Canada | 382071 |
| Specialty Ingredients (LSI) | BARCHLOR | China | 10022318 |
| Specialty Ingredients (LSI) | BARCHLOR | India | 2238951 |
| Specialty Ingredients (LSI) | BARCHLOR | Japan | 4017635 |
| Specialty Ingredients (LSI) | BARCHLOR | Switzerland | 389011 |
| Specialty Ingredients (LSI) | BARCHLOR | United Kingdom | 1033402 |
| Specialty Ingredients (LSI) | BARCHLOR | United States | 912080 |
| Specialty Ingredients (LSI) | BARDAC | Austria | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Benelux | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Bosnia & Herzegovina | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Brazil | 6603203 |
| Specialty Ingredients (LSI) | BARDAC | Brazil | 818402490 |
| Specialty Ingredients (LSI) | BARDAC | Canada | 387792 |
| Specialty Ingredients (LSI) | BARDAC | Chile | 785011 |
| Specialty Ingredients (LSI) | BARDAC | Chile | 470287 |
| Specialty Ingredients (LSI) | BARDAC | China | 10021724 |
| Specialty Ingredients (LSI) | BARDAC | Colombia | 178072 |
| Specialty Ingredients (LSI) | BARDAC | Costa Rica | 93392 |
| Specialty Ingredients (LSI) | BARDAC | Croatia | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Czechia | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Egypt | 378478 |
| Specialty Ingredients (LSI) | BARDAC | European Union | 378478 |
| Specialty Ingredients (LSI) | BARDAC | France | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Germany | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Hungary | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Indonesia | IDM000664514 |
| Specialty Ingredients (LSI) | BARDAC | Indonesia | IDM000664964 |
| Specialty Ingredients (LSI) | BARDAC | Italy | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Japan | 2447691 |
| Specialty Ingredients (LSI) | BARDAC | Korea, Republic of | 334053 |
| Specialty Ingredients (LSI) | BARDAC | Korea, Republic of | 4003340530000 |
| Specialty Ingredients (LSI) | BARDAC | Liechtenstein | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Madrid Protocol | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Malaysia | 2014061050 |
| Specialty Ingredients (LSI) | BARDAC | Malaysia | 2014061049 |
| Specialty Ingredients (LSI) | BARDAC | Mexico | 965396 |
| Specialty Ingredients (LSI) | BARDAC | Mexico | 707589 |
| Specialty Ingredients (LSI) | BARDAC | Morocco | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Philippines | 4/2014/00009431 |
| Specialty Ingredients (LSI) | BARDAC | Portugal | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Romania | 378478 |
| Specialty Ingredients (LSI) | BARDAC | San Marino | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Serbia | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Slovakia | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Slovenia | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Spain | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Switzerland | 389013 |
| Specialty Ingredients (LSI) | BARDAC | Thailand | 161103070 |
| Specialty Ingredients (LSI) | BARDAC | Thailand | 161100161 |
| Specialty Ingredients (LSI) | BARDAC | Tunisia | 378478 |
| Specialty Ingredients (LSI) | BARDAC | Turkey | 201676483 |
| Specialty Ingredients (LSI) | BARDAC | Ukraine | 378478 |
| Specialty Ingredients (LSI) | BARDAC | United Kingdom | 1040693 |
| Specialty Ingredients (LSI) | BARDAC | United Kingdom | 974435 |
| Specialty Ingredients (LSI) | BARDAC | United States | 933731 |
| Specialty Ingredients (LSI) | BARDAC | Venezuela, Bolivarian Republic of | P19070 |
| Specialty Ingredients (LSI) | BARDAC | Viet Nam | 378478 |
| Specialty Ingredients (LSI) | BARDAC (Katakana Characters) | Japan | 2696672 |
| Specialty Ingredients (LSI) | BARDAP | China | 10022323 |
| Specialty Ingredients (LSI) | BARDAP | Czechia | 223754 |
| Specialty Ingredients (LSI) | BARDAP | European Union | 000817668 |
| Specialty Ingredients (LSI) | BARDAP | Hungary | 159309 |
| Specialty Ingredients (LSI) | BARDAP | India | 1163373 |
| Specialty Ingredients (LSI) | BARDAP | Russian Federation | 178226 |
| Specialty Ingredients (LSI) | BARDAP | Slovakia | 190423 |
| Specialty Ingredients (LSI) | BARDAP | Switzerland | 455450 |
| Specialty Ingredients (LSI) | BARDAP | Turkey | 201678162 |
| Specialty Ingredients (LSI) | BARDAP | Ukraine | 244576 |
| Specialty Ingredients (LSI) | BARLENE | Austria | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Benelux | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Bosnia & Herzegovina | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Brazil | 813576393 |
| Specialty Ingredients (LSI) | BARLENE | Canada | 380547 |
| Specialty Ingredients (LSI) | BARLENE | China | 10022317 |
| Specialty Ingredients (LSI) | BARLENE | Egypt | 378479 |
| Specialty Ingredients (LSI) | BARLENE | France | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Germany | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Hungary | 378479 |
| Specialty Ingredients (LSI) | BARLENE | India | 1162707 |
| Specialty Ingredients (LSI) | BARLENE | Italy | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Japan | 4058503 |
| Specialty Ingredients (LSI) | BARLENE | Liechtenstein | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Macau | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Madrid Protocol | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Morocco | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Portugal | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Romania | 378479 |
| Specialty Ingredients (LSI) | BARLENE | San Marino | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Serbia | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Spain | 378479 |
| Specialty Ingredients (LSI) | BARLENE | Switzerland | 389010 |
| Specialty Ingredients (LSI) | BARLENE | Tunisia | 378479 |
| Specialty Ingredients (LSI) | BARLENE | United Kingdom | 974434 |
| Specialty Ingredients (LSI) | BARLENE | United States | 934776 |
| Specialty Ingredients (LSI) | BARLOX | Austria | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Benelux | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Bosnia & Herzegovina | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Canada | TMA377385 |
| Specialty Ingredients (LSI) | BARLOX | China | 10022316 |
| Specialty Ingredients (LSI) | BARLOX | Egypt | 378480 |
| Specialty Ingredients (LSI) | BARLOX | France | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Germany | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Hungary | 378480 |
| Specialty Ingredients (LSI) | BARLOX | India | 1163847 |
| Specialty Ingredients (LSI) | BARLOX | Indonesia | IDM000670075 |
| Specialty Ingredients (LSI) | BARLOX | Italy | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Japan | 2439377 |
| Specialty Ingredients (LSI) | BARLOX | Liechtenstein | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Madrid Protocol | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Morocco | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Portugal | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Romania | 378480 |
| Specialty Ingredients (LSI) | BARLOX | San Marino | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Serbia | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Spain | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Switzerland | 389012 |
| Specialty Ingredients (LSI) | BARLOX | Tunisia | 378480 |
| Specialty Ingredients (LSI) | BARLOX | Turkey | 2016/76464 |
| Specialty Ingredients (LSI) | BARLOX | United Kingdom | UK00000974433 |
| Specialty Ingredients (LSI) | BARLOX | United States | 0898548 |
| Specialty Ingredients (LSI) | BARQUAT | Austria | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Benelux | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Bosnia & Herzegovina | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Brazil | 818402598 |
| Specialty Ingredients (LSI) | BARQUAT | Canada | 381733 |
| Specialty Ingredients (LSI) | BARQUAT | China | 10021723 |
| Specialty Ingredients (LSI) | BARQUAT | Costa Rica | 77367 |
| Specialty Ingredients (LSI) | BARQUAT | Costa Rica | 93389 |
| Specialty Ingredients (LSI) | BARQUAT | Egypt | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | European Union | 1258903 |
| Specialty Ingredients (LSI) | BARQUAT | France | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Germany | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Hungary | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | India | 2238926 |
| Specialty Ingredients (LSI) | BARQUAT | India | 2238920 |
| Specialty Ingredients (LSI) | BARQUAT | India | 1163539 |
| Specialty Ingredients (LSI) | BARQUAT | India | 1163477 |
| Specialty Ingredients (LSI) | BARQUAT | India | 1122871 |
| Specialty Ingredients (LSI) | BARQUAT | Indonesia | IDM000664513 |
| Specialty Ingredients (LSI) | BARQUAT | Italy | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Japan | 2223159 |
| Specialty Ingredients (LSI) | BARQUAT | Liechtenstein | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Madrid Protocol | 1258903 |
| Specialty Ingredients (LSI) | BARQUAT | Madrid Protocol | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Malaysia | 2014061058 |
| Specialty Ingredients (LSI) | BARQUAT | Malaysia | 2014061057 |
| Specialty Ingredients (LSI) | BARQUAT | Morocco | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Philippines | 4/2014/00009430 |
| Specialty Ingredients (LSI) | BARQUAT | Portugal | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Romania | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Russian Federation | 1258903 |
| Specialty Ingredients (LSI) | BARQUAT | San Marino | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Serbia | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Spain | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Switzerland | 389009 |
| Specialty Ingredients (LSI) | BARQUAT | Thailand | 171122244 |
| Specialty Ingredients (LSI) | BARQUAT | Thailand | 161100160 |
| Specialty Ingredients (LSI) | BARQUAT | Thailand | 177107 |
| Specialty Ingredients (LSI) | BARQUAT | Tunisia | 378481 |
| Specialty Ingredients (LSI) | BARQUAT | Turkey | 201676472 |
| Specialty Ingredients (LSI) | BARQUAT | Ukraine | 1258903 |
| Specialty Ingredients (LSI) | BARQUAT | United Kingdom | 974432 |
| Specialty Ingredients (LSI) | BARQUAT | United States | 915357 |
| Specialty Ingredients (LSI) | BARQUAT | Venezuela, Bolivarian Republic of | 190535 |
| Specialty Ingredients (LSI) | BARQUAT | Viet Nam | 378481 |
| Specialty Ingredients (LSI) | BARRACHLOR | Canada | 1073654 |
| Specialty Ingredients (LSI) | BARRACHLOR | Mexico | 1858218 |
| Specialty Ingredients (LSI) | BARRACHLOR | Mexico | 1858217 |
| Specialty Ingredients (LSI) | BARRACHLOR | New Zealand | 665014 |
| Specialty Ingredients (LSI) | BARRACHLOR | New Zealand | 665015 |
| Specialty Ingredients (LSI) | BARRACHLOR | United States | 5664514 |
| Specialty Ingredients (LSI) | BENZOCIL | China | 12,030,694 |
| Specialty Ingredients (LSI) | BETAVERA & Design | United States | 2148165 |
| Specialty Ingredients (LSI) | B-ETAVERA & Design | United States | 2143224 |
| Specialty Ingredients (LSI) | B-GEL & Design | China | 7775100 |
| Specialty Ingredients (LSI) | B-GEL & Design | European Union | 004556957 |
| Specialty Ingredients (LSI) | BIOCELL | European Union | 015394794 |
| Specialty Ingredients (LSI) | BIOCELL | Switzerland | 696306 |
| Specialty Ingredients (LSI) | BIOCYDE | Costa Rica | 82186 |
| Specialty Ingredients (LSI) | BIODYNES | Australia | 818684 |
| Specialty Ingredients (LSI) | BIODYNES | Brazil | 826244769 |
| Specialty Ingredients (LSI) | BIODYNES | Canada | 630839 |
| Specialty Ingredients (LSI) | BIODYNES | China | 818684 |
| Specialty Ingredients (LSI) | BIODYNES | European Union | 003630589 |
| Specialty Ingredients (LSI) | BIODYNES | Japan | 818684 |
| Specialty Ingredients (LSI) | BIODYNES | Korea, Republic of | 818684 |
| Specialty Ingredients (LSI) | BIODYNES | Madrid Protocol | 818684 |
| Specialty Ingredients (LSI) | BIODYNES | South Africa | 200400887 |
| Specialty Ingredients (LSI) | BIODYNES | Taiwan, Province of China | 1629355 |
| Specialty Ingredients (LSI) | BIODYNES | Turkey | 818684 |
| Specialty Ingredients (LSI) | BIODYNES | United States | 1412787 |
| Specialty Ingredients (LSI) | BIODYNES TRF | United States | 2227472 |
| Specialty Ingredients (LSI) | BIO-GENTLE | Madrid Protocol | 1432586 |
| Specialty Ingredients (LSI) | BIO-GENTLE | Mexico | 1432586 |
| Specialty Ingredients (LSI) | BIOLUMEN | China | 8296642 |
| Specialty Ingredients (LSI) | BIOLUMEN | Japan | 5570934 |
| Specialty Ingredients (LSI) | BIOLUMEN | Japan | 5379840 |
| Specialty Ingredients (LSI) | BIO-POL | United States | 1816533 |
| Specialty Ingredients (LSI) | BIOSAN | New Zealand | 223575 |
| Specialty Ingredients (LSI) | BIOVERT | Brazil | 826367054 |
| Specialty Ingredients (LSI) | BIOVERT | Canada | 690110 |
| Specialty Ingredients (LSI) | BIOVERT | China | 830639 |
| Specialty Ingredients (LSI) | BIOVERT | European Union | 003702099 |
| Specialty Ingredients (LSI) | BIOVERT | Japan | 830639 |
| Specialty Ingredients (LSI) | BIOVERT | Korea, Republic of | 830639 |
| Specialty Ingredients (LSI) | BIOVERT | Madrid Protocol | 830639 |
| Specialty Ingredients (LSI) | BIOVERT | South Africa | 200403591 |
| Specialty Ingredients (LSI) | BIOVERT | Turkey | 830639 |
| Specialty Ingredients (LSI) | BIOVERT | United States | 3023039 |
| Specialty Ingredients (LSI) | BLUE LABEL & Design (Diamond) | Canada | TMA973773 |
| Specialty Ingredients (LSI) | BLUE LABEL & Design (Diamond) | United States | 1804494 |
| Specialty Ingredients (LSI) | BLUE LABEL & Design (Rectangle) | United States | 1802108 |
| Specialty Ingredients (LSI) | BOIS PLEIN AIR | Canada | TMA255441 |
| Specialty Ingredients (LSI) | BOROLITH | South Africa | 200213888 |
| Specialty Ingredients (LSI) | BOROLITH | South Africa | 946138 |
| Specialty Ingredients (LSI) | BREAKING THE CHAIN OF TRANSMISSION | Australia | 1431667 |
| Specialty Ingredients (LSI) | BREAKING THE CHAIN OF TRANSMISSION | China | 1431667 |
| Specialty Ingredients (LSI) | BREAKING THE CHAIN OF TRANSMISSION | Madrid Protocol | 1431667 |
| Specialty Ingredients (LSI) | BREAKING THE CHAIN OF TRANSMISSION | Switzerland | 721225 |
| Specialty Ingredients (LSI) | BREAKING THE CHAIN OF TRANSMISSION | United States | 1431667 |
| Specialty Ingredients (LSI) | BROOKOSOME | United States | 1760876 |
| Specialty Ingredients (LSI) | BRUNO | Australia | 1041872 |
| Specialty Ingredients (LSI) | BRUNO | New Zealand | 721332 |
| Specialty Ingredients (LSI) | BUMPER | New Zealand | 655895 |
| Specialty Ingredients (LSI) | BURNOUT | New Zealand | 718442 |
| Specialty Ingredients (LSI) | BUTTERFLY (Design) | United States | 4692756 |
| Specialty Ingredients (LSI) | CALM DOWN, SKIN! | Canada | 1062504 |
| Specialty Ingredients (LSI) | CALM DOWN, SKIN! | European Union | 18025792 |
| Specialty Ingredients (LSI) | CANOPY | China | 7002994 |
| Specialty Ingredients (LSI) | CANOPY (Chinese Characters) | China | 7002996 |
| Specialty Ingredients (LSI) | CARBOFOS | New Zealand | 273330 |
| Specialty Ingredients (LSI) | CARBOQUAT | China | 13700975 |
| Specialty Ingredients (LSI) | CARBOQUAT | European Union | 013629639 |
| Specialty Ingredients (LSI) | CARBOQUAT | India | 1164178 |
| Specialty Ingredients (LSI) | CARBOQUAT | India | 2238960 |
| Specialty Ingredients (LSI) | CARBOQUAT | Turkey | 201678169 |
| Specialty Ingredients (LSI) | CARBOQUAT | United States | 2792027 |
| Specialty Ingredients (LSI) | CARBOSHIELD | European Union | 9967274 |
| Specialty Ingredients (LSI) | CARBOSHIELD | India | 2238918 |
| Specialty Ingredients (LSI) | CARBOSHIELD | India | 2238950 |
| Specialty Ingredients (LSI) | CARBOSHIELD | Madrid Protocol | 1315107 |
| Specialty Ingredients (LSI) | CARBOSHIELD | Russian Federation | 1315107 |
| Specialty Ingredients (LSI) | CARBOSHIELD | Switzerland | 1315107 |
| Specialty Ingredients (LSI) | CARBOSHIELD | Turkey | 1315107 |
| Specialty Ingredients (LSI) | CARBOSHIELD | Ukraine | 1315107 |
| Specialty Ingredients (LSI) | CARBOSHIELD | United States | 2922767 |
| Specialty Ingredients (LSI) | CARSOQUAT | China | 10021758 |
| Specialty Ingredients (LSI) | CARSOQUAT | European Union | 05695562 |
| Specialty Ingredients (LSI) | CARSOQUAT | India | 2238938 |
| Specialty Ingredients (LSI) | CARSOQUAT | India | 1162652 |
| Specialty Ingredients (LSI) | CARSOQUAT | United States | 1250777 |
| Specialty Ingredients (LSI) | CEDARTONE | United States | 1,279,852 |
| Specialty Ingredients (LSI) | CEDARTONE CLASSIC | Canada | TMA499932 |
| Specialty Ingredients (LSI) | CEDARTONE PLUS | Canada | TMA458816 |
| Specialty Ingredients (LSI) | CEDARTONE WOOD & Design | Canada | TMA452956 |
| Specialty Ingredients (LSI) | CELENCO | Argentina | 2836882 |
| Specialty Ingredients (LSI) | CELENCO | Argentina | 2836881 |
| Specialty Ingredients (LSI) | CELENCO | Brazil | 910414041 |
| Specialty Ingredients (LSI) | CELENCO | Brazil | 910414114 |
| Specialty Ingredients (LSI) | CELENCO | Chile | 1230609 |
| Specialty Ingredients (LSI) | CELENCO | China | 1305945 |
| Specialty Ingredients (LSI) | CELENCO | European Union | 015730831 |
| Specialty Ingredients (LSI) | CELENCO | European Union | 1305945 |
| Specialty Ingredients (LSI) | CELENCO | Madrid Protocol | 1305945 |
| Specialty Ingredients (LSI) | CELENCO | Paraguay | 441021 |
| Specialty Ingredients (LSI) | CELENCO | Paraguay | 441022 |
| Specialty Ingredients (LSI) | CELENCO | Peru | 14132 |
| Specialty Ingredients (LSI) | CELENCO | Russian Federation | 1305945 |
| Specialty Ingredients (LSI) | CELENCO | Switzerland | 685217 |
| Specialty Ingredients (LSI) | CERAMID | United States | 1187308 |
| Specialty Ingredients (LSI) | CHEMONITE | Canada | UCA09200 |
| Specialty Ingredients (LSI) | CHEMONITE | United States | 3823780 |
| Specialty Ingredients (LSI) | CHEMONITE | United States | 1088324 |
| Specialty Ingredients (LSI) | CHEMONITE | United States | 616052 |
| Specialty Ingredients (LSI) | CHLOROCARB | New Zealand | 254717 |
| Specialty Ingredients (LSI) | CHLOROTEK | New Zealand | 254716 |
| Specialty Ingredients (LSI) | CHRONOSPHERE | United States | 2821289 |
| Specialty Ingredients (LSI) | CLEARBLEND TECHNOLOGY | United States | 4039113 |
| Specialty Ingredients (LSI) | CLONE | New Zealand | 981392 |
| Specialty Ingredients (LSI) | CLONE | New Zealand | 981441 |
| Specialty Ingredients (LSI) | COBRA | New Zealand | 726094 |
| Specialty Ingredients (LSI) | COMBAT | New Zealand | 843569 |
| Specialty Ingredients (LSI) | COMBINEERING | Australia | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Brazil | 915929775 |
| Specialty Ingredients (LSI) | COMBINEERING | Brazil | 915869926 |
| Specialty Ingredients (LSI) | COMBINEERING | China | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | China | 1508096 |
| Specialty Ingredients (LSI) | COMBINEERING | European Union | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | European Union | 1508096 |
| Specialty Ingredients (LSI) | COMBINEERING | India | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Japan | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Korea, Republic of | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Madrid Protocol | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Madrid Protocol | 1508096 |
| Specialty Ingredients (LSI) | COMBINEERING | New Zealand | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | New Zealand | 1508096 |
| Specialty Ingredients (LSI) | COMBINEERING | Russian Federation | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Russian Federation | 1508096 |
| Specialty Ingredients (LSI) | COMBINEERING | Singapore | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Singapore | 1508096 |
| Specialty Ingredients (LSI) | COMBINEERING | Switzerland | 1431784 |
| Specialty Ingredients (LSI) | COMBINEERING | Taiwan, Province of China | 1985418 |
| Specialty Ingredients (LSI) | COMBINEERING | United States | 5759474 |
| Specialty Ingredients (LSI) | COMPUTREAT | New Zealand | 270585 |
| Specialty Ingredients (LSI) | COPPER OMADINE | Argentina | 3002468 |
| Specialty Ingredients (LSI) | COPPER OMADINE | Chile | 1276095 |
| Specialty Ingredients (LSI) | COPPER OMADINE | China | 10638671 |
| Specialty Ingredients (LSI) | COPPER OMADINE | China | 10638670 |
| Specialty Ingredients (LSI) | COPPER OMADINE | China | 10638669 |
| Specialty Ingredients (LSI) | COPPER OMADINE | European Union | 015120272 |
| Specialty Ingredients (LSI) | COPPER OMADINE | United States | 5045453 |
| Specialty Ingredients (LSI) | COSMETIC INGREDIENTS AND IDEAS | United States | 1505461 |
| Specialty Ingredients (LSI) | COSMOCIL | Argentina | 2221134 |
| Specialty Ingredients (LSI) | COSMOCIL | Australia | 1369452 |
| Specialty Ingredients (LSI) | COSMOCIL | Bulgaria | 41839 |
| Specialty Ingredients (LSI) | COSMOCIL | China | 1907355 |
| Specialty Ingredients (LSI) | COSMOCIL | Denmark | 1980 00114 |
| Specialty Ingredients (LSI) | COSMOCIL | France | 1353734 |
| Specialty Ingredients (LSI) | COSMOCIL | Germany | 971052 |
| Specialty Ingredients (LSI) | COSMOCIL | Hong Kong | 300121472 |
| Specialty Ingredients (LSI) | COSMOCIL | Indonesia | IDM000291070 |
| Specialty Ingredients (LSI) | COSMOCIL | Ireland | 90208 |
| Specialty Ingredients (LSI) | COSMOCIL | Italy | 335949 |
| Specialty Ingredients (LSI) | COSMOCIL | Madrid Protocol | 1244166 |
| Specialty Ingredients (LSI) | COSMOCIL | Malaysia | 2014067588 |
| Specialty Ingredients (LSI) | COSMOCIL | Paraguay | 381770 |
| Specialty Ingredients (LSI) | COSMOCIL | Philippines | 1244116 |
| Specialty Ingredients (LSI) | COSMOCIL | Poland | 155786 |
| Specialty Ingredients (LSI) | COSMOCIL | Portugal | 352303 |
| Specialty Ingredients (LSI) | COSMOCIL | Russian Federation | 456926 |
| Specialty Ingredients (LSI) | COSMOCIL | Switzerland | 284983 |
| Specialty Ingredients (LSI) | COSMOCIL | Taiwan, Province of China | 980427 |
| Specialty Ingredients (LSI) | COSMOCIL | Taiwan, Province of China | 1020049 |
| Specialty Ingredients (LSI) | COSMOCIL | Ukraine | 1244166 |
| Specialty Ingredients (LSI) | COSMOCIL | United Kingdom | 1066679 |
| Specialty Ingredients (LSI) | COSMOCIL | United States | 2662050 |
| Specialty Ingredients (LSI) | COSMOCIL (Katakana Characters) | Japan | 5159859 |
| Specialty Ingredients (LSI) | COSMOCIL CQ | Brazil | 820764787 |
| Specialty Ingredients (LSI) | COSMOCIL CQ | Brazil | 816878153 |
| Specialty Ingredients (LSI) | COSMOCIL CQ | Japan | 4209862 |
| Specialty Ingredients (LSI) | COSMOCIL CQ (Katakana Characters) | Japan | 4234527 |
| Specialty Ingredients (LSI) | CREOL | European Union | 011425981 |
| Specialty Ingredients (LSI) | CREOL | Norway | 240108 |
| Specialty Ingredients (LSI) | CUSOL | Australia | 725576 |
| Specialty Ingredients (LSI) | CUSOL | New Zealand | 265556 |
| Specialty Ingredients (LSI) | CYHELLA | Australia | 1175594 |
| Specialty Ingredients (LSI) | CYHELLA | Brazil | 903568918 |
| Specialty Ingredients (LSI) | CYHELLA | Mexico | 1931356 |
| Specialty Ingredients (LSI) | CYHELLA | Mexico | 1931353 |
| Specialty Ingredients (LSI) | CYHELLA | New Zealand | 768002 |
| Specialty Ingredients (LSI) | CYHELLA | Taiwan, Province of China | 2037474 |
| Specialty Ingredients (LSI) | DANTABROM | Canada | 375315 |
| Specialty Ingredients (LSI) | DANTOBROM | Australia | 644989 |
| Specialty Ingredients (LSI) | DANTOBROM | Australia | 644991 |
| Specialty Ingredients (LSI) | DANTOBROM | Austria | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | Benelux | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | Brazil | 821128612 |
| Specialty Ingredients (LSI) | DANTOBROM | Brazil | 821128663 |
| Specialty Ingredients (LSI) | DANTOBROM | Canada | 393103 |
| Specialty Ingredients (LSI) | DANTOBROM | China | 10021730 |
| Specialty Ingredients (LSI) | DANTOBROM | China | 10021729 |
| Specialty Ingredients (LSI) | DANTOBROM | European Union | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | France | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | Germany | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | India | 1162784 |
| Specialty Ingredients (LSI) | DANTOBROM | India | 2238925 |
| Specialty Ingredients (LSI) | DANTOBROM | India | 1163314 |
| Specialty Ingredients (LSI) | DANTOBROM | Italy | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | Japan | 2250116 |
| Specialty Ingredients (LSI) | DANTOBROM | Madrid Protocol | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | Mexico | 489098 |
| Specialty Ingredients (LSI) | DANTOBROM | Mexico | 489101 |
| Specialty Ingredients (LSI) | DANTOBROM | Portugal | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | Spain | 560945 |
| Specialty Ingredients (LSI) | DANTOBROM | Switzerland | 378805 |
| Specialty Ingredients (LSI) | DANTOBROM | Turkey | 2016/78143 |
| Specialty Ingredients (LSI) | DANTOBROM | United Kingdom | 1358132 |
| Specialty Ingredients (LSI) | DANTOBROM | United States | 1464099 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Austria | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Benelux | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Brazil | 821128604 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Brazil | 821128655 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Canada | 453624 |
| Specialty Ingredients (LSI) | DANTOCHLOR | China | 10021728 |
| Specialty Ingredients (LSI) | DANTOCHLOR | China | 10021727 |
| Specialty Ingredients (LSI) | DANTOCHLOR | France | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Germany | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | India | 2238943 |
| Specialty Ingredients (LSI) | DANTOCHLOR | India | 2238924 |
| Specialty Ingredients (LSI) | DANTOCHLOR | India | 1164176 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Italy | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Japan | 2439378 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Madrid Protocol | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Portugal | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Spain | 560946 |
| Specialty Ingredients (LSI) | DANTOCHLOR | Switzerland | 378806 |
| Specialty Ingredients (LSI) | DANTOCHLOR | United Kingdom | 1405267 |
| Specialty Ingredients (LSI) | DANTOCHLOR | United Kingdom | 1405266 |
| Specialty Ingredients (LSI) | DANTOCHLOR | United States | 1457850 |
| Specialty Ingredients (LSI) | DANTOCOL | United States | 1054585 |
| Specialty Ingredients (LSI) | DANTOGARD | Austria | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | Benelux | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | Brazil | 81840262 |
| Specialty Ingredients (LSI) | DANTOGARD | Canada | 377386 |
| Specialty Ingredients (LSI) | DANTOGARD | China | 10022320 |
| Specialty Ingredients (LSI) | DANTOGARD | France | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | Germany | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | India | 1123152 |
| Specialty Ingredients (LSI) | DANTOGARD | India | 2238917 |
| Specialty Ingredients (LSI) | DANTOGARD | India | 2238922 |
| Specialty Ingredients (LSI) | DANTOGARD | Italy | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | Madrid Protocol | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | Portugal | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | Spain | 560947 |
| Specialty Ingredients (LSI) | DANTOGARD | Switzerland | 378807 |
| Specialty Ingredients (LSI) | DANTOGARD | Turkey | 2016/76490 |
| Specialty Ingredients (LSI) | DANTOGARD | United Kingdom | 1403056 |
| Specialty Ingredients (LSI) | DANTOGARD | United States | 1419626 |
| Specialty Ingredients (LSI) | DANTOIN | Canada | 381365 |
| Specialty Ingredients (LSI) | DANTOIN | China | 10022315 |
| Specialty Ingredients (LSI) | DANTOIN | China | 10021749 |
| Specialty Ingredients (LSI) | DANTOIN | European Union | 015115207 |
| Specialty Ingredients (LSI) | DANTOIN | India | 2238929 |
| Specialty Ingredients (LSI) | DANTOIN | India | 1207459 |
| Specialty Ingredients (LSI) | DANTOIN | Japan | 3530831 |
| Specialty Ingredients (LSI) | DANTOIN | South Africa | 2016/15710 |
| Specialty Ingredients (LSI) | DANTOIN | South Africa | 2016/15711 |
| Specialty Ingredients (LSI) | DANTOIN | Spain | 2672061 |
| Specialty Ingredients (LSI) | DANTOIN | Turkey | 2016/78131 |
| Specialty Ingredients (LSI) | DANTOIN | United Kingdom | 1422514 |
| Specialty Ingredients (LSI) | DANTOIN | United States | 2111567 |
| Specialty Ingredients (LSI) | DANTOSERVE | United States | 2692272 |
| Specialty Ingredients (LSI) | DANTOSPERSE | United States | 1106410 |
| Specialty Ingredients (LSI) | DEFENCE | New Zealand | 646108 |
| Specialty Ingredients (LSI) | DEFENCE | New Zealand | 646109 |
| Specialty Ingredients (LSI) | DELCIDE | Argentina | 2648302 |
| Specialty Ingredients (LSI) | DELCIDE | Argentina | 2603584 |
| Specialty Ingredients (LSI) | DELCIDE | Argentina | 2907087 |
| Specialty Ingredients (LSI) | DELCIDE | Brazil | 830800727 |
| Specialty Ingredients (LSI) | DELCIDE | Chile | 1209306 |
| Specialty Ingredients (LSI) | DELCIDE | Chile | 1028909 |
| Specialty Ingredients (LSI) | DELCIDE | Colombia | 423015 |
| Specialty Ingredients (LSI) | DELCIDE | Peru | 1183962 |
| Specialty Ingredients (LSI) | DELCIDE | Uruguay | 449907 |
| Specialty Ingredients (LSI) | DENSIL | Argentina | 1658010 |
| Specialty Ingredients (LSI) | DENSIL | Australia | 332503 |
| Specialty Ingredients (LSI) | DENSIL | Benelux | 358837 |
| Specialty Ingredients (LSI) | DENSIL | Brazil | 818336676 |
| Specialty Ingredients (LSI) | DENSIL | Bulgaria | 41840 |
| Specialty Ingredients (LSI) | DENSIL | China | 1712443 |
| Specialty Ingredients (LSI) | DENSIL | Denmark | 1980 02037 |
| Specialty Ingredients (LSI) | DENSIL | European Union | 1204489 |
| Specialty Ingredients (LSI) | DENSIL | Finland | 80587 |
| Specialty Ingredients (LSI) | DENSIL | France | 1516813 |
| Specialty Ingredients (LSI) | DENSIL | Germany | 1049547 |
| Specialty Ingredients (LSI) | DENSIL | India | 917272 |
| Specialty Ingredients (LSI) | DENSIL | Indonesia | IDM000291069 |
| Specialty Ingredients (LSI) | DENSIL | Ireland | 93850 |
| Specialty Ingredients (LSI) | DENSIL | Italy | 370140 |
| Specialty Ingredients (LSI) | DENSIL | Japan | 1998406 |
| Specialty Ingredients (LSI) | DENSIL | Madrid Protocol | 1204489 |
| Specialty Ingredients (LSI) | DENSIL | Malaysia | 2015052849 |
| Specialty Ingredients (LSI) | DENSIL | Mexico | 339349 |
| Specialty Ingredients (LSI) | DENSIL | New Zealand | 143150 |
| Specialty Ingredients (LSI) | DENSIL | Nigeria | 78482 |
| Specialty Ingredients (LSI) | DENSIL | Norway | 108795 |
| Specialty Ingredients (LSI) | DENSIL | Philippines | 42002004491 |
| Specialty Ingredients (LSI) | DENSIL | Poland | 155785 |
| Specialty Ingredients (LSI) | DENSIL | Portugal | 352302 |
| Specialty Ingredients (LSI) | DENSIL | Sweden | 174951 |
| Specialty Ingredients (LSI) | DENSIL | Switzerland | 484844 |
| Specialty Ingredients (LSI) | DENSIL | Taiwan, Province of China | 997330 |
| Specialty Ingredients (LSI) | DENSIL | Thailand | 169397 |
| Specialty Ingredients (LSI) | DENSIL | Turkey | 1204489 |
| Specialty Ingredients (LSI) | DENSIL | Ukraine | 1204489 |
| Specialty Ingredients (LSI) | DENSIL | United Kingdom | 1113526 |
| Specialty Ingredients (LSI) | DENSIL | United States | 2477317 |
| Specialty Ingredients (LSI) | DENSIL | Uruguay | 389252 |
| Specialty Ingredients (LSI) | DEPTH CHARGE | New Zealand | 650823 |
| Specialty Ingredients (LSI) | DERMAFLUX | China | 1017030 |
| Specialty Ingredients (LSI) | DERMAFLUX | Madrid Protocol | 1017030 |
| Specialty Ingredients (LSI) | DERMAFLUX | United States | 3346320 |
| Specialty Ingredients (LSI) | DEWDROP | New Zealand | 637448 |
| Specialty Ingredients (LSI) | DIACON | Canada | 611867 |
| Specialty Ingredients (LSI) | DIACON | United States | 2838515 |
| Specialty Ingredients (LSI) | DIAMOND (Design) | United States | 5193267 |
| Specialty Ingredients (LSI) | DIFFUSOL | Australia | 463600 |
| Specialty Ingredients (LSI) | DIFFUSOL | Indonesia | IDM000000809 |
| Specialty Ingredients (LSI) | DIFFUSOL | Malaysia | M069800 |
| Specialty Ingredients (LSI) | DIFFUSOL | New Zealand | 171679 |
| Specialty Ingredients (LSI) | DIFFUSOL & Design | Australia | 474995 |
| Specialty Ingredients (LSI) | DIP 'N' GRO | New Zealand | 265557 |
| Specialty Ingredients (LSI) | DRICON | Australia | 459407 |
| Specialty Ingredients (LSI) | DRICON | Australia | 459406 |
| Specialty Ingredients (LSI) | DRICON | Austria | 97478 |
| Specialty Ingredients (LSI) | DRICON | Azerbaijan | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Belarus | 1124370 |
| Specialty Ingredients (LSI) | DRICON | Benelux | 371617 |
| Specialty Ingredients (LSI) | DRICON | Canada | TMA269044 |
| Specialty Ingredients (LSI) | DRICON | Chile | 1033259 |
| Specialty Ingredients (LSI) | DRICON | Denmark | 1982 016331 |
| Specialty Ingredients (LSI) | DRICON | Estonia | 1124370 |
| Specialty Ingredients (LSI) | DRICON | European Union | 1768720 |
| Specialty Ingredients (LSI) | DRICON | European Union | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Finland | 84582 |
| Specialty Ingredients (LSI) | DRICON | Georgia | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Germany | 1037003 |
| Specialty Ingredients (LSI) | DRICON | Greece | 68010 |
| Specialty Ingredients (LSI) | DRICON | Indonesia | 361257 |
| Specialty Ingredients (LSI) | DRICON | Indonesia | 373478 |
| Specialty Ingredients (LSI) | DRICON | Ireland | 99819 |
| Specialty Ingredients (LSI) | DRICON | Ireland | 99818 |
| Specialty Ingredients (LSI) | DRICON | Italy | 1401969 |
| Specialty Ingredients (LSI) | DRICON | Japan | 1718785 |
| Specialty Ingredients (LSI) | DRICON | Kazakhstan | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Korea, Republic of | 40-0780794 |
| Specialty Ingredients (LSI) | DRICON | Kyrgyzstan | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Macedonia, The Former Yugoslav Republic of | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Madrid Protocol | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Madrid Protocol | 1124370 |
| Specialty Ingredients (LSI) | DRICON | Malaysia | 3004137 |
| Specialty Ingredients (LSI) | DRICON | Malaysia | 84/04929 |
| Specialty Ingredients (LSI) | DRICON | New Zealand | 140623 |
| Specialty Ingredients (LSI) | DRICON | Norway | 111787 |
| Specialty Ingredients (LSI) | DRICON | Portugal | 210754 |
| Specialty Ingredients (LSI) | DRICON | Portugal | 210753 |
| Specialty Ingredients (LSI) | DRICON | Russian Federation | 1124370 |
| Specialty Ingredients (LSI) | DRICON | Russian Federation | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Singapore | T8404313D |
| Specialty Ingredients (LSI) | DRICON | Singapore | 431284 |
| Specialty Ingredients (LSI) | DRICON | South Africa | 19820371 |
| Specialty Ingredients (LSI) | DRICON | South Africa | 820370 |
| Specialty Ingredients (LSI) | DRICON | Spain | 962803 |
| Specialty Ingredients (LSI) | DRICON | Sweden | 177757 |
| Specialty Ingredients (LSI) | DRICON | Switzerland | P-310255 |
| Specialty Ingredients (LSI) | DRICON | Tajikistan | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Thailand | 147099 |
| Specialty Ingredients (LSI) | DRICON | Thailand | 138961 |
| Specialty Ingredients (LSI) | DRICON | Turkey | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Turkmenistan | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Ukraine | 1117895 |
| Specialty Ingredients (LSI) | DRICON | Ukraine | 1124370 |
| Specialty Ingredients (LSI) | DRICON | United Kingdom | 1145787 |
| Specialty Ingredients (LSI) | DRICON | United Kingdom | 1145786 |
| Specialty Ingredients (LSI) | DRICON | United States | 1,181,741 |
| Specialty Ingredients (LSI) | DRICON | United States | 1,176,221 |
| Specialty Ingredients (LSI) | DRICON | Uzbekistan | 1117895 |
| Specialty Ingredients (LSI) | DRIFIX | Australia | 705352 |
| Specialty Ingredients (LSI) | DRIFIX | New Zealand | 255082 |
| Specialty Ingredients (LSI) | DUOEFFECTEV | European Union | 018060297 |
| Specialty Ingredients (LSI) | DUOMOISTEV | Brazil | 914823965 |
| Specialty Ingredients (LSI) | DUOMOISTEV | European Union | 017914903 |
| Specialty Ingredients (LSI) | DUOMOISTEV | Switzerland | 723143 |
| Specialty Ingredients (LSI) | DYNAMO | New Zealand | 981442 |
| Specialty Ingredients (LSI) | DYNAMO | New Zealand | 981396 |
| Specialty Ingredients (LSI) | E T | Canada | TMA453651 |
| Specialty Ingredients (LSI) | ECOBOARD (Series) | New Zealand | 706867 |
| Specialty Ingredients (LSI) | ECODECK (Series) | Australia | 1038947 |
| Specialty Ingredients (LSI) | ECOSEAL | New Zealand | 630291 |
| Specialty Ingredients (LSI) | ECOWOOD & Design | New Zealand | 638127 |
| Specialty Ingredients (LSI) | ECOWOOD & Design | New Zealand | 1111494 |
| Specialty Ingredients (LSI) | ECOWOOD (Series) | Australia | 1013623 |
| Specialty Ingredients (LSI) | EFFEXEL | Brazil | 914640887 |
| Specialty Ingredients (LSI) | EFFEXEL | Brazil | 912644516 |
| Specialty Ingredients (LSI) | EFFEXEL | Brazil | 911098976 |
| Specialty Ingredients (LSI) | EFFEXEL | European Union | 015452816 |
| Specialty Ingredients (LSI) | EFFEXEL | European Union | 016650426 |
| Specialty Ingredients (LSI) | EFFEXEL | Madrid Protocol | 1506896 |
| Specialty Ingredients (LSI) | EFFEXEL | Mexico | 1821906 |
| Specialty Ingredients (LSI) | EFFEXEL | New Zealand | 1506896 |
| Specialty Ingredients (LSI) | EFFEXEL | United States | 5590740 |
| Specialty Ingredients (LSI) | ELIMINEX | New Zealand | 98484 |
| Specialty Ingredients (LSI) | EMYLA | Australia | 1455888 |
| Specialty Ingredients (LSI) | EMYLA | European Union | 1455888 |
| Specialty Ingredients (LSI) | EMYLA | India | 1455888 |
| Specialty Ingredients (LSI) | EMYLA | Japan | 1455888 |
| Specialty Ingredients (LSI) | EMYLA | Madrid Protocol | 1455888 |
| Specialty Ingredients (LSI) | EMYLA | New Zealand | 1455888 |
| Specialty Ingredients (LSI) | EMYLA | Russian Federation | 1455888 |
| Specialty Ingredients (LSI) | EMYLA | Switzerland | 1455888 |
| Specialty Ingredients (LSI) | ENBLU | Indonesia | IDM0000440326 |
| Specialty Ingredients (LSI) | ENBLU | Indonesia | IDM000440325 |
| Specialty Ingredients (LSI) | ENBORA | Indonesia | 392953 |
| Specialty Ingredients (LSI) | ENBORA | Indonesia | IDM000440327 |
| Specialty Ingredients (LSI) | ENBORER | Indonesia | IDM000480610 |
| Specialty Ingredients (LSI) | ENCAPS | Australia | 1032853 |
| Specialty Ingredients (LSI) | ENCAPS | New Zealand | 716399 |
| Specialty Ingredients (LSI) | END-SEAL | Benelux | 438471 |
| Specialty Ingredients (LSI) | END-SEAL BROWN & Design | European Union | 017875795 |
| Specialty Ingredients (LSI) | END-SEAL GREEN & Design | European Union | 017875798 |
| Specialty Ingredients (LSI) | END-SEAL YELLOW & Design | European Union | 017875799 |
| Specialty Ingredients (LSI) | ENHANCE | New Zealand | 204438 |
| Specialty Ingredients (LSI) | ENSEAL | China | 8927223 |
| Specialty Ingredients (LSI) | ENSEAL (Chinese Characters) | China | 10445149 |
| Specialty Ingredients (LSI) | ENSELE | European Union | 8612582 |
| Specialty Ingredients (LSI) | ENSELE | New Zealand | 112305 |
| Specialty Ingredients (LSI) | ENSELE | Singapore | T8300930G |
| Specialty Ingredients (LSI) | ENSELE | United Kingdom | 838172 |
| Specialty Ingredients (LSI) | ENTIBLU | Indonesia | IDM000480609 |
| Specialty Ingredients (LSI) | ENVISION A WORLD BUILT WITH WOOD | United States | 5605509 |
| Specialty Ingredients (LSI) | EPOCH | New Zealand | 744650 |
| Specialty Ingredients (LSI) | ESTEEM | New Zealand | 1002621 |
| Specialty Ingredients (LSI) | ET | United States | 1762876 |
| Specialty Ingredients (LSI) | ETHOSPERSE | United States | 802050 |
| Specialty Ingredients (LSI) | EXPO 500 | New Zealand | 627345 |
| Specialty Ingredients (LSI) | EXTRA | United States | 1753495 |
| Specialty Ingredients (LSI) | EXTRA WOLMANIZED & Design | Canada | TMA443619 |
| Specialty Ingredients (LSI) | EYE PRO | Australia | 1169682 |
| Specialty Ingredients (LSI) | EYE PRO | European Union | 005777511 |
| Specialty Ingredients (LSI) | EYE PRO | Japan | 1169682 |
| Specialty Ingredients (LSI) | EYE PRO | Madrid Protocol | 1169682 |
| Specialty Ingredients (LSI) | EYE PRO | New Zealand | 1169682 |
| Specialty Ingredients (LSI) | EYE PRO | Russian Federation | 1169682 |
| Specialty Ingredients (LSI) | EYE PRO | United States | 3319292 |
| Specialty Ingredients (LSI) | E-Z DRUM | United States | 1508707 |
| Specialty Ingredients (LSI) | FIBRO SILK | European Union | 017888341 |
| Specialty Ingredients (LSI) | FIBRO SILK | United States | 5870932 |
| Specialty Ingredients (LSI) | FIRE AWAY | United States | 2,834,194 |
| Specialty Ingredients (LSI) | FIRESHEATH | Australia | 1254980 |
| Specialty Ingredients (LSI) | FIRESHEATH | Madrid Protocol | 1254980 |
| Specialty Ingredients (LSI) | FIRESHEATH | Mexico | 1254980 |
| Specialty Ingredients (LSI) | FIRESHEATH | United States | 4727175 |
| Specialty Ingredients (LSI) | FLAMECHECK | European Union | 8744641 |
| Specialty Ingredients (LSI) | FLAMTARD | Australia | 464167 |
| Specialty Ingredients (LSI) | FLORASAN | New Zealand | 264454 |
| Specialty Ingredients (LSI) | FMB | Brazil | 821128639 |
| Specialty Ingredients (LSI) | FMB | Canada | 551708 |
| Specialty Ingredients (LSI) | FMB | European Union | 001122498 |
| Specialty Ingredients (LSI) | FMB | India | 1162936 |
| Specialty Ingredients (LSI) | FMB | India | 2238933 |
| Specialty Ingredients (LSI) | FMB | Mexico | 609366 |
| Specialty Ingredients (LSI) | FMB | United States | 2404129 |
| Specialty Ingredients (LSI) | FORMULACREATE | United States | 4598170 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | Brazil | 840087080 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | Canada | 851833 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | China | 1122266 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | European Union | 1122266 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | India | 2315881 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | Japan | 1122266 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | Madrid Protocol | 1122266 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | South Africa | 201208081 |
| Specialty Ingredients (LSI) | FORMULAPROTECT | United States | 4329311 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design | Brazil | 916375188 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design | Brazil | 916375366 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design | Chile | 1297348 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design | Colombia | 623807 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design (Black Shield) | Brazil | 916763331 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design (Black Shield) | Brazil | 916763390 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design (Red Shield Only) | Brazil | 916477827 |
| Specialty Ingredients (LSI) | FORMULATED WITH LONZAGARD & Design (Red Shield Only) | Brazil | 916478017 |
| Specialty Ingredients (LSI) | FOSCHEK | New Zealand | 215738 |
| Specialty Ingredients (LSI) | FRAMEBOR | New Zealand | 775369 |
| Specialty Ingredients (LSI) | FRAMECOAT | New Zealand | 305827 |
| Specialty Ingredients (LSI) | FRAMEGUARD | Australia | 1277351 |
| Specialty Ingredients (LSI) | FRAMEGUARD | Canada | TMA771728 |
| Specialty Ingredients (LSI) | FRAMEGUARD | Chile | 1208266 |
| Specialty Ingredients (LSI) | FRAMEGUARD | Japan | 5266014 |
| Specialty Ingredients (LSI) | FRAMEGUARD | United States | 3517135 |
| Specialty Ingredients (LSI) | FRAMEGUARD | United States | 2,779,790 |
| Specialty Ingredients (LSI) | FRAMEGUARD (Katakana Characters) | Japan | 5305596 |
| Specialty Ingredients (LSI) | FRAMESEAL (Series) | New Zealand | 703047 |
| Specialty Ingredients (LSI) | FREXUS | Argentina | 2235060 |
| Specialty Ingredients (LSI) | FREXUS | Australia | 893613 |
| Specialty Ingredients (LSI) | FREXUS | Brazil | 827152582 |
| Specialty Ingredients (LSI) | FREXUS | Chile | 1236619 |
| Specialty Ingredients (LSI) | FREXUS | China | 893613 |
| Specialty Ingredients (LSI) | FREXUS | Colombia | 313623 |
| Specialty Ingredients (LSI) | FREXUS | European Union | 002411981 |
| Specialty Ingredients (LSI) | FREXUS | India | 1389498 |
| Specialty Ingredients (LSI) | FREXUS | India | 1396555 |
| Specialty Ingredients (LSI) | FREXUS | Indonesia | IDM000132156 |
| Specialty Ingredients (LSI) | FREXUS | Madrid Protocol | 893613 |
| Specialty Ingredients (LSI) | FREXUS | Mexico | 948973 |
| Specialty Ingredients (LSI) | FREXUS | Peru | 242093 |
| Specialty Ingredients (LSI) | FREXUS | South Africa | 200521133 |
| Specialty Ingredients (LSI) | FREXUS | Uruguay | 473647 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | Australia | 1418298 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | Canada | TMA1071004 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | China | 1418298 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | European Union | 1418298 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | Japan | 1418298 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | Madrid Protocol | 1418298 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | Switzerland | 1418298 |
| Specialty Ingredients (LSI) | FROM MOLECULE TO MIRROR | United States | 5795658 |
| Specialty Ingredients (LSI) | FRX | United States | 2,776,744 |
| Specialty Ingredients (LSI) | FRX | United States | 2,779,942 |
| Specialty Ingredients (LSI) | GENTI-FOL | United States | 2800251 |
| Specialty Ingredients (LSI) | GEOGARD | Australia | 1440957 |
| Specialty Ingredients (LSI) | GEOGARD | Brazil | 829528814 |
| Specialty Ingredients (LSI) | GEOGARD | China | 10,021,757 |
| Specialty Ingredients (LSI) | GEOGARD | European Union | 13171971 |
| Specialty Ingredients (LSI) | GEOGARD | India | 1162877 |
| Specialty Ingredients (LSI) | GEOGARD | India | 1626599 |
| Specialty Ingredients (LSI) | GEOGARD | Indonesia | IDM000574782 |
| Specialty Ingredients (LSI) | GEOGARD | Madrid Protocol | 1243295 |
| Specialty Ingredients (LSI) | GEOGARD | Malaysia | 2014067573 |
| Specialty Ingredients (LSI) | GEOGARD | New Zealand | 1243295 |
| Specialty Ingredients (LSI) | GEOGARD | Philippines | 1243295 |
| Specialty Ingredients (LSI) | GEOGARD | Russian Federation | 1243295 |
| Specialty Ingredients (LSI) | GEOGARD | Turkey | 1243295 |
| Specialty Ingredients (LSI) | GEOGARD | Ukraine | 1243295 |
| Specialty Ingredients (LSI) | GEOGARD | United States | 2675607 |
| Specialty Ingredients (LSI) | GEOGARD (Chinese Characters) | China | 17435085 |
| Specialty Ingredients (LSI) | GEOGARD (Chinese Characters) | China | 17434992 |
| Specialty Ingredients (LSI) | GEOGARD (Chinese Characters) | China | 17434921 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | Australia | 1440955 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | China | 1321028 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | European Union | 1321028 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | Madrid Protocol | 1321028 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | Russian Federation | 1321028 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | Switzerland | 1321028 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | Turkey | 1321028 |
| Specialty Ingredients (LSI) | GEOGARD ULTRA | United States | 4142666 |
| Specialty Ingredients (LSI) | GLYCACIL | Benelux | 560438 |
| Specialty Ingredients (LSI) | GLYCACIL | Brazil | 818402628 |
| Specialty Ingredients (LSI) | GLYCACIL | China | 10021756 |
| Specialty Ingredients (LSI) | GLYCACIL | France | 94542866 |
| Specialty Ingredients (LSI) | GLYCACIL | Germany | 39402005 |
| Specialty Ingredients (LSI) | GLYCACIL | India | 1626600 |
| Specialty Ingredients (LSI) | GLYCACIL | India | 1163502 |
| Specialty Ingredients (LSI) | GLYCACIL | Italy | 302014902302725 |
| Specialty Ingredients (LSI) | GLYCACIL | Japan | 4112176 |
| Specialty Ingredients (LSI) | GLYCACIL | Madrid Protocol | 1243427 |
| Specialty Ingredients (LSI) | GLYCACIL | Malaysia | 2014067577 |
| Specialty Ingredients (LSI) | GLYCACIL | Philippines | 1243427 |
| Specialty Ingredients (LSI) | GLYCACIL | Russian Federation | 1243427 |
| Specialty Ingredients (LSI) | GLYCACIL | Spain | 1929242 |
| Specialty Ingredients (LSI) | GLYCACIL | Ukraine | 1243427 |
| Specialty Ingredients (LSI) | GLYCACIL | United Kingdom | 2009031 |
| Specialty Ingredients (LSI) | GLYCACIL | United States | 1631228 |
| Specialty Ingredients (LSI) | GLYCO | United States | 1113386 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Benelux | 560948 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Canada | 380548 |
| Specialty Ingredients (LSI) | GLYCOLUBE | China | 10022319 |
| Specialty Ingredients (LSI) | GLYCOLUBE | France | 560948 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Germany | 560948 |
| Specialty Ingredients (LSI) | GLYCOLUBE | India | 1233230 |
| Specialty Ingredients (LSI) | GLYCOLUBE | India | 1233229 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Italy | 560948 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Japan | 2489372 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Madrid Protocol | 560948 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Portugal | 560948 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Spain | 560948 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Switzerland | 378808 |
| Specialty Ingredients (LSI) | GLYCOLUBE | Turkey | 2016/78154 |
| Specialty Ingredients (LSI) | GLYCOLUBE | United Kingdom | 1403057 |
| Specialty Ingredients (LSI) | GLYCOLUBE | United States | 4093719 |
| Specialty Ingredients (LSI) | GLYCOMUL | China | 10021748 |
| Specialty Ingredients (LSI) | GLYCOMUL | India | 1122639 |
| Specialty Ingredients (LSI) | GLYCOMUL | India | 1163196 |
| Specialty Ingredients (LSI) | GLYCOMUL | Turkey | 2016/78146 |
| Specialty Ingredients (LSI) | GLYCOMUL | United States | 694424 |
| Specialty Ingredients (LSI) | GLYCONOL | United States | 906998 |
| Specialty Ingredients (LSI) | GLYCOSERVE | United States | 1423494 |
| Specialty Ingredients (LSI) | GLYCOSPERSE | China | 10021744 |
| Specialty Ingredients (LSI) | GLYCOSPERSE | European Union | 015099741 |
| Specialty Ingredients (LSI) | GLYCOSPERSE | India | 2238949 |
| Specialty Ingredients (LSI) | GLYCOSPERSE | India | 2238927 |
| Specialty Ingredients (LSI) | GLYCOSPERSE | Spain | 2672059 |
| Specialty Ingredients (LSI) | GLYCOSPERSE | United States | 694767 |
| Specialty Ingredients (LSI) | GLYCOSTAT | United States | 1256492 |
| Specialty Ingredients (LSI) | GLYCOWAX | United States | 1106411 |
| Specialty Ingredients (LSI) | GLYDANT | Argentina | 2094162 |
| Specialty Ingredients (LSI) | GLYDANT | Austria | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Benelux | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Brazil | 818402636 |
| Specialty Ingredients (LSI) | GLYDANT | Canada | 377387 |
| Specialty Ingredients (LSI) | GLYDANT | China | 4314597 |
| Specialty Ingredients (LSI) | GLYDANT | France | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Germany | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Hong Kong | 300290213 |
| Specialty Ingredients (LSI) | GLYDANT | India | 1163588 |
| Specialty Ingredients (LSI) | GLYDANT | India | 1626597 |
| Specialty Ingredients (LSI) | GLYDANT | Indonesia | IDM000574577 |
| Specialty Ingredients (LSI) | GLYDANT | Italy | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Japan | 2250118 |
| Specialty Ingredients (LSI) | GLYDANT | Madrid Protocol | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Malaysia | 2014067582 |
| Specialty Ingredients (LSI) | GLYDANT | Mexico | 489099 |
| Specialty Ingredients (LSI) | GLYDANT | Philippines | 4-2015-00004081 |
| Specialty Ingredients (LSI) | GLYDANT | Portugal | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Russian Federation | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Spain | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | Switzerland | 378809 |
| Specialty Ingredients (LSI) | GLYDANT | Taiwan, Province of China | 708303 |
| Specialty Ingredients (LSI) | GLYDANT | Turkey | 2016/78116 |
| Specialty Ingredients (LSI) | GLYDANT | Ukraine | 560949 |
| Specialty Ingredients (LSI) | GLYDANT | United Kingdom | 1403060 |
| Specialty Ingredients (LSI) | GLYDANT | United States | 1152036 |
| Specialty Ingredients (LSI) | GLYDANT | Venezuela, Bolivarian Republic of | P-246755 |
| Specialty Ingredients (LSI) | GLYDANT (Chinese Characters) | China | 4314595 |
| Specialty Ingredients (LSI) | GLYDANT (Chinese Characters) | China | 4314596 |
| Specialty Ingredients (LSI) | GLYDANT (Chinese Characters) | Hong Kong | 300293652 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Argentina | 2094163 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Benelux | 560437 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Brazil | 818402571 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Canada | 446096 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | China | 10021755 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | France | 94542867 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Germany | 39402006 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | India | 2238948 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | India | 2238906 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Italy | 1089499 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Japan | 3307876 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Mexico | 489100 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Spain | 1929444 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Taiwan, Province of China | 708302 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | United Kingdom | 2009030 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | United States | 1680897 |
| Specialty Ingredients (LSI) | GLYDANT PLUS | Venezuela, Bolivarian Republic of | P-246756 |
| Specialty Ingredients (LSI) | GLYTEX | United States | 1257253 |
| Specialty Ingredients (LSI) | GURU | New Zealand | 984649 |
| Specialty Ingredients (LSI) | H2OBIOEV | Australia | 1442345 |
| Specialty Ingredients (LSI) | H2OBIOEV | Brazil | 916295168 |
| Specialty Ingredients (LSI) | H2OBIOEV | Canada | TMA1071017 |
| Specialty Ingredients (LSI) | H2OBIOEV | European Union | 1442345 |
| Specialty Ingredients (LSI) | H2OBIOEV | Japan | 1442345 |
| Specialty Ingredients (LSI) | H2OBIOEV | Madrid Protocol | 1442345 |
| Specialty Ingredients (LSI) | H2OBIOEV | Switzerland | 1442345 |
| Specialty Ingredients (LSI) | H2OBIOEV | United States | 5892956 |
| Specialty Ingredients (LSI) | HALEX | New Zealand | 803224 |
| Specialty Ingredients (LSI) | HEADMASTER | New Zealand | 974066 |
| Specialty Ingredients (LSI) | HEADSTART | New Zealand | 815331 |
| Specialty Ingredients (LSI) | HICKSON | United Kingdom | 1171502 |
| Specialty Ingredients (LSI) | HICKSON | United Kingdom | 1171501 |
| Specialty Ingredients (LSI) | HICKSON | United Kingdom | 1171500 |
| Specialty Ingredients (LSI) | HICKSON DECOR | European Union | 8612641 |
| Specialty Ingredients (LSI) | HICKSON DECOR | Turkey | 2016/76601 |
| Specialty Ingredients (LSI) | HICKSON DECOR | Turkey | 200939950 |
| Specialty Ingredients (LSI) | HICKSON DECOR | Ukraine | 242374 |
| Specialty Ingredients (LSI) | HICKSON TIMBERCARE & Design | New Zealand | 184863 |
| Specialty Ingredients (LSI) | HORGEN | Colombia | 645726 |
| Specialty Ingredients (LSI) | HORGEN | Mexico | 2058008 |
| Specialty Ingredients (LSI) | HUSTLER | New Zealand | 1016967 |
| Specialty Ingredients (LSI) | HYAMINE | Australia | 114773 |
| Specialty Ingredients (LSI) | HYAMINE | Australia | 215362 |
| Specialty Ingredients (LSI) | HYAMINE | Brazil | 002475464 |
| Specialty Ingredients (LSI) | HYAMINE | Brazil | 2470012 |
| Specialty Ingredients (LSI) | HYAMINE | Canada | UCA22890 |
| Specialty Ingredients (LSI) | HYAMINE | Chile | 763411 |
| Specialty Ingredients (LSI) | HYAMINE | China | 10021721 |
| Specialty Ingredients (LSI) | HYAMINE | Denmark | VR 1951 00806 |
| Specialty Ingredients (LSI) | HYAMINE | Finland | 24980 |
| Specialty Ingredients (LSI) | HYAMINE | France | 1510660 |
| Specialty Ingredients (LSI) | HYAMINE | India | 41139 |
| Specialty Ingredients (LSI) | HYAMINE | Israel | 27081 |
| Specialty Ingredients (LSI) | HYAMINE | Italy | 1332584 |
| Specialty Ingredients (LSI) | HYAMINE | Japan | 440660 |
| Specialty Ingredients (LSI) | HYAMINE | Madrid Protocol | 1216644 |
| Specialty Ingredients (LSI) | HYAMINE | Mexico | 372072 |
| Specialty Ingredients (LSI) | HYAMINE | New Zealand | 53669 |
| Specialty Ingredients (LSI) | HYAMINE | Paraguay | 287017 |
| Specialty Ingredients (LSI) | HYAMINE | Philippines | 4-2014-00009432 |
| Specialty Ingredients (LSI) | HYAMINE | Portugal | 128139 |
| Specialty Ingredients (LSI) | HYAMINE | South Africa | 632127 |
| Specialty Ingredients (LSI) | HYAMINE | Spain | 312806 |
| Specialty Ingredients (LSI) | HYAMINE | Spain | 314861 |
| Specialty Ingredients (LSI) | HYAMINE | Switzerland | 377445 |
| Specialty Ingredients (LSI) | HYAMINE | Taiwan, Province of China | 9289 |
| Specialty Ingredients (LSI) | HYAMINE | Thailand | 171109866 |
| Specialty Ingredients (LSI) | HYAMINE | Thailand | 142950 |
| Specialty Ingredients (LSI) | HYAMINE | United States | 324202 |
| Specialty Ingredients (LSI) | HYAMINE | Uruguay | 473126 |
| Specialty Ingredients (LSI) | HYAMINE | Viet Nam | 1216644 |
| Specialty Ingredients (LSI) | HYA-MINE | United Kingdom | 834138 |
| Specialty Ingredients (LSI) | HYAMINE (Katakana Characters) | Japan | 519985 |
| Specialty Ingredients (LSI) | HYDROMIDE | European Union | 005777421 |
| Specialty Ingredients (LSI) | HYDROMIDE | United States | 3306395 |
| Specialty Ingredients (LSI) | HYGLO & Design | New Zealand | 795038 |
| Specialty Ingredients (LSI) | ICARUS | New Zealand | 1021178 |
| Specialty Ingredients (LSI) | IDILI-CLENZ | Argentina | 2873556 |
| Specialty Ingredients (LSI) | IDILI-CLENZ | Brazil | 909889082 |
| Specialty Ingredients (LSI) | IDILI-CLENZ | Colombia | 547649 |
| Specialty Ingredients (LSI) | IDILI-GUAR+ | Argentina | 2812478 |
| Specialty Ingredients (LSI) | IDILI-GUAR+ | Brazil | 909889023 |
| Specialty Ingredients (LSI) | IDILI-GUAR+ | Colombia | 547647 |
| Specialty Ingredients (LSI) | IDILI-THIX | Argentina | 2812477 |
| Specialty Ingredients (LSI) | IDILI-THIX | Brazil | 2299542 |
| Specialty Ingredients (LSI) | IDILI-THIX | Colombia | 29573 |
| Specialty Ingredients (LSI) | IGNITE | New Zealand | 728519 |
| Specialty Ingredients (LSI) | IMERSOL | European Union | 015981137 |
| Specialty Ingredients (LSI) | IMERSOL | Turkey | 2016/76614 |
| Specialty Ingredients (LSI) | IMERSOL | Turkey | 104603 |
| Specialty Ingredients (LSI) | IMERSOL | Ukraine | 243095 |
| Specialty Ingredients (LSI) | IMERSOL | United Kingdom | 1001161 |
| Specialty Ingredients (LSI) | IMMUTAN | Fiji | 17915 |
| Specialty Ingredients (LSI) | IMMUTAN | New Zealand | 72565 |
| Specialty Ingredients (LSI) | INFO-TREATER | European Union | 2174951 |
| Specialty Ingredients (LSI) | INFO-TREATER | Latvia | M50355 |
| Specialty Ingredients (LSI) | INFO-TREATER | Norway | 214566 |
| Specialty Ingredients (LSI) | INGREDIENTS AND IDEAS | Switzerland | 677071 |
| Specialty Ingredients (LSI) | INSPIRE THE FORMULATOR...EXCITE THE CONSUMER... | European Union | 013914941 |
| Specialty Ingredients (LSI) | INSPIRE THE FORMULATOR...EXCITE THE CONSUMER... | United States | 5024234 |
| Specialty Ingredients (LSI) | INSTRUGARD | China | 35459206 |
| Specialty Ingredients (LSI) | INSTRUGARD | China | 34710039 |
| Specialty Ingredients (LSI) | INVISIBLE WARRIOR | China | 33266722 |
| Specialty Ingredients (LSI) | INVISIBLE WARRIOR | European Union | 017950040 |
| Specialty Ingredients (LSI) | ISOCIL | Australia | 1316536 |
| Specialty Ingredients (LSI) | ISOCIL | Brazil | 819904937 |
| Specialty Ingredients (LSI) | ISOCIL | China | 10021759 |
| Specialty Ingredients (LSI) | ISOCIL | European Union | 015115181 |
| Specialty Ingredients (LSI) | ISOCIL | India | 1626598 |
| Specialty Ingredients (LSI) | ISOCIL | Madrid Protocol | 1316536 |
| Specialty Ingredients (LSI) | ISOCIL | Madrid Protocol | 015115181 |
| Specialty Ingredients (LSI) | ISOCIL | Mexico | 1316536 |
| Specialty Ingredients (LSI) | ISOCIL | Russian Federation | 1316536 |
| Specialty Ingredients (LSI) | ISOCIL | South Africa | 2016/20471 |
| Specialty Ingredients (LSI) | ISOCIL | South Africa | 2016/20470 |
| Specialty Ingredients (LSI) | ISOCIL | Turkey | 2016/78093 |
| Specialty Ingredients (LSI) | ISOCIL | United States | 2355597 |
| Specialty Ingredients (LSI) | ISOCIL | United States | 2674161 |
| Specialty Ingredients (LSI) | JAQ | European Union | 018022941 |
| Specialty Ingredients (LSI) | JAQ | United States | 5834810 |
| Specialty Ingredients (LSI) | JAZZ | New Zealand | 627863 |
| Specialty Ingredients (LSI) | JAZZ | New Zealand | 627839 |
| Specialty Ingredients (LSI) | JUMBOTANISHIKUN | Japan | 5716828 |
| Specialty Ingredients (LSI) | JUMBOTANISHIKUN (Hiragana Characters) | Japan | 5716829 |
| Specialty Ingredients (LSI) | KALAS | New Zealand | 254715 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY | Madrid Protocol | 1525548 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY | Madrid Protocol | 1508519 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY | United States | 5833387 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY | United States | 4675683 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | Australia | 1244882 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | Canada | 1033916 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | European Union | 1347941 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | European Union | 1244882 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | India | 1244882 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | Madrid Protocol | 1244882 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | Madrid Protocol | 1347941 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | New Zealand | 1347941 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | Russian Federation | 1244882 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | Switzerland | 1347941 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | Ukraine | 1244882 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | United Kingdom | 1244882 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design | United States | 4675686 |
| Specialty Ingredients (LSI) | KEEPING OUR WORLD HEALTHY & Design (Blue Butterfly) | United States | 6014192 |
| Specialty Ingredients (LSI) | KEYWOOD | European Union | 8811499 |
| Specialty Ingredients (LSI) | KIWIDECK (Series) | New Zealand | 701582 |
| Specialty Ingredients (LSI) | KLEENSAN | New Zealand | 264455 |
| Specialty Ingredients (LSI) | KNOW YOUR WOOD | Canada | TMA969434 |
| Specialty Ingredients (LSI) | KNOW YOUR WOOD | United States | 4736723 |
| Specialty Ingredients (LSI) | KOTEK | Australia | 719683 |
| Specialty Ingredients (LSI) | KOTEK | New Zealand | 632963 |
| Specialty Ingredients (LSI) | KYTOGEN | New Zealand | 796144 |
| Specialty Ingredients (LSI) | LACTOPRO | European Union | 017970166 |
| Specialty Ingredients (LSI) | LACTOPRO | United States | 5727913 |
| Specialty Ingredients (LSI) | LARACARE | Belarus | 1286857 |
| Specialty Ingredients (LSI) | LARACARE | European Union | 011647799 |
| Specialty Ingredients (LSI) | LARACARE | France | 96628346 |
| Specialty Ingredients (LSI) | LARACARE | Germany | 39625760 |
| Specialty Ingredients (LSI) | LARACARE | India | 1163664 |
| Specialty Ingredients (LSI) | LARACARE | India | 2338910 |
| Specialty Ingredients (LSI) | LARACARE | Italy | VI96C000160 |
| Specialty Ingredients (LSI) | LARACARE | Kazakhstan | 1286857 |
| Specialty Ingredients (LSI) | LARACARE | Madrid Protocol | 1286857 |
| Specialty Ingredients (LSI) | LARACARE | Nigeria | F/TM/O/2018/126222 |
| Specialty Ingredients (LSI) | LARACARE | Russian Federation | 1286857 |
| Specialty Ingredients (LSI) | LARACARE | Ukraine | 1286857 |
| Specialty Ingredients (LSI) | LARACARE | United States | 2154125 |
| Specialty Ingredients (LSI) | LARAQUAT | European Union | 1199111 |
| Specialty Ingredients (LSI) | LARAQUAT | Madrid Protocol | 1199111 |
| Specialty Ingredients (LSI) | LARAQUAT | United States | 4809401 |
| Specialty Ingredients (LSI) | LAZER | New Zealand | 152563 |
| Specialty Ingredients (LSI) | LIBA | Australia | 729642 |
| Specialty Ingredients (LSI) | LIBA | New Zealand | 153307 |
| Specialty Ingredients (LSI) | LONZA TREAT RIGHT | European Union | 017506189 |
| Specialty Ingredients (LSI) | LONZA WOOD PROTECTION | South Carolina | 202506 |
| Specialty Ingredients (LSI) | LONZABAC | Austria | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Benelux | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Canada | TMA590924 |
| Specialty Ingredients (LSI) | LONZABAC | China | 24620485 |
| Specialty Ingredients (LSI) | LONZABAC | Denmark | 1989 03138 |
| Specialty Ingredients (LSI) | LONZABAC | European Union | 0511246 |
| Specialty Ingredients (LSI) | LONZABAC | Finland | 105209 |
| Specialty Ingredients (LSI) | LONZABAC | France | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Germany | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Italy | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Madrid Protocol | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Mexico | 760995 |
| Specialty Ingredients (LSI) | LONZABAC | Mexico | 802330 |
| Specialty Ingredients (LSI) | LONZABAC | Portugal | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Spain | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | Sweden | 211882 |
| Specialty Ingredients (LSI) | LONZABAC | Switzerland | 352263 |
| Specialty Ingredients (LSI) | LONZABAC | Turkey | 201446612 |
| Specialty Ingredients (LSI) | LONZABAC | Ukraine | 511246 |
| Specialty Ingredients (LSI) | LONZABAC | United States | 3559042 |
| Specialty Ingredients (LSI) | LONZABAC | United States | 2803019 |
| Specialty Ingredients (LSI) | LONZACURE | Austria | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Benelux | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Bosnia & Herzegovina | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Brazil | 910355339 |
| Specialty Ingredients (LSI) | LONZACURE | Canada | TMA361907 |
| Specialty Ingredients (LSI) | LONZACURE | China | 18509668 |
| Specialty Ingredients (LSI) | LONZACURE | Croatia | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Czechia | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Denmark | 15481988 |
| Specialty Ingredients (LSI) | LONZACURE | France | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Germany | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Hungary | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Indonesia | IDM000603369 |
| Specialty Ingredients (LSI) | LONZACURE | Ireland | 121557 |
| Specialty Ingredients (LSI) | LONZACURE | Italy | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Japan | 2322414 |
| Specialty Ingredients (LSI) | LONZACURE | Madrid Protocol | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Portugal | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Serbia | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Slovakia | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Slovenia | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Spain | 509904 |
| Specialty Ingredients (LSI) | LONZACURE | Switzerland | 351175 |
| Specialty Ingredients (LSI) | LONZACURE | Taiwan, Province of China | 1781991 |
| Specialty Ingredients (LSI) | LONZACURE | United Kingdom | 1295236 |
| Specialty Ingredients (LSI) | LONZACURE | United States | 1527614 |
| Specialty Ingredients (LSI) | LONZADUR | Australia | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | China | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | European Union | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | India | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | Japan | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | Madrid Protocol | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | New Zealand | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | Russian Federation | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | Singapore | 1450648 |
| Specialty Ingredients (LSI) | LONZADUR | Switzerland | 732773 |
| Specialty Ingredients (LSI) | LONZADUR | United States | 5847842 |
| Specialty Ingredients (LSI) | LONZAGARD | Argentina | 2082630 |
| Specialty Ingredients (LSI) | LONZAGARD | Australia | 1035324 |
| Specialty Ingredients (LSI) | LONZAGARD | Austria | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Benelux | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Brazil | 827033109 |
| Specialty Ingredients (LSI) | LONZAGARD | Canada | TMA663584 |
| Specialty Ingredients (LSI) | LONZAGARD | Chile | 720333 |
| Specialty Ingredients (LSI) | LONZAGARD | China | 35459318 |
| Specialty Ingredients (LSI) | LONZAGARD | China | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | China | 7696177 |
| Specialty Ingredients (LSI) | LONZAGARD | China | 7696147 |
| Specialty Ingredients (LSI) | LONZAGARD | Colombia | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Denmark | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | European Union | 013979943 |
| Specialty Ingredients (LSI) | LONZAGARD | Finland | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | France | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Germany | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Greece | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Hong Kong | 300291988 |
| Specialty Ingredients (LSI) | LONZAGARD | India | 1312196 |
| Specialty Ingredients (LSI) | LONZAGARD | Ireland | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Italy | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Japan | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Madrid Protocol | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Mexico | 870830 |
| Specialty Ingredients (LSI) | LONZAGARD | Portugal | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | South Africa | 200416834 |
| Specialty Ingredients (LSI) | LONZAGARD | Spain | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Sweden | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | Switzerland | 525151 |
| Specialty Ingredients (LSI) | LONZAGARD | Taiwan, Province of China | 1150187 |
| Specialty Ingredients (LSI) | LONZAGARD | United Kingdom | 837448 |
| Specialty Ingredients (LSI) | LONZAGARD | United States | 4836776 |
| Specialty Ingredients (LSI) | LONZAGARD | Venezuela, Bolivarian Republic of | 265033 |
| Specialty Ingredients (LSI) | LONZAGARD (Chinese Characters) | China | 35459205A |
| Specialty Ingredients (LSI) | LONZAGARD (Chinese Characters) | China | 7696180 |
| Specialty Ingredients (LSI) | LONZAGARD (Chinese Characters) | China | 7696123 |
| Specialty Ingredients (LSI) | LONZAINE | Argentina | 2148097 |
| Specialty Ingredients (LSI) | LONZAINE | Brazil | 818402610 |
| Specialty Ingredients (LSI) | LONZAINE | Canada | TMA389641 |
| Specialty Ingredients (LSI) | LONZAINE | Israel | 97545 |
| Specialty Ingredients (LSI) | LONZAINE | Switzerland | 271968 |
| Specialty Ingredients (LSI) | LONZAINE | Taiwan, Province of China | 755022 |
| Specialty Ingredients (LSI) | LONZAINE | United Kingdom | 1403053 |
| Specialty Ingredients (LSI) | LONZAINE | United States | 1031102 |
| Specialty Ingredients (LSI) | LONZAMON | Australia | 523103 |
| Specialty Ingredients (LSI) | LONZAMON | Austria | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Belarus | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Benelux | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Bosnia & Herzegovina | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Canada | TMA412224 |
| Specialty Ingredients (LSI) | LONZAMON | Croatia | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Czechia | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Denmark | VR199107255 |
| Specialty Ingredients (LSI) | LONZAMON | Estonia | 9170 |
| Specialty Ingredients (LSI) | LONZAMON | France | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Georgia | 43 |
| Specialty Ingredients (LSI) | LONZAMON | Germany | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Hungary | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Italy | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Japan | 2421272 |
| Specialty Ingredients (LSI) | LONZAMON | Kazakhstan | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Latvia | 16747 |
| Specialty Ingredients (LSI) | LONZAMON | Lithuania | 7823 |
| Specialty Ingredients (LSI) | LONZAMON | Madrid Protocol | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Mexico | 377167 |
| Specialty Ingredients (LSI) | LONZAMON | Norway | 144568 |
| Specialty Ingredients (LSI) | LONZAMON | Portugal | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Russian Federation | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Serbia | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Slovakia | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Slovenia | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | South Africa | 8910741 |
| Specialty Ingredients (LSI) | LONZAMON | Spain | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | Sweden | 226654 |
| Specialty Ingredients (LSI) | LONZAMON | Sweden | 226654 |
| Specialty Ingredients (LSI) | LONZAMON | Switzerland | 374003 |
| Specialty Ingredients (LSI) | LONZAMON | Ukraine | 546378 |
| Specialty Ingredients (LSI) | LONZAMON | United Kingdom | 1404255 |
| Specialty Ingredients (LSI) | LONZAMON | United States | 1627873 |
| Specialty Ingredients (LSI) | LONZAMON | Uzbekistan | 546378 |
| Specialty Ingredients (LSI) | LONZAPOL | Austria | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Austria | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Benelux | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Benelux | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | France | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | France | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Germany | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Germany | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Italy | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Italy | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Madrid Protocol | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Portugal | 203483 |
| Specialty Ingredients (LSI) | LONZAPOL | Spain | 203483 |
| Specialty Ingredients (LSI) | LONZASERVE | Brazil | 823522113 |
| Specialty Ingredients (LSI) | LONZASERVE | Brazil | 823522105 |
| Specialty Ingredients (LSI) | LONZASERVE | Canada | TMA773811 |
| Specialty Ingredients (LSI) | LONZASERVE | China | 13,466,977 |
| Specialty Ingredients (LSI) | LONZASERVE | China | 12,030,688 |
| Specialty Ingredients (LSI) | LONZASERVE | China | 12,030,687 |
| Specialty Ingredients (LSI) | LONZASERVE | European Union | 002046928 |
| Specialty Ingredients (LSI) | LONZASERVE | Mexico | 845902 |
| Specialty Ingredients (LSI) | LONZASERVE | Mexico | 845901 |
| Specialty Ingredients (LSI) | LONZASERVE | Turkey | 2016/78089 |
| Specialty Ingredients (LSI) | LONZASERVE | United States | 4854495 |
| Specialty Ingredients (LSI) | LONZEST | Australia | 1209267 |
| Specialty Ingredients (LSI) | LONZEST | Brazil | 918767539 |
| Specialty Ingredients (LSI) | LONZEST | Canada | TMA383627 |
| Specialty Ingredients (LSI) | LONZEST | China | 10021743 |
| Specialty Ingredients (LSI) | LONZEST | European Union | 1209267 |
| Specialty Ingredients (LSI) | LONZEST | India | 1162724 |
| Specialty Ingredients (LSI) | LONZEST | India | 2238946 |
| Specialty Ingredients (LSI) | LONZEST | Japan | 2439379 |
| Specialty Ingredients (LSI) | LONZEST | Madrid Protocol | 1209267 |
| Specialty Ingredients (LSI) | LONZEST | Malaysia | 2014066943 |
| Specialty Ingredients (LSI) | LONZEST | New Zealand | 1209267 |
| Specialty Ingredients (LSI) | LONZEST | Russian Federation | 1209267 |
| Specialty Ingredients (LSI) | LONZEST | Switzerland | 378810 |
| Specialty Ingredients (LSI) | LONZEST | Turkey | 1209267 |
| Specialty Ingredients (LSI) | LONZEST | United Kingdom | 1449700 |
| Specialty Ingredients (LSI) | LONZEST | United Kingdom | 1403061 |
| Specialty Ingredients (LSI) | LONZEST | United States | 1482091 |
| Specialty Ingredients (LSI) | LUGANO | Colombia | 639751 |
| Specialty Ingredients (LSI) | LUGANO | Mexico | 2058010 |
| Specialty Ingredients (LSI) | LUMBRELLA | United States | 3974505 |
| Specialty Ingredients (LSI) | LUXVEIL | Brazil | 830335692 |
| Specialty Ingredients (LSI) | LUXVEIL | Canada | 791763 |
| Specialty Ingredients (LSI) | LUXVEIL | China | 1010534 |
| Specialty Ingredients (LSI) | LUXVEIL | European Union | 008441735 |
| Specialty Ingredients (LSI) | LUXVEIL | Japan | 2009357030 |
| Specialty Ingredients (LSI) | LUXVEIL | Korea, Republic of | 1010534 |
| Specialty Ingredients (LSI) | LUXVEIL | Madrid Protocol | 1010534 |
| Specialty Ingredients (LSI) | MAX CL | New Zealand | 707195 |
| Specialty Ingredients (LSI) | MAX MZ | New Zealand | 607120 |
| Specialty Ingredients (LSI) | META | Algeria | 213234 |
| Specialty Ingredients (LSI) | META | Argentina | 1877042 |
| Specialty Ingredients (LSI) | META | Armenia | 213234 |
| Specialty Ingredients (LSI) | META | Australia | 717609 |
| Specialty Ingredients (LSI) | META | Australia | 73344 |
| Specialty Ingredients (LSI) | META | Austria | 213234 |
| Specialty Ingredients (LSI) | META | Belarus | 213234 |
| Specialty Ingredients (LSI) | META | Benelux | 213234 |
| Specialty Ingredients (LSI) | META | Bosnia & Herzegovina | 213234 |
| Specialty Ingredients (LSI) | META | Brazil | 910276455 |
| Specialty Ingredients (LSI) | META | Bulgaria | 213234 |
| Specialty Ingredients (LSI) | META | Canada | TMA394181 |
| Specialty Ingredients (LSI) | META | Chile | 740460 |
| Specialty Ingredients (LSI) | META | China | 768201 |
| Specialty Ingredients (LSI) | META | Costa Rica | 158602 |
| Specialty Ingredients (LSI) | META | Croatia | 213234 |
| Specialty Ingredients (LSI) | META | Cyprus | 213234 |
| Specialty Ingredients (LSI) | META | Czechia | 213234 |
| Specialty Ingredients (LSI) | META | Denmark | 196300330 |
| Specialty Ingredients (LSI) | META | Egypt | 213234 |
| Specialty Ingredients (LSI) | META | Estonia | 22506 |
| Specialty Ingredients (LSI) | META | Finland | 213794 |
| Specialty Ingredients (LSI) | META | France | 213234 |
| Specialty Ingredients (LSI) | META | Germany | 213234 |
| Specialty Ingredients (LSI) | META | Greece | 136367 |
| Specialty Ingredients (LSI) | META | Hong Kong | 300488962 |
| Specialty Ingredients (LSI) | META | Hungary | 213234 |
| Specialty Ingredients (LSI) | META | India | 1383217 |
| Specialty Ingredients (LSI) | META | Iran, Islamic Republic of | 213234 |
| Specialty Ingredients (LSI) | META | Israel | 21877 |
| Specialty Ingredients (LSI) | META | Italy | 213234 |
| Specialty Ingredients (LSI) | META | Japan | 213234 |
| Specialty Ingredients (LSI) | META | Japan | 4124288 |
| Specialty Ingredients (LSI) | META | Kazakhstan | 213234 |
| Specialty Ingredients (LSI) | META | Kenya | 213234 |
| Specialty Ingredients (LSI) | META | Korea, Republic of | 213234 |
| Specialty Ingredients (LSI) | META | Lao People's Democratic Republic | 13191 |
| Specialty Ingredients (LSI) | META | Lao People's Democratic Republic | 13192 |
| Specialty Ingredients (LSI) | META | Latvia | 213234 |
| Specialty Ingredients (LSI) | META | Libya | 9974 |
| Specialty Ingredients (LSI) | META | Libya | 9973 |
| Specialty Ingredients (LSI) | META | Liechtenstein | 213234 |
| Specialty Ingredients (LSI) | META | Lithuania | 213234 |
| Specialty Ingredients (LSI) | META | Madagascar | 007307291MV |
| Specialty Ingredients (LSI) | META | Madrid Protocol | 213234 |
| Specialty Ingredients (LSI) | META | Malaysia | M041646 |
| Specialty Ingredients (LSI) | META | Mexico | 917333 |
| Specialty Ingredients (LSI) | META | Moldova, Republic of | 213234 |
| Specialty Ingredients (LSI) | META | Monaco | 213234 |
| Specialty Ingredients (LSI) | META | Morocco | 213234 |
| Specialty Ingredients (LSI) | META | Mozambique | 213234 |
| Specialty Ingredients (LSI) | META | New Zealand | 67407 |
| Specialty Ingredients (LSI) | META | Norway | 213234 |
| Specialty Ingredients (LSI) | META | Panama | 14722101 |
| Specialty Ingredients (LSI) | META | Panama | 14722001 |
| Specialty Ingredients (LSI) | META | Paraguay | 294682 |
| Specialty Ingredients (LSI) | META | Paraguay | 445862 |
| Specialty Ingredients (LSI) | META | Poland | 213234 |
| Specialty Ingredients (LSI) | META | Portugal | 213234 |
| Specialty Ingredients (LSI) | META | Romania | 213234 |
| Specialty Ingredients (LSI) | META | Russian Federation | 213234 |
| Specialty Ingredients (LSI) | META | San Marino | 213234 |
| Specialty Ingredients (LSI) | META | Saudi Arabia | 142607003 |
| Specialty Ingredients (LSI) | META | Saudi Arabia | 142607004 |
| Specialty Ingredients (LSI) | META | Saudi Arabia | 86837 |
| Specialty Ingredients (LSI) | META | Saudi Arabia | 86127 |
| Specialty Ingredients (LSI) | META | Serbia | 213234 |
| Specialty Ingredients (LSI) | META | Singapore | T3902712E |
| Specialty Ingredients (LSI) | META | Slovakia | 213234 |
| Specialty Ingredients (LSI) | META | Slovenia | 213234 |
| Specialty Ingredients (LSI) | META | South Africa | 13447 |
| Specialty Ingredients (LSI) | META | Spain | 213234 |
| Specialty Ingredients (LSI) | META | Sri Lanka | 127188 |
| Specialty Ingredients (LSI) | META | Sweden | 26919 |
| Specialty Ingredients (LSI) | META | Switzerland | 295654 |
| Specialty Ingredients (LSI) | META | Taiwan, Province of China | 898333 |
| Specialty Ingredients (LSI) | META | Thailand | 242229 |
| Specialty Ingredients (LSI) | META | Thailand | 241579 |
| Specialty Ingredients (LSI) | META | Tunisia | EE052147 |
| Specialty Ingredients (LSI) | META | Turkey | 213234 |
| Specialty Ingredients (LSI) | META | Ukraine | 213234 |
| Specialty Ingredients (LSI) | META | United Kingdom | 213234 |
| Specialty Ingredients (LSI) | META | United Kingdom | 409799 |
| Specialty Ingredients (LSI) | META | United States | 0373813 |
| Specialty Ingredients (LSI) | META | Venezuela, Bolivarian Republic of | 209814 |
| Specialty Ingredients (LSI) | META | Viet Nam | 213234 |
| Specialty Ingredients (LSI) | META | Zimbabwe | 9362005 |
| Specialty Ingredients (LSI) | META | Zimbabwe | 9352005 |
| Specialty Ingredients (LSI) | META & Design | Bulgaria | 8445 |
| Specialty Ingredients (LSI) | META & Design | Canada | TMA204832 |
| Specialty Ingredients (LSI) | META & Design | Greece | 48390 |
| Specialty Ingredients (LSI) | META & Design | Poland | 51154 |
| Specialty Ingredients (LSI) | META & Design | Turkey | 134064 |
| Specialty Ingredients (LSI) | META (Chinese Characters) | China | 854080 |
| Specialty Ingredients (LSI) | META (Chinese Characters) | China | 3326105 |
| Specialty Ingredients (LSI) | META (Chinese Characters) | Hong Kong | 200306102AA |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Albania | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Algeria | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Antigua & Barbuda | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Argentina | 2559465 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Argentina | 2559464 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Armenia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Australia | 875433 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Austria | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Azerbaijan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Belarus | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Bhutan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Bosnia & Herzegovina | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Brazil | 823922294 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Bulgaria | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Canada | TMA589974 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | China | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Croatia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Cuba | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Czechia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Denmark | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Egypt | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Estonia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Eswatini | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Finland | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | France | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Georgia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Germany | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Hungary | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Iceland | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Italy | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Japan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Kazakhstan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Kenya | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Kyrgyzstan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Latvia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Lesotho | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Liberia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Liechtenstein | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Lithuania | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Macedonia, The Former Yugoslav Republic of | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Madrid Protocol | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Malaysia | 1006042 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Malaysia | 1006041 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Moldova, Republic of | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Monaco | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Mongolia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Morocco | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Mozambique | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | New Zealand | 637480 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | New Zealand | 637479 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Norway | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Poland | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Portugal | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Romania | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Russian Federation | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Serbia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Sierra Leone | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Singapore | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Slovakia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Slovenia | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Spain | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Sudan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Sweden | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Switzerland | 479818 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Taiwan, Province of China | 1008801 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Taiwan, Province of China | 987233 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Taiwan, Province of China | 1010377 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Tajikistan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Thailand | 166087 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Thailand | 166408 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Turkey | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Turkmenistan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Ukraine | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | United Kingdom | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | United States | 2726457 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Uzbekistan | 754998 |
| Specialty Ingredients (LSI) | META THE MOLLUSCICIDE & Design | Viet Nam | 754998 |
| Specialty Ingredients (LSI) | METABIOTIC | China | 6515353 |
| Specialty Ingredients (LSI) | METABIOTICS | Canada | 786585 |
| Specialty Ingredients (LSI) | METABIOTICS | China | 6563678 |
| Specialty Ingredients (LSI) | METABIOTICS | European Union | 006655518 |
| Specialty Ingredients (LSI) | METABIOTICS | European Union | 006565618 |
| Specialty Ingredients (LSI) | METABIOTICS | Japan | 5308375 |
| Specialty Ingredients (LSI) | METABIOTICS | Korea, Republic of | 786991 |
| Specialty Ingredients (LSI) | METABIOTICS | South Africa | 200800690 |
| Specialty Ingredients (LSI) | METABIOTICS | United States | 3693303 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | China | 4990688 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | China | 4990689 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | China | 4990686 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | China | 4990687 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Hong Kong | 300523683 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Hong Kong | 300523674 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | India | 1404676 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | India | 1404675 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Indonesia | IDM000142320 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Indonesia | IDM000142317 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Indonesia | IDM000142318 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Indonesia | IDM000142319 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Japan | 4965827 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Japan | 4967779 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Korea, Republic of | 40701419 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Korea, Republic of | 40701418 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Singapore | T0522089E |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Singapore | T05220901 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Singapore | T0522092E |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Singapore | T0522091G |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Taiwan, Province of China | 1210777 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Taiwan, Province of China | 1210776 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Thailand | 244086 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Thailand | 264706 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Thailand | 244806 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Thailand | 264705 |
| Specialty Ingredients (LSI) | METALI (Chinese Characters) | Thailand | 244085 |
| Specialty Ingredients (LSI) | METRO | New Zealand | 707196 |
| Specialty Ingredients (LSI) | MIKROKILL | Australia | 1081359 |
| Specialty Ingredients (LSI) | MIKROKILL | China | 863158 |
| Specialty Ingredients (LSI) | MIKROKILL | European Union | 003886058 |
| Specialty Ingredients (LSI) | MIKROKILL | India | 1353619 |
| Specialty Ingredients (LSI) | MIKROKILL | Japan | 863158 |
| Specialty Ingredients (LSI) | MIKROKILL | Madrid Protocol | 863158 |
| Specialty Ingredients (LSI) | MIKROKILL | Singapore | TO512255I |
| Specialty Ingredients (LSI) | MIKROKILL | Thailand | 240494 |
| Specialty Ingredients (LSI) | MIKROKILL | United States | 3049011 |
| Specialty Ingredients (LSI) | MILLENNIUM | New Zealand | 1101018 |
| Specialty Ingredients (LSI) | MILTEK | New Zealand | 262089 |
| Specialty Ingredients (LSI) | MISCELLANEOUS (Design) (Chinese Characters) | China | 7002993 |
| Specialty Ingredients (LSI) | MISCELLANEOUS (Design) (Chinese Characters) | China | 7002992 |
| Specialty Ingredients (LSI) | MISCELLANEOUS (Design) (Chinese Characters) | China | 7002991 |
| Specialty Ingredients (LSI) | MISCELLANEOUS (Design) (Chinese Characters) | China | 7002990 |
| Specialty Ingredients (LSI) | MISCELLANEOUS (Design) (Chinese Characters) | China | 7002998 |
| Specialty Ingredients (LSI) | MODIFECT | Australia | 1405115 |
| Specialty Ingredients (LSI) | MODIFECT | Brazil | 914346938 |
| Specialty Ingredients (LSI) | MODIFECT | Canada | 1070075 |
| Specialty Ingredients (LSI) | MODIFECT | China | 1405115 |
| Specialty Ingredients (LSI) | MODIFECT | European Union | 1405115 |
| Specialty Ingredients (LSI) | MODIFECT | Japan | 1405115 |
| Specialty Ingredients (LSI) | MODIFECT | Madrid Protocol | 1405115 |
| Specialty Ingredients (LSI) | MODIFECT | Switzerland | 721062 |
| Specialty Ingredients (LSI) | MOLD PATROL | Canada | 630400 |
| Specialty Ingredients (LSI) | MOLD PATROL | United States | 2862636 |
| Specialty Ingredients (LSI) | MONDO | New Zealand | 1021177 |
| Specialty Ingredients (LSI) | MORTAR | Australia | 1122945 |
| Specialty Ingredients (LSI) | MORTAR | New Zealand | 744645 |
| Specialty Ingredients (LSI) | MOSSOFF | New Zealand | 265560 |
| Specialty Ingredients (LSI) | MPT | Australia | 1584253 |
| Specialty Ingredients (LSI) | MPT | New Zealand | 985725 |
| Specialty Ingredients (LSI) | MULTI-FILM | New Zealand | 80818 |
| Specialty Ingredients (LSI) | MULTIFRUIT | China | 15615515 |
| Specialty Ingredients (LSI) | MULTIFRUIT | United States | 1877348 |
| Specialty Ingredients (LSI) | MULTIFRUIT BSC | European Union | 13805701 |
| Specialty Ingredients (LSI) | MYCOSTAT | Canada | 579741 |
| Specialty Ingredients (LSI) | MYCOSTAT | Chile | 719292 |
| Specialty Ingredients (LSI) | MYCOSTAT | European Union | 3740412 |
| Specialty Ingredients (LSI) | MYCOSTAT | United States | 2810555 |
| Specialty Ingredients (LSI) | NAB | European Union | 014573737 |
| Specialty Ingredients (LSI) | NAB | United States | 2666602 |
| Specialty Ingredients (LSI) | NAMENAITO (Katakana Characters) | Japan | 5683766 |
| Specialty Ingredients (LSI) | NATRULON | Argentina | 2026035 |
| Specialty Ingredients (LSI) | NATRULON | Brazil | 825982618 |
| Specialty Ingredients (LSI) | NATRULON | Brazil | 825982600 |
| Specialty Ingredients (LSI) | NATRULON | Canada | TMA623521 |
| Specialty Ingredients (LSI) | NATRULON | Canada | TMA623897 |
| Specialty Ingredients (LSI) | NATRULON | China | 10021754 |
| Specialty Ingredients (LSI) | NATRULON | European Union | 003376861 |
| Specialty Ingredients (LSI) | NATRULON | European Union | 003346459 |
| Specialty Ingredients (LSI) | NATRULON | India | 2238907 |
| Specialty Ingredients (LSI) | NATRULON | Japan | 4743323 |
| Specialty Ingredients (LSI) | NATRULON | Mexico | 814634 |
| Specialty Ingredients (LSI) | NATRULON | Mexico | 817944 |
| Specialty Ingredients (LSI) | NATRULON | Switzerland | 515431 |
| Specialty Ingredients (LSI) | NATRULON | Taiwan, Province of China | 1114632 |
| Specialty Ingredients (LSI) | NATRULON | Taiwan, Province of China | 1103627 |
| Specialty Ingredients (LSI) | NATRULON | United States | 2890390 |
| Specialty Ingredients (LSI) | NATURAL SELECT | Canada | TMA639593 |
| Specialty Ingredients (LSI) | NCX | Benelux | 323551 |
| Specialty Ingredients (LSI) | NCX | France | 1245950 |
| Specialty Ingredients (LSI) | NEEKO | New Zealand | 761059 |
| Specialty Ingredients (LSI) | NEPTUNE | New Zealand | 714461 |
| Specialty Ingredients (LSI) | NEXUS | New Zealand | 954052 |
| Specialty Ingredients (LSI) | NIACIN & Design | European Union | 1156355 |
| Specialty Ingredients (LSI) | NIACIN & Design | Madrid Protocol | 1156355 |
| Specialty Ingredients (LSI) | NIACIN & Design | Switzerland | 1156355 |
| Specialty Ingredients (LSI) | NIACIN & Design | United States | 4418663 |
| Specialty Ingredients (LSI) | NON-COM | Australia | 264395 |
| Specialty Ingredients (LSI) | NON-COM | Belarus | 1121379 |
| Specialty Ingredients (LSI) | NON-COM | Canada | TMA145024 |
| Specialty Ingredients (LSI) | NON-COM | Denmark | VR 1973 01669 |
| Specialty Ingredients (LSI) | NON-COM | Denmark | 1973 02663 |
| Specialty Ingredients (LSI) | NON-COM | European Union | 8612541 |
| Specialty Ingredients (LSI) | NON-COM | Ireland | 79774 |
| Specialty Ingredients (LSI) | NON-COM | Ireland | 79600 |
| Specialty Ingredients (LSI) | NON-COM | Madrid Protocol | 1121379 |
| Specialty Ingredients (LSI) | NON-COM | Russian Federation | 1121379 |
| Specialty Ingredients (LSI) | NON-COM | Singapore | T7358488J |
| Specialty Ingredients (LSI) | NON-COM | Ukraine | 1121379 |
| Specialty Ingredients (LSI) | NON-COM | United Kingdom | 987425 |
| Specialty Ingredients (LSI) | NORE BIO | Australia | 1490731 |
| Specialty Ingredients (LSI) | NORE BIO | China | 1490731 |
| Specialty Ingredients (LSI) | NORE BIO | European Union | 1490731 |
| Specialty Ingredients (LSI) | NORE BIO | Madrid Protocol | 1490731 |
| Specialty Ingredients (LSI) | NORE BIO | New Zealand | 1490731 |
| Specialty Ingredients (LSI) | NORE BIO | Switzerland | 1490731 |
| Specialty Ingredients (LSI) | NUCHEM | New Zealand | 254714 |
| Specialty Ingredients (LSI) | NUCHEM & Design | New Zealand | 667747 |
| Specialty Ingredients (LSI) | NUCHEM & Design | New Zealand | 667746 |
| Specialty Ingredients (LSI) | NUCHEM & Design | New Zealand | 667748 |
| Specialty Ingredients (LSI) | NUCHEM & Design | New Zealand | 663451 |
| Specialty Ingredients (LSI) | NUCHEM & Design | New Zealand | 663452 |
| Specialty Ingredients (LSI) | NUGEN | Brazil | 916598799 |
| Specialty Ingredients (LSI) | NUGEN | European Union | 1348929 |
| Specialty Ingredients (LSI) | NUGEN | Madrid Protocol | 1348929 |
| Specialty Ingredients (LSI) | NUGEN | New Zealand | 1348929 |
| Specialty Ingredients (LSI) | NUGEN | Russian Federation | 1348929 |
| Specialty Ingredients (LSI) | NUGEN | Switzerland | 1348929 |
| Specialty Ingredients (LSI) | NUGEN | United States | 5192971 |
| Specialty Ingredients (LSI) | NUGEN | United States | 5137901 |
| Specialty Ingredients (LSI) | OLEO | New Zealand | 787911 |
| Specialty Ingredients (LSI) | OLEO TECHNOLOGY | New Zealand | 843543 |
| Specialty Ingredients (LSI) | OMACIDE | Argentina | 2686745 |
| Specialty Ingredients (LSI) | OMACIDE | Australia | 264084 |
| Specialty Ingredients (LSI) | OMACIDE | Brazil | 825362253 |
| Specialty Ingredients (LSI) | OMACIDE | Chile | 692955 |
| Specialty Ingredients (LSI) | OMACIDE | China | 3527138 |
| Specialty Ingredients (LSI) | OMACIDE | European Union | 1203717 |
| Specialty Ingredients (LSI) | OMACIDE | Indonesia | IDM000006820 |
| Specialty Ingredients (LSI) | OMACIDE | Israel | 36640 |
| Specialty Ingredients (LSI) | OMACIDE | Japan | 1491639 |
| Specialty Ingredients (LSI) | OMACIDE | Korea, Republic of | 584624 |
| Specialty Ingredients (LSI) | OMACIDE | Madrid Protocol | 1203717 |
| Specialty Ingredients (LSI) | OMACIDE | Malaysia | 3003772 |
| Specialty Ingredients (LSI) | OMACIDE | New Zealand | 102604 |
| Specialty Ingredients (LSI) | OMACIDE | Singapore | T03045401 |
| Specialty Ingredients (LSI) |